19 - Treatment of stimulant dependence  pp. 369-380


By Mehmet Sofuoglu, Kostas Agath and Thomas R. Kosten

Image View Previous Chapter Next Chapter



Editor's note

Cocaine, amphetamine and methamphetamine are the stimulants considered in this chapter. Yet most of the treatments discussed primarily deal with issues related to cocaine. Despite a growing knowledge base as to the underlying action of stimulants, we have not found psychopharmacologic treatments that consistently can be counted upon to be effective in the treatment of the misuse of substances within this class. There are single randomized control trials that show effectiveness for fluoxetine, imipramine, disulfiram, some dopamine agents and adrenergic blocking agents, but there are few RCT replications of the effectiveness of these agents. The treatment of stimulant abuse remains primarily psychosocial, especially treatments that use a cognitive-behavioral approach, an approach whose effectiveness can be further enhanced with contingency management and the use of vouchers. There is some growing interest and studies of combined cognitive behavioral approaches with pharmacotherapy, but even here no single pharmacotherapeutic agent or class of agents stands out. The measures of effectiveness are usually (a) the presence of drug-free urines and (b) the continued involvement in the treatment program which is referred to as treatment retention.

Introduction

Cocaine and amphetamine addictions have become major public health concerns for over 20 years worldwide. The estimated annual prevalence of cocaine abusers in the population over 15 years of age is 0.3% globally, 0.4% in Europe and 1.7% in the Americas, while the relevant figures for amphetamine abusers are 0.6% globally, 0.7% in Europe and 0.7% in the Americas (United Nations Office for Drug Control and Crime Prevention, 2000).

Reference Title: REFERENCES

Reference Type: reference-list

American Psychiatric Association (1952). Diagnostic and Statistical Manual, Mental Disorders, 1st edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders, 2nd edn. Washington, DC: American Psychiatric Association.
American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Association.
Blashfield, R. K. & Fuller, A. K. (1996). Predicting the DSM-V. Journal of Nervous and Mental Disease, 184, 4–7.
Carroll, B. J., Feinberg, M., Greden, J. F. et al. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Archives of General Psychiatry, 38, 15–22.
Cicchetti, D. V. & Sparrow, S. S. (1981). Developing criteria for the rating of specific items in a given inventory. American Journal of Mental Deficiency, 86, 127–37.
Davenport, Y. B., Ebert, M. H., Adland, M. L. & Goodwin, F. K. (1977). Couples group therapy as an adjunct to lithium maintenance of the manic patient. American Journal of Orthopsychiatry, 47, 495–502.
Davidson, K. (2000). Cognitive Therapy for Personality Disorders: a Guide for Clinicians. London: Butterworth-Heinemann.
Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23, 455–68.
Frank, E., Swartz, H. A. & Kupfer, D. J. (2000). Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biological Psychiatry, 48, 593–604.
Frank, E., Prien, R. F., Jarrett, R. B. et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder – remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851–5.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Hoche, A. (1910). Die Melancholiefrage. Zeitschrift für die Gesellschaft für Nervenheilkunde und Psychiatrie, 21, 193–203.
Jacobson, E. (1971). Depression: Comparative Studies of Normal, Neurotic, and Psychotic Conditions. New York: International Universities Press.
Kendell, R. & Jablensky, A. (2003). Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry, 160, 4–12.
Kessing, L. V. (2004). Severity of depressive episodes according to ICD–10: prediction of risk of relapse and suicide. British Journal of Psychiatry, 184, 153–6.
Klein, D. F. & Fink, M. (1962). Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 119, 432–8.
Klein, D. F. (1964). Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia, 5, 397–408.
Kuhn, R. (1958). The treatment of depressive states with G22355 (imipramine hydrochloride). American Journal of Psychiatry, 115, 459–64.
Kupfer, D., First, M. B. & Regier, D. E. (2002). Introduction. In A Research Agenda for DSM-V, pp. xv–xxiii. Washington, DC: American Psychiatric Association.
Sachs, G. S., Thase, M. E., Otto, M. W. et al. (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry, 53, 1028–42.
Shorter, E. & Tyrer, P. (2003). The separation of anxiety and depressive disorders: blind alley in psychopharmacology and the classification of disease. British Medical Journal, 327, 158–60.
Tyrer, P. & Davidson, K. (2000). Cognitive therapy in personality disorders. In Review of Psychiatry: personality disorders, ed. G. O. Gabbard & J. Gunderson. Washington, DC: American Psychiatric Press.
Tyrer, P. & Steinberg, D. (2005). Models for Mental Disorder: Conceptual Models in Psychiatry, 4th edn. Chichester, UK: Wiley.
World Health Organization (1975). International Classification of Diseases, 9th Revision, Clinical Modification. Geneva: World Health Organization.
World Health Organization (1978). International Classification of Diseases, 9th Revision, Clinical Modification. Ann Arbor, MI: Commission on Professional and Hospital Activities.
Young, J. E., Klosko, J. S. & Weishaar, M. E. (2003). Schema Therapy: A Practitioner's Guide. New York: The Guilford Press.

Reference Title: REFERENCES

Reference Type: reference-list

Abély, P. (1939). Le traitement actuel de la démence précoce et d'autres psychoses par l'insuline et le cardiazol. Annales Médico-Psychologiques, 97, 555–66.
Abrams, R. (1988). Interview with Lothar Kalinowsky. Convulsive Therapy, 4, 24–39.
Accornero, F. (1970) Testimonianza oculare sulla scoperta dell'electtroshock. Pagina di Story della Medicina, 14, 38–52 [translated into English by Frank Sicuro and Giovanna Morena as: Accornero, F. (1988). An eyewitness account of the discovery of electroshock. Convulsive Therapy, 4, 40–9].
Ackerknecht, E. H. (1973). Therapeutics. From the Primitives to the 20th Century. New York: Hafner Press.
Ackner, B., Harris, A. & Oldham, A. J. (1957). Insulin treatment of schizophrenia, a controlled study. Lancet, i, 607–11.
Adams, J. (1889). Is general paralysis of the insane a curable disease? British Medical Journal, ii, 1187.
Agazzi, E. (1985). Commensurability, incommensurability, and cumulativity in scientific knowledge. Erkenntnis, 22, 51–77.
Amard, L. V. F. (1807). Traité analytique de la folie et des moyens de la guérir. Lyon: Ballanche.
Anonymous (1891). Surgical treatment of general paralysis of the insane. British Medical Journal, ii, 596.
Anonymous (1894). Edinburgh Medico-Chirurgical Society. Discussion on intracraneal surgery. Lancet, i, 607–9.
Anonymous (1927). Thomas Claye Shaw: Obituary. Lancet, i, 260.
Anonymous (1979). Catalogue: ‘Exposiao sobre a vida e obra de Egas Moniz’. Bial, Porto: Faculdade de Medicine do Porto.
Aretaeus (1856). The extant works of Aretaeus, The Cappadocian, edited and translated by F Adams. London: Sydenham Society.
Bach, C. (1907). Nekrolog Dr. G Burckhardt. Allgemeine Zeitschrift für Psychiatrie, 64, 529–34.
Baeyer, W. R. von (1951). Die moderne psychiatrische Schockbehandlung. Stuttgart: Georg Thieme.
Baguenier-Desormeaux, A. (1983). Étude sur le traitement moral et ses origines philosophiques. Mémoire pour le C.E.S. de Psychiatrie. Angers: Ronéot.
Barahona Fernandez, H. J. de (1956). Egas Moniz. In Grosse Nervenärzte, Vol. 1, ed. K. Kolle, pp. 187–8. Stuttgart: Thieme.
Barbier, J. B. G. (1824). Traité Élémentaire de Matière Médicale, 2nd edn, 3 Vols. Paris: Méquignon-Marvis.
Barcia, D. (ed.) (1998). Historia de la psicofarmacología. Madrid: You & Us.
Baruk, H. (1955). Les Thérapeutiques Psychiatriques. Paris: Presses Universitaires de France.
Batt, J. C. (1943). One hundred depressive psychoses treated with electrically induced convulsions. Journal of Mental Science, 89, 289–96.
Bayle, A. L. (1826). Traite des Maladies du Cerveau. Paris: Gabon.
Bechterew, W. & Puuseppe, M. (1912). La chirurgie des Aliénés. Archives de Neurologie, 34, 1–17, 69–89.
Beier, L. Mc. (1987). Sufferers and Healers: the Experience of Illness in Seventeenth Century England. London: Routledge.
Bennett, M. R. & Hacker, P. M. S. (2003). Philosophical Foundations of Neuroscience. Oxford: Blackwell.
Bernier, F. (1674). Abregé de la Philosophie de Mr Gassendi. Paris: Langlois.
Berrios, G. E. (1991). Psychosurgery in Britain and elsewhere. In 150 years of British Psychiatry, ed. G. E. Berrios & Freeman H., pp. 180–96. London: Gaskell.
Berrios, G. E. (1994). Historiography of mental symptoms and diseases. History of Psychiatry, 5, 175–90.
Berrios, G. E. (1996). The History of Mental Symptoms. Cambridge: Cambridge University Press.
Berrios, G. E. (1997). The origins of psychosurgery: Shaw, Burckhardt and Moniz. History of Psychiatry, 8, 61–81.
Berrios, G. E. (1997). The scientific origins of electroconvulsive therapy. History of Psychiatry, 8, 105–19.
Berrios, G. E. & Freeman, H. (ed.) (1991). 150 years of British Psychiatry 1841–1991. London: Gaskell.
Berrios, G. E. & Marková, I. S. (2002). Biological psychiatry: conceptual issues. In Biological Psychiatry, ed. H. D'Haenen, J. A. den Boer & P. Willner, pp. 3–24. New York: John Wiley.
Beveridge, A. (2004). Clouston, Sir Thomas Smith (1840–1915). Oxford Dictionary of National Biography. Oxford: Oxford University Press.
Biagioli, M. (1990). The anthropology of incommensurability. Studies in History and Philosophy of Science, 21, 183–209.
Binet & Rebatel (1895). Un cas d'affection mental guéri par la trépanation. Lyon Medical, 12th May 1895.
Bini, L. (1948). Le Demenze Presenili. Rome: Edizioni Italiane.
Bini, L. & Bazzi, T. (1954). Trattato di Psichiatria, 2 Vols. Milan: F. Vallardi.
Bloor, D. (1991). Knowledge and Social Imagery, 2nd edn. Chicago: The University of Chicago Press.
Blumer, A. (1892). The surgical treatment of insanity. American Journal of Insanity, 49, 222.
Boinet, E. (no date). Les Doctrines Médicales. Leur Évolution. Paris: Flammarion.
Bordeu, A. (1775). Recherches sur les maladies chroniques. Paris.
Borgarello, G. (1939). Clinical results of one hundred cases of mental illness treated with electroshock. Schizofrenie, 9, 131–6.
Boudon, V. (2000). Galien de Pergame. In Dictionnaire des Philosophes Antiques, Vol 3, ed. R. Goulet, pp. 440–66. Paris: CNRS Éditions.
Bourne, H. (1953). The insulin myth. Lancet, II, 964–8.
Braslow, J. T. (1997). Mental Ills and Bodily Cures. Psychiatric Treatment in the First Half of the Twentieth Century. Berkeley CA: University of California Press.
Braslow, J. T. (2000). Therapeutics and the history of psychiatry. Bulletin for the History of Medicine, 74, 794–802
Braunmühl, A. von (1938). Die Insulinshockbehandlung der Schizophrenie. Berlin: Springer.
Braunmühl, A. von (1947). Insulinshock und Heilkrampf in der Psychiatrie. Stuttgart: Wissenschaftliche Verlagsgesellschaft.
Breathnach, C. S. (1990). Cerletti. Irish Journal of Psychological Medicine, 7, 177.
Brock, A. J. (1929). Greek Medicine. London: J. M. Dent.
Brown, G. H. (1955). Munk's Roll: Lives of the Fellows of the Royal College of Physicians of London 1826–1925, Vol. IV. London: Royal College of Physicians.
Brown, T. (1970). The College of Physicians and the acceptance of iatromechanism in England 1665–1695. Bulletin for the History of Medicine, 44, 12–30.
Brunschwig, J. & Nussbaum, M. C. (ed.) (1993). Passions and Perceptions. Cambridge: Cambridge University Press.
Buchner de, T. (1753). De transitu morbi chronici in acutum, et acuti in chronicum. Halle.
Burckhardt, G. (1891). Ueber rindenexcisionen, als beitrag zur operativen therapie der psychosen. Allgemeine Zeitschrift für Psychiatrie, 47, 463–548.
Butterfield, H. (1931). Whig Interpretation of History. London: G. Bell and Sons.
Bynum, W. (1964). Rationales for therapy in British Psychiatry 1780–1835. Medical History, 18, 317–34.
Bynum, W. F. (1973). The anatomical method, natural theology, and the functions of the brain. Isis, 64, 444–68.
Bynum, W. F. & Porter, R. (ed.) (1987). Medical Fringe and Medical Orthodoxy 1750–1850. London: Croom-Helm.
Bynum, W. & Nutton, V. (ed.) (1991). Essays in the History of Therapeutics. Amsterdam, Atlanta: Clio Medica.
Caelius Aurelianus (1950). On Acute Diseases, edited and translated by I. E. Drabkin. Chicago: Chicago University Press.
Carbonell, C.-O. (1991). L'Historiographie. Paris: Presses Universitaires de France.
Carlson, E. T. & Dain, N. (1960). The psychotherapy that was moral treatment. American Journal of Psychiatry, 117, 519–24.
Carter, R. B. (1983). Descartes' Medical Philosophy. Baltimore, MD: The Johns Hopkins University Press.
Cerletti, U. (1940). L'elettroshock. Rivista Sperimentale di Freniatria, 64, 209–310
Cerletti, U. (1950). Old and new information about electroshock. American Journal of Psychiatry, 107, 87–94.
Cerletti, U. (1956). Electroshock therapy. In The Great Physiodynamic Therapies in Psychiatry, ed. A. M. Sackler, M. D. Sackler, R. R. Sackler & F. Martinez-Ibañez, pp. 91–120. New York: Hoeber-Harper Book.
Chast, F. (1995). Histoire contemporaine des medicaments. Paris: La Découverte.
Chen, X. (1997). Thomas Kuhn's latest notion of incommensurability. Journal for General Philosophy of Science, 28, 257–73.
Chereau, A. (1881). Signatures mystiques. In Dictionnaire Encyclopédique des Sciences Médicales, Vol. 90, ed. A. Dechambre, pp. 615–18.
Claude, H. & Rubenovitch, P. (1940). Therapeutiques Biologiques des Affections Mentales. Paris: Masson.
Cogan, T. (1802). A Philosophical Treatise on the Passions. London: S. Hazard.
Coley, N. G. (1979). ‘Cures without care’. ‘Chymical physicians’ and mineral waters in seventeenth-century English medicine. Medical History, 23, 191–214.
Colombier, J. & Doublet, F. (1785). Instruction sur la maniére de gouverner les insensés. Paris: L'Imprimerie Royale.
Conry, Y. (1982). Thomas Willis ou le Premier Discours Rationaliste en Pathologie Mentale. L'information Psychiatrique, 58, 313–23.
Cooper, R. (2005). Classifying Madness. A Philosophical Examination of the Diagnostic and Statistical Manual of Mental Disorders. Berlin: Springer.
Cossa, P. (1945). Thérapeutique neurologique et psychiatrique. Paris: Masson.
Cramond, W. A. (1987). Lessons from the insulin history in psychiatry. Australian and New Zealand Journal of Psychiatry, 21, 320–6.
Cripps, H. (1889). The surgical treatment of general paralysis. British Medical Journal, ii, 1215–16.
Curti, M. (1974). Philanthropy. In The Dictionary of the History of Ideas: Studies of Selected Pivotal Ideas, Vol. 3, ed. P. P. Wiener, pp. 486–93. New York: Charles Scribner's Sons.
D'Aulney, J. & Malineau, R. (1956). Depuis l'avènement de la chlorpromazine la cure de Sake est elle condamnée? L'Encéphale, 45, 656–60.
Danziger, K. (1997). Naming of the Mind. London: Sage.
Daquin, J. (1792). La Philosophie de la folie, ou Essai philosophique sur le traitement des personnes attaquées de folie. Paris: Née de La Rochelle.
Daremberg, Ch. (no date). Galien considéré comme philosophe. Paris: De Fain.
David, H. P. (1954). A critique of psychiatric and psychological research on insulin treatment in schizophrenia. American Journal of Psychiatry, 100, 774–6.
Dawson, W. S. (1939). Cardiazol convulsion therapy in the psychoses. Medical Journal of Australia, 26, 497–501.
Delay, J. & Maillard, J. (1945). L'électrochoc dans les différentes formes cliniques de la confusion mentale. Annales Médico-Psychologiques, 103, 474–8.
Delay, J. (1950). Méthodes Biologiques en Clinique Psychiatrique. Paris: Masson.
Delmas-Marsalet, P. (1943). L'électrochoc thérapeutique et la dissolution-reconstruction. Paris: J.B. Baillière.
Despret, V. (1999). Ces emotions qui nous fabriquent. Paris: Collection Les Empêcheurs de Penser en Rond.
Desrosières, A. (1998). The Politics of Large Numbers. A History of Statistical Reasoning. Translated by Camille Naish. Cambridge, MA: Harvard University Press.
Diderot, D. & D'Alembert, J. R. (1753). Encyclopédie ou Dictionnaire raisonné des sciences, des arts et des métiers par une société de gens de lettres. 3rd Vol. Paris: chez Briasson: David l'aîné: Le Breton: Durand.
Digby, A. (1985). Moral treatment at the Retreat, 1796–1846. In Anatomy of Madness, Vol. II.
Digby, A. (2004). Tuke, Daniel Hack (1827–1895). Oxford Dictionary of National Biography. Oxford: Oxford University Press.
Dixon, T. (2003). From Passions to Emotions. Cambridge: Cambridge University Press.
Domino, E. F. (1999). History of modern psychopharmacology: a personal view with an emphasis on antidepressants. Psychosomatic Medicine, 61, 591–8.
Dumas, C. L. (1812). Doctrine générale des maladies chroniques. Paris.
Edgeworth, F. Y. (1881). Mathematical Psychics: an Essay on the Application of Mathematics to the Moral Sciences. London: Kegan Paul.
Endler, N. S. (1988). The origins of electroconvulsive therapy (ECT). Convulsive Therapy, 4, 5–23.
Ey, H. (1978). La notion de ‘maladie morale’ et de ‘traitement moral’ dans la psychiatrie Française et Allemande du debut du XIXme Siècle. Perspectives Psychiatriques, 1, 12–35.
Faure, O. (ed.) (1999). Les Thérapeutiques: savoirs et usages. Paris: Foundation Marcel Merieux.
Finner, R. W. (1954). Duration of convulsion in electric shock therapy. Journal of Nervous and Mental Disease, 111, 530–7.
Fitzgerald, O. W. S. (1943). Experiences in the treatment of depressive states by electrically induced convulsions. Journal of Mental Science, 89, 73–80.
Fleming, G. W. T. (1950). Recent Progress in Psychiatry. London: Churchill.
Fleming, G. W. T. H., Golla, F. L. & Walter, W. G. (1939). Electric-convulsion therapy of schizophrenia. Lancet, II, 1353–5.
Forel, A. (1937). Out of my Life and Work, translated by B. Miall. London: George Allen & Unwin.
Forel, O. L. (1941). L'Électroshoc en psychiatrie. Annales Médico-Psychologiques, 99, 32–40.
Frank, E., Prien, R. F., Jarrett, R. B. et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry, 48, 851–5.
Frank, R. G. (1980). Harvey and the Oxford Physiologists. A Study of Scientific Ideas. Berkeley: University of California Press.
Freeman, W. & Watts, J. (1950). Psychosurgery; In Treatment of Mental Disorders and Intractable Pain. Springfield, IL: Charles C. Thomas.
Freudenberg, R. (1941). On the curability of mental diseases by ‘shock’ treatment. Journal of Mental Science, 87, 529–44.
Fulton, J. F. & Jacobsen, C. F. (1935). The functions of the frontal lobes: a comparative study in monkeys, chimpanzees and man. In Proceedings of 2nd International Congress, Neurology Abstracts.
Fulton, J. F. (1948). Functional Localization in the Frontal Lobes and Cerebellum. Oxford: Clarendon Press.
Fulton, J. F. (1951). Frontal Lobotomy and Affective Behaviour. A Neurophysiological Analysis. New York: W W Norton.
Garcia Ballester, L. (1972). Alma y enfermedad en la obra de Galeno. Valencia: Universidad de Valencia.
Gayral, L. & Dauty, R. (1957). Nouvelles Chimiothérapies en Psychiatrie. Paris: Masson.
Geller, M. R. (1962). The Treatment of Psychiatric Disorders with Insulin 1936–1960. A Selected Annotated Bibliography. Washington: United States Government Printing Office.
Genil-Perrin, G. (1913). Histoire des origines et de l'évolution de l'idée de dégénérescence en médicine mentale. Paris: A Leclerc.
Gigerenzer, G., Swijtink, Z., Porter, T. et al. (1989). The Empire of Chance. Cambridge: Cambridge University Press.
Golinski, J. (1998). Making Natural Knowledge. Cambridge: Cambridge University Press.
Goodall, E. (1893). Transient motor and sensory disturbance following upon trephining in a case of general paralysis of the Insane. British Medical Journal, ii, 117.
Gordon, H. L. (1948). Fifty shock therapy theories. Military Surgeon, 103, 397–401.
Gordon, H. L. (ed.) (1958). The New Chemotherapy in Mental Illness. New York: Philosophical Library.
Grasset, H. (1910). La médicine naturiste a travers les siècles. Paris: Rousset.
Graumann, C. F. & Gergen, K. J. (ed.) (1996). Historical Dimensions of Psychological Discourse. Cambridge: Cambridge University Press.
Gray, B. (1905). A History of English Philanthropy from the Dissolution of the Monasteries to the Taking of the First Census. London: P.S. King and Son.
Griesinger, W. (1861). Die Pathologie und Therapie der psychischen Krankheiten, 2nd edn. Stuttgart: Krabbe.
Grondin, J. (1991). Einführung in die philosophische Hermeneutik. Darmstadt: Wissenschaftliche Buchgesellschaft.
Guillant, Le L., Bonnafé, L. & Mignot, H. (1964). Problèmes posés par la chronicité sur le plan des institutions psychiatriques. Paris: Masson.
Gutiérrez, M. T., Primo, F. & Gutiérrez, J. L. (1990). Apuntes para la historia del Hospital Psiquiátrico San Luis, de Palencia. Informaciones Psiquiátricas, 121, 227–39.
Hagenbach, N. (1907). Dr. Gottlieb Burckhardt. Korrespondenzblatt für Schweizer Arzte, 37, 257–60.
Hankinson, R. J. (1998). Galen on Antecedent Causes. Cambridge: Cambridge University Press.
Haslam, J. (1809). Observations of Madness and Melancholy. London: Callow.
Healy, D. (2002). The Creation of Psychopharmacology. Cambridge, MA: Harvard University Press.
Healy, D. (2004). Let them eat Prozac. New York: New York University Press.
Hécaen, H. & Lanteri-Laura, G. (1977). Evolution des connaissances et des doctrines sur les localizations cérébrales. Paris: Descleé de Brouwer.
Heinroth, J. C. (1975). Textbook of Disturbances of Mental Life, Vol. 1. Translated by J. Schmorak. Baltimore, MD: Johns Hopkins University Press.
Hemphill, R. E. & Walter, W. G. (1941). The treatment of mental disorders by electrically induced convulsions. Journal of Mental Science, 87, 256–75.
Henry, J. (1986). Occult qualities and the experimental philosophy: active principles in pre-Newtonian Matter Theory. History of Science, 24, 335–81.
Hermeil (1856). Recherches sur le traitement de l'aliénation mentale. Paris: Simon.
Higby, G. J. & Stroud, E. C. (ed.) (1997). The Inside Story of Medicines. A Symposium. Madison, WI: American Institute of the History of Pharmacy.
Hippocrates (1967). The Art. English Translation by W. H. S. Jones, Vol. 2, pp. 190–217. London: W. Heinemann.
Hobson, R. F. (1953). Prognostic factors in electro convulsive therapy. Journal of Neurology, Neurosurgery and Psychiatry, 16, 275–81.
Horsley, V. (1892). Trephining. In A Dictionary of Psychological Medicine, Vol. 2, ed. D. H. Tuke, pp. 1324–7. London: Churchill.
Hounau, H. M. (1807). Des principales sources des maladies chroniques. Paris.
Hoyningen-Huene, P. (1990). Kuhn's conception of incommensurability. Studies in History and Philosophy of Science, 21, 481–92.
Iggers, G. G. (1997). Historiography in the Twentieth Century. Hanover: Wesleyan University Press.
Impastato, D. J. (1960). The story of the first electroshock treatment. American Journal of Psychiatry, 116, 1113–14.
Ireland, W. W. (1891). Operative treatment of insanity. Journal of Mental Science, 37, 613–18.
Jacobsen, C. F., Wolfe, J. B. & Jackson, T. A. (1935). An experimental analysis of the functions of the frontal association areas in primates. Journal of Nervous and Mental Disease, 82, 1–14.
James, F. E. (1992). Insulin treatment in psychiatry. History of Psychiatry, 3, 221–35.
James, S. (1997). Passion and Action. Oxford: Oxford University Press.
Jones, K. (2000). Insulin coma therapy in schizophrenia. Journal of the Royal Society of Medicine, 93, 147–9.
Jordan, W. (1959). Philanthropy in England, 1480–1660: a Study of the Changing Patterns of English Social Aspirations. London: G. Allen & Unwin.
Kahlbaum, K. (1863). Die Gruppirung der psychischen Krankheiten und die Eintheilung der Seelenstrungen. Danzig: A.W. Kafemann.
Keel, O. (2001). L'Avènement de la medicine clinique moderne en Europe 1750–1815. Montreal: Les Presses de L'Université de Montréal.
Kennedy, A. (1940). The treatment of mental disorders by induced convulsions. Journal of Neurology and Psychiatry, 3, 49–82.
Kovalevsky, P. J. (1890). Hygiène et traitement des maladies mentales et nerveuses. Translated by W. de Holstein. Paris: Alcan.
Kraepelin, E. (1983). Lebenserinnerungen. Berlin: Springer.
Krafft-Ebing, R. von (1893). Lehrbuch der Psychiatrie, 5th edn. Stuttgart: Enke.
Kraft, I. (1961). Edouard Séguin and 19th century moral treatment of idiots. Bulletin of the History of Medicine, 35, 393–418.
Kragh, H. (1987). The Historiography of Science. Cambridge: Cambridge University Press.
Krapf, E. (1928). Epilepsie und schizophrenie. Archiv für Psychiatrie und Nervenkrankheiten, 83, 547–86.
Kuhn, T. (1962). The Structure of Scientific Revolutions. Chicago: Chicago University Press.
Laín-Entralgo, P. (1970). The Therapy of the Word in Classical Antiquity. Translated by L. J. Rather & J. M. Sharp. New Haven: Yale University Press.
Laín-Entralgo, P. (1978). Historia de la Medicina. Barcelona: Salvat.
Lamarche, A., Beaujeu, J. & Estienne, G. (1941). Le Traitement par l'électroshoc. Annales Médico-Psychologiques, 99, 251–61.
Landré-Beauvais, A. J. (1813). Séméiotique. Paris: Brosson.
Lanteri-Laura, G. (1997). La Chronicité en psychiatrie. Paris: Collection de Les Empêcheurs de Penser en Rond, Synthélabo.
Lapipe, M. & Rondepierre, J. (1941). Essai d'un apparel français pour l'électroshoc. Annales Médico-Psychologiques, 99, 87–95.
Laporte, J. (2004). Natural Kinds and Conceptual Change. Cambridge: Cambridge University Press.
Laudan, L. (1977). Progress and its Problems towards a Theory of Scientific Growth. Berkeley, CA: University of California Press.
Leduc, S. (1902). Production du sommel et de l'anesthésie générale par les courantes électriques. Comptes Rendus de l'Académie des Sciences, 135, 878–9.
Lefevre, G. (1971). La Naissance de l'historiographie moderne. Paris: Flammarion.
Lehmann, H. E. & Ban, T. A. (1997). The history of the psychopharmacology of schizophrenia. Canadian Journal of Psychiatry, 42, 152–62.
Leuret, F. (1838). Du Traitement moral de la Folie. Paris: Baillière.
Levi, A. (1964). French Moralists. The Theory of the Passions 1585–1649. Oxford: Clarendon Press.
Lewin, L. (1998). Phantastica. Rochester: Park Street Press.
López-Muñoz, F. & Álamo, C. (ed.) (1998). Historia de la Neuropsicofarmacología. Madrid: Eurobooks.
Luys, J. B. (1893). Le Traitement de la Folie. Paris: Rueff.
Macht, D. I. (1920). Johns Hopkins Hospital, Bulletin, 31, 167.
Magnan, V. (ed.) (1898). Traitement des maladies mentales. In Traité de Thérapeutique Appliqué, ed. A. Robin. Paris: Rueff.
Malzberg, B. (1943). The outcome of electric shock therapy in the New York civil state hospitals. Psychiatric Quarterly, 17, 154–63.
Marks, H. M. (1997). The Progress of Experiment. Cambridge: Cambridge University Press.
Martinet, J. F. (1813). Traité des maladies chroniques. Paris.
Matthews, J. N. S. (2000). An Introduction to Randomized Controlled Clinical Trials. London: Arnold.
McPherson, J. & Wallace, D. (1892). The surgical treatment of general paralysis of the insane. British Medical Journal, ii, 167–70.
Médioni, G. (1992). Die griechische Medizin nach Hippokrates. In Illustrierte Geschichte der Medizin, Vol. 1, ed. R. Toellner, pp. 351–92. Erlangen: Müller.
Meduna, L. J. (1934). Über experimentelle Campherepilepsie. Archiv für Psychiatrie und Nervenkrankheiten, 102, 333–9.
Meduna, L. J. (1937). Die Konvulsionstherapie der Schizophrenie. Halle: Carl Marhold.
Meduna, L. J. (1938). General discussion of the cardiazol therapy. American Journal of Psychiatry, 94 (Suppl.), 40–50.
Meduna, L. J. (1950). Genèse du traitement de la schizophrénie par le cardiazol. Annales Médico-Psychologiques, 97, 546–54.
Meduna, L. J. (1943). Dysharmonism in psychosis and its correction by shock. Journal of Nervous and Mental Disease, 98, 5–13.
Milne-Edwards, H. & Vavasseur, P. (1828). Manuel de Matière Médicale, 2nd edn. Paris: Compère Jeune.
Moncrieff, J. (1999). An investigation into the precendents of modern drug treatment in psychiatry. History of Psychiatry, 1999, 10, 475–90.
Moniz, E. & Lima, A. (1936). Premiers essais de psycho-chirurgie. Technique et résultats. Lisboa Medica, 13, 152–61.
Moniz, E. (1936). Tentatives opératoires dans le traitement de certaines psychoses. Paris: Masson.
Moniz, E. (1948). Mein weg zur leukotomie. Deutsche Medizinische Wochenschrift, 73, 581–3.
Moore, N. P. (1943). The maintenance treatment of chronic psychotics by electrically induced convulsions. Journal of Mental Science, 89, 257–69.
Müller, Ch. R. (1958). Gottlieb Burckhardt: Le Pére de la Topectomie. Revue Médicale de la Suisse Romande, 28, 726–30.
Nathan, T. & Stengers, I. (2004). Médicins et Sorciers. Paris: Collection Les Empêcheurs de Penser en Rond.
Nyirö, J. & Jablonsky, A. (1929). Einige daten zur prognose der epilepsie, mit besonderer rücksicht auf die konstitution. Psychiatrische Neurologische Wochenschrift, 31, 547–9.
Oakes, G. (1988). Weber and Rickert. Concept Formation in the Cultural Sciences. Cambridge, MA: MIT Press.
Pachter, H. M. (1951). Paracelsus. New York: Shuman.
Pagel, W. (1958). Paracelsus: an Introduction to Philosophical Medicine in the Era of the Renaissance. Basel: Karger.
Paget S. (2004). Horsley, Sir Victor Alexander Haden (1857–1916), rev. Overy, C. Oxford Dictionary of National Biography. Oxford: Oxford University Press.
Parry-Jones, W. (1972). The Trade in Lunacy. A Study of Private Madhouses in England in the Eighteenth and Nineteenth Centuries. London: Routledge & Kegan Paul.
Passione, R. (2004). Italian psychiatry in an international context: Ugo Cerletti and the case of electroshock. History of Psychiatry, 15, 83–104.
Penrose, L. S. & Marr, W. B. (1943). Results of shock therapy evaluated by estimating chances of patients remaining in hospital without such treatment. Journal of Mental Science, 89, 374–80.
Pereira, A. L. & Pita, J. R. (ed.) (2000). Egas Moniz. Coimbra: Minerva.
Petersen, J. (1877). Haupmomente in der geschichtlichen Entwicklung der medicinischen Therapie. Copenhagen: Höst.
Pinel, Ph. (1809). Traité médico-philosophique sur l'alienation mentale, 2nd edn. Paris: Brosson.
Pinel, Ph. (1813). Chronique. In Dictionnaire des sciences médicales, ed. Adelon et al. Paris: Panckoucke.
Porter, R. (ed.) (1985). Patients and Practitioners. Lay Perceptions of Medicine in Pre-industrial Society. Cambridge: Cambridge University Press.
Porter, R. (1993). Disease, Medicine and Society in England 1550–1860, 2nd edn. Cambridge: Cambridge University Press.
Porter, R. & Wear, A. (ed.) (1987) Problems and Methods in the History of Medicine. London: Croom Helm.
Porter, R. & Teich, M. (ed.) (1995). Drugs and Narcotics in History. Cambridge: Cambridge University Press.
Postel, J. (1979). Naissance et decadence du traitement moral pendant la première moitie du XIX Siècle. L'Evolution Psychiatrique, 44, 585–616.
Potter, J. (1996). Representing Reality. London: Sage.
Pressman, J. D. (1988). Sufficient promise: John F. Fulton and the origins of psychosurgery. Bulletin of the History of Medicine, 62, 1–29.
Pulver, S. E. (1961). The first electroconvulsive treatment given in the United States. American Journal of Psychiatry, 117, 845–6.
Puuseppe, M. (1937). Alcune considerazioni sugli interventi chirurgici nelle malattie mentali. Giornale Accademia Medica Torino, 100, 3–16.
Revington, G. (1889). Is general paralysis of the insane a curable disease? British Medical Journal, 1889, ii, 1187.
Revington, G. (1890). The surgical treatment of general paralysis of the insane. British Medical Journal, i, 749.
Rey, M. (1891). Trépan dans un cas de paralysie générale. Archives de Neurologie, 22, 260.
Ribes, F. (1860). Traité d'hygiène thérapeutique ou application des moyens de l'hygiène au traitement des maladies. Paris: Ballière.
Riddle, J. M. (1992). The methodology of historical drug research. In Quid pro quo: Studies in the History of Drugs, Variorum Collected Studies Series CS367, pp. 1–19. Great Yarmouth.
Rinkel, M. & Himwich, H. E. (ed.) (1959). Insulin Treatment in Psychiatry. New York: Philosophical Library.
Rolleston, H. D (2004). Allbutt, Sir Thomas Clifford (1836–1925), rev. Alexander G. Bearn. Oxford Dictionary of National Biography. Oxford: Oxford University Press.
Rosenberg, C. E. (1997). The therapeutic revolution: medicine, meaning and social change in nineteenth century America. Perspectives in Biology and Medicine, 20, 485–506.
Roth, M. (1951). Changes in the EEG under barbiturate anaesthesia produced by electro-convulsive treatment and their significance for the theory of ECT action. Electroencephalography and Clinical Neurophysiology, 3, 261–80.
Ruffat, M. (1996). 175 ans d'industrie pharmaceutique française. Paris: La Découverte.
Rush, A. J., Thase, M. E. & Dube, S. (2003). Research issues in the study of difficult-to-treat depression. Biological Psychiatry, 53, 743–53.
Sachs, G. S. & Rush, A. J. (2003). Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals? Journal of Clinical Psychiatry, 64 (Suppl. 6), 18–22.
Sakel, M. (1935). Neue Behandlungsmethode der Schizophrenie. Wien: Moritz Perles.
Samuel, E. (1943). Some complications arising during electrical convulsive therapy. Journal of Mental Science, 89, 81–4.
Sander, W. (1868). Über eine spezielle Form der primären Verrückheit. Archiv für Psychiatrie und Nervenkrankheiten, 1, 387–419.
Scull, A. T. (1979). Moral treatment reconsidered: some sociological comments on an episode in the history of British psychiatry. Psychological Medicine, 9.
Séguin, É. (1846). Traitement Moral, hygiéne et éducation des idiots et des autres enfants arriérés. Paris: Baillière.
Semelaigne, R. (1895). Sur la chirurgie cérébrale dans les aliénations mentales. Annales Médico-Psychologiques, 1, 394–420.
Seppilli, G. (1891). La cura chirurgica delle malattie mentali. Rivista Sperimentale di Freniatria e di Medicina Legale, 27, 369–74.
Shaw, T. C. & Cripps, H. (1890). On the surgical treatment of general paralysis. British Medical Journal, i, 1364.
Shaw, T. C. (1889). The surgical treatment of insanity. British Medical Journal, ii, 1090–1.
Shaw, T. C. (1891). Surgical treatment of general paralysis of the Insane. British Medical Journal, ii, 581–3.
Shaw, T. C. (1892). Surgery and insanity. Saint Bartholomew's Hospital Reports, 28, 55–68.
Sherrington, C. S. (2004). Ferrier, Sir David (1843–1928), rev. Michael Bevan. Oxford Dictionary of National Biography. Oxford: Oxford University Press.
Shipley, W. H. & McGregor, J. S. (1940). The clinical applications of electrically induced convulsions. Proceedings of the Royal Society of Medicine, 30, 267–9.
Shorter, E. (1997). A History of Psychiatry. New York: Wiley.
Shorvon, H. J. & Shorvon, L. M. (1943). Spinal anaesthesia in electric convulsive therapy. Journal of Mental Science, 89, 69–72.
Siegel, R. E. (1973). Galen on Psychology, Psychopathology and Function and Diseases of the Nervous System. Basel: Karger.
Smith, L. H. (1942). Electroshock treatment in the psychoses. American Journal of Psychiatry, 98, 558–61.
Smith, P. (1890). The surgical treatment of general paralysis. British Medical Journal, i, 11–12.
Störck, A. de (1887). Études de thérapeutique experimentale. Translated by H. Piedvache. Paris: Baillière.
Suzuki, A. (1995). The politics and ideology of non-restraint. Medical History.
Taper, M. L. & Lele, S. R. (ed.) (2004). The Nature of Statistical Evidence. Statistical, Philosophical and Empirical Considerations. Chicago: The University of Chicago Press.
Telesko, W. (2001). The Wisdom of Nature. The Healing Powers and Symbolisms of Plants and Animals in the Middle Ages. Munich: Prestel.
Temkin, O. (1973). Galenism. Ithaca: Cornell University Press.
Thase, M. E. (2003). Evaluating antidepressant therapies: remission as the optimal outcome. Journal of Clinical Psychiatry, 64 (Suppl. 13), 18–25.
Thorpe, J. G. (1962). The current status of prognostic test indicators for electroconvulsive therapy. Psychosomatic Medicine, 24, 554–68.
Tow, P. M. (1955). Personality Changes following Frontal Leucotomy. London: Oxford University Press.
Tröhler, U. (2000). To Improve the Evidence of Medicine. The 18th century British Origins of a Critical Approach. Edinburgh: Royal College of Physicians of Edinburgh Publications.
Trousseau, A. & Pidoux, H. (1877). Traité de Thérapeutique et de Matière Médicale, 9th edn, 2 Vols. Paris: Asselin.
Tuke, D. H. (1892). Therapeutics. In A Dictionary of Psychological Medicine, 2 Vols, ed. D. H. Tuke, pp. 1290–3. London: Churchill.
Tuke, J. B. (1890). The surgical treatment of intracranial fluid pressure. British Medical Journal, i, 8–11.
Tuke, J. B. (1891). A plea for the scientific study of insanity. British Medical Journal, i, 1161–6.
Valenstein, E. S. (1986). Great and Desperate Cures. The Rise and Decline of Psychosurgery and other Radical Treatments of Mental Illness. New York: Basic Books.
Virey (1821). Signature. In Dictionaire des Sciences Médicales, ed. Adelon et al. Vol. 51, pp. 262–7. Paris: C. L. F. Panckoucke.
Vogel, M. J. & Rosenberg, C. E. (ed.) (1979). The Therapeutic Revolution: Essays on the Social History of American Medicine. Pennsylvania: University of Pennsylvania Press.
Wade, N. J., Norrsell, U. & Presly, A. (2005). Cox's chair: ‘a moral and a medical mean in the treatment of maniacs’. History of Psychiatry, 16, 73–88.
Wagner, C. G. (1890). A case of trephining for general paralysis. American Journal of Insanity, 47, 59–66.
Walker, A. E. (1970). Egas Moniz. In The Founders of Neurology, 2nd edn, ed. W. Haymaker & F. Schiller, pp. 489–92. Thomas, IL.
Wallace, W. A. (1972). Causality and Scientific Explanation, Vol. 1. Ann Arbor, MI: The University of Michigan Press.
Warner, J. H. (1997). The Therapeutic Perspective. Medical Practice, Knowledge, and Identity in America 1820–1885. Princeton: Princeton University Press.
Weitbrecht, H. J. (1949). Studie zur psychopathologie krampfbehandelter Psychosen. Stuttgart: Georg Thieme.
Whitaker, H. A., Stemmer, B. & Joanette, Y. (1996). A psychosurgical chapter in the history of cerebral localization: the six cases of Gottlieb Burckhardt. In Classical Cases in Neuropsychology, ed. C. Code, C.-W. Wallesch, Y. Joanette & A. Roch, pp. 275–304. Hove: Lawrence Erlbaum.
Willis, T. (1685). The London Practice of Physick. London: Basset.
Wilson, I. G. H. (1937). A Study of Hypoglycaemic Shock in Schizophrenia. London: His Majesty's Stationery Office.
Worcester, W. L. (1891). Surgery of the central nervous system (Account of the Berlin meeting). American Journal of Insanity, 47, 410–13.
Wortis, S. B. et al. (ed.) (1953). Psychiatric Treatment. Baltimore: The Williams Wilkins Company.
Young, R. M. (1966). Scholarship and the history of the behavioural sciences. History of Science, 5, 1–51.

Reference Title: REFERENCES

Reference Type: reference-list

Bell, C. J., Hood, S. D. & Nutt, D. J. (2005). Acute tryptophan depletion part 2: Australia and New Zealand. Journal of Psychiatry, 39, 565–74.
Feighner, J. P., Robins, E., Guze, S. B. et al. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.
Geddes, J., Carney, S., Davies, C. et al. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 361, 653–61.
Gill, D. & Hatcher, S. (2000). Antidepressants for depression in medical illness. Cochrane Database of Systematic Reviews, 4, CD001312. Oxford: Update Software Ltd.
Guaiana, G., Barbui, C. & Hotopf, M. (2003). Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews, 2, CD004186. Oxford: Update Software Ltd.
Guess, H., Kleinman, A., Kusek, J. & Engel, L. (2002). The Science of Placebo: Towards an Interdisciplinary Research Agenda. London: BMJ Books.
Hughes, J. R., Stead, L. F., Lancaster, T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD000031. DOI: 10.1002/14651858.CD000031.pub2. Oxford: Update Software Ltd.
March, J., Kratochvil, C., Clarke, G. et al. (2004). AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1046–56.
Mulrow, C. D., Williams, J. W. Jr, Trivedi, M. et al. (1998). Treatment of depression – newer pharmacotherapies. Psychopharmacology Bulletin, 34, 409–95.
Mulrow, C. D., Williams, J. W. Jr, Chiquette, E. et al. (2000). Efficacy of newer medications for treating depression in primary care patients. American Journal of Medicine, 108, 54–64.
NICE (2005) http://www.nice.org.uk/page.aspx?o=appraisals.inprogress.dementianonalzheimer
NICE (2006) Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder in children and adolescents – guidance. www.nice.org.uk/uk
Nunes, E. V. & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. Journal of the American Medical Association, 291, 1887–96.
Nutt, D. J. (2003). Death and dependence: current controversies over the selective serotonin reuptake inhibitors. Journal of Psychopharmacology, 17, 355–64.
Overall, J. E. & Rhoades, H. M. (1982). Refinement of phenomenological classification in clinical psychopharmacology research. Psychopharmacology (Berlin), 77, 24–30.
Safer, D. J. (2002). Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. Journal of Nervous and Mental Disease, 190, 583–92.
Soyka, M. & Chick, J. (2003). Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. American Journal of Addiction, 12, S69–80.
Unutzer, J., Katon, W., Callahan, C. M. et al. (2003). Depression treatment in a sample of 1,801 depressed older adults in primary care. Journal of the American Geriatric Society, 51, 505–14.
Whitehead, C., Moss, S., Cardno, A. & Lewis, G. (2002). Antidepressants for people with both schizophrenia and depression. Cochrane Database of Systematic Reviews, 2, CD002305. Oxford: Update Software Ltd.
Williams, J. W. Jr, Mulrow, C. D., Chiquette, E., Noel, P. H., Aguilar, C. & Cornell, J. (2000). A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Annals of Internal Medicine, 132, 743–56.
Wilson, K., Mottram, P., Sivanranthan, A. & Nightingale, A. (2001). Antidepressant versus placebo for depressed elderly. Cochrane Database of Systematic Reviews, 2, CD000561. Oxford: Update Software Ltd.

Reference Title: REFERENCES

Reference Type: reference-list

Aarsland, D., Larsen, J. P., Waage, O. & Langeveld, J. H. (1997). Maintenance electroconvulsive therapy for Parkinson's disease. Convulsive Therapy, 13, 274–7.
Abrams, R. (1997). The mortality rate with ECT. Convulsive Therapy, 13, 125–7.
Abrams, R. (2002). Electroconvulsive Therapy, 4th edn. New York: Oxford University Press.
Abrams, R. & Taylor, M. A. (1985). A prospective follow-up study of cognitive functions after ECT. Convulsive Therapy, 1, 4–9.
Addington, D., Addington, J. M. & Ens, I. (1993). Mentally retarded patients on general hospital psychiatric units. Canadian Journal of Psychiatry, 38, 134–42.
AETMIS (2002). The Use of Electroconvulsive Therapy in Quebec. Montreal: AETMIS.
Albala, A. A., Greden, J. F., Tarika, J. & Carroll, B. J. (1981). Changes in serial dexamethasone suppression tests among unipolar depressive patients receiving electroconvulsive treatment. Biological Psychiatry, 16, 551–60.
Alexopoulos, G. S., Shamoian, C. J., Lucas, J., Weiser, N. & Berger, H. (1984). Medical problems of geriatric psychiatric patients and younger controls during electroconvulsive therapy. Journal of the American Geriatrics Society, 32, 651–4.
Altshuler, L. L., Post, R. M., Leverich, G. S., Mikalauskas, K., Rosoff, A. & Ackerman, L. (1995). Antidepressant-induced mania and cycle acceleration: a controversy revisited. American Journal of Psychiatry, 152, 1130–8.
Altshuler, L. L., Cohen, L., Szuba, M. P., Burt, V. K., Gitlin, M. & Mintz, J. (1996). Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. American Journal of Psychiatry, 153, 592–606.
American Psychiatric Association Committee on Electroconvulsive Therapy (2001). The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd edn. Washington, DC: American Psychiatric Association.
Andersen, K., Balldin, J., Gottfries, C. G. et al. (1987). A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with “on-off” phenomena. Acta Neurologica Scandinavica, 76, 191–9.
Arnold, O. H. & Stepan, H. (1952). Untersuchungen zur Frage der akuten todlichen, Katatonie. Wiener Zeitschrift fur Nervenheilkunde und Deren Grenzgebiete, 4, 235–58.
Avery, D. & Lubrano, A. (1979). Depression treated with imipramine and ECT: the DeCarolis study reconsidered. American Journal of Psychiatry, 136, 559–62.
Avery, D. & Winokur, G. (1978). Suicide, attempted suicide, and relapse rates in depression. Archives of General Psychiatry, 35, 749–53.
Aziz, M., Maixner, D. F., DeQuardo, J., Aldridge, A. & Tandon, R. (2001). ECT and mental retardation: a review and case reports. Journal of ECT, 17, 149–52.
Babington, R. G. & Wedeking, P. W. (1975). Blockade of tardive seizures in rats by electroconvulsive shock. Brain Research, 88, 141–4.
Bagadia, V. N., Abhyankar, R. R., Doshi, J., Pradhan, P. V. & Shah, L. P. (1983). A double blind controlled study of ECT vs chlorpromazine in schizophrenia. Journal of the Association of Physicians of India, 31, 637–40.
Baldessarini, R. J. (2001). Drugs and the treatment of psychiatric disorders: antidepressant and antianxiety agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn, ed. J. G. Hardman, L. E. Gilman & A. G. Gilman, pp. 447–83. New York: McGraw-Hill.
Baldessarini, R. J. & Tondo, L. (2003). Suicide risk and treatments for patients with bipolar disorder. Journal of the American Medical Association, 290, 1517–19.
Balldin, J., Granerus, A. K., Lindstedt, G., Modigh, K. & Walinder, J. (1981). Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms. Journal of Neural Transmission, 52, 199–211.
Barker, A. T., Jalinous, R. & Freeston, I. L. (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet, 1, 1106–7.
Bates, W. J. & Smeltzer, D. J. (1982). Electroconvulsive treatment of psychotic self-injurious behavior in a patient with severe mental retardation. American Journal of Psychiatry, 139, 1355–6.
Bebchuck, J. M., Barnhill, J. & Dawkins, K. (1996). ECT and mental retardation. American Journal of Psychiatry, 153, 1231.
Benatov, R., Sirota, P. & Megged, S. (1996). Neuroleptic-resistant schizophrenia treated with clozapine and ECT. Convulsive Therapy, 12, 117–21.
Benbow, S. M. (1988). ECT for depression in dementia. British Journal of Psychiatry, 152, 859.
Bergman, J. D. & Harris, J. C. (1998). Mental retardation. In Comprehensive Textbook of Psychiatry, ed. S. Kaplan & B. Sadock, p. 2224. Baltimore, MD: Williams & Wilkins.
Berrouschot, J., Rolle, K., Kuhn, H. J. & Schneider, D. (1997). Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. Journal of Neurological Science, 150, 173–6.
Bhatia, S. C., Bhatia, S. K. & Gupta, S. (1998). Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. Journal of ECT, 14, 280–3.
Bhatia, S. C., Baldwin, S. A. & Bhatia, S. K. (1999). Electroconvulsive therapy during the third trimester of pregnancy. Journal of ECT, 15, 270–4.
Birkenhager, T. K., Pluijms, E. M. & Lucius, S. A. (2003). ECT response in delusional versus non-delusional depressed inpatients. Journal of Affective Disorders, 74, 191–5.
Black, D. W., Winokur, G. & Nasrallah, A. (1989). Illness duration and acute response in major depression. Convulsive Therapy, 5, 338–43.
Boodman, S. G. (1996). Shock therapy … it's back. The Washington Post, p. 24.
Bostwick, J. M. & Pankratz, V. S. (2000). Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry, 157, 1925–32.
Bourgon, L. N. & Kellner, C. H. (2000). Relapse of depression after ECT: a review. Journal of ECT, 16, 19–31.
Bourne, H. (1954). Convulsion dependence. Lancet, 2, 1193–6.
Bradvik, L. & Berglund, M. (2000). Treatment and suicide in severe depression: a case-control study of antidepressant therapy at last contact before suicide. Journal of ECT, 16, 399–408.
Brandon, S. P., Cowley, C., McDonald, P., Neville, R., Palmer, R. & Wellstood-Eason, S. (1984). Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. British Medical Journal, 288, 22–5.
Brandon, S., Cowley, P., McDonald, C., Neville, P., Palmer, R. & Wellstood-Eason, S. (1985). Leicester ECT trial: Results in schizophrenia. British Journal of Psychiatry, 146, 177–83.
Breggin, P. R. (1991). Toxic Psychiatry: Why Therapy, Empathy, and Love Must Replace the Drugs, Electroshock, and Biochemical Theories of the “New Psychiatry”. New York: St. Martin's Press.
Brill, N. O., Crumpton, E., Eiduson, S., Crayson, H. M., Hellman, L. I. & Richards, R. A. (1959). Relative effectiveness of various components of electroconvulsive therapy. Archives of Neurology and Psychiatry, 81, 627–35.
Buchan, H., Johnstone, E., McPherson, K., Palmer, R. L., Crow, T. J. & Brandon, S. (1992). Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. British Journal of Psychiatry, 160, 355–9.
Burd, L., Fisher, W., Vesely, B. N., Williams, M., Kerbeshian, J. & Leech, C. (1991). Prevalence of psychoactive drug use among North Dakota group home residents. American Journal of Mental Retardation, 96, 119–26.
Burke, W. J., Rubin, E. H., Zorumski, C. F. & Wetzel, R. D. (1987). The safety of ECT in geriatric psychiatry. Journal of the American Geriatrics Society, 35, 516–21.
Burt T., Lisanby, S. H. & Sackeim, H. (2002). Neuropsychiatric applications of transcranial magnetic stimulation: a meta-analysis. International Journal of Neuropsychopharmacology, 5, 73–103.
Calev, A., Ben-Tzvi, E., Shapira, B., Drexler, H., Carasso, R. & Lerer, B. (1989). Distinct memory impairments following electroconvulsive therapy and imipramine. Psychology Medicine, 19, 111–19.
Calev, A., Kochavlev, E., Tubi, N. et al. (1991a). Change in attitude toward electroconvulsive therapy: effects of treatment, time since treatment, and severity of depression. Convulsive Therapy, 7, 184–9.
Calev, A., Nigal, D., Shapira, B. et al. (1991b). Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. Journal of Nervous and Mental Disorders, 179, 526–33.
Caplan, G. (1945). Treatment of epilepsy by electrically induced convulsions. A preliminary report. British Medical Journal, 1, 511–12.
Caplan, G. (1946). Electrical convulsion therapy in treatment of epilepsy. Journal of Mental Science, 784–93.
Carlyle, W., Killick, L. & Ancill, R. (1991). ECT: an effective treatment in the screaming demented patient. Journal of the American Geriatrics Society, 39, 637.
Cardwell, B. A. & Nakai, B. (1995). Seizure activity in combined clozapine and ECT: a retrospective view. Convulsive Therapy, 11, 110–13.
Cattan, R. A., Barry, P. P., Mead, G., Reefe, W. E., Gay, A. & Silverman, M. (1990). Electroconvulsive therapy in octogenarians. Journal of the American Geriatrics Society, 38, 753–8.
Chan, C. H., Janicak, P. G., Davis, J. M., Altman, E., Andriukaitis, S. & Hedeker, D. (1987). Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. Journal of Clinical Psychiatry, 48, 197–200.
Chanpattana, W., Chakrabhand, M. L., Sackeim, H. A. et al. (1999). Continuation ECT in treatment-resistant schizophrenia: a controlled study. Journal of ECT, 15, 178–92.
Chanpattana, W. & Chakrabhand, M. L. (2001). Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Research, 105, 107–15.
Chanpattana, W. & Kramer, B. A. (2003). Acute and maintenance ECT with flupentixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophrenia Research, 63, 189–93.
Chanpattana, W. (1999). Maintenance ECT in mentally retarded, treatment-resistant schizophrenic patients. Journal of ECT, 5, 150–3.
Chanpattana, W. (2000). Maintenance ECT in treatment-resistant schizophrenia. Journal of the Medical Association of Thailand, 83, 657–62.
Chen, P., Ganguli, M., Mulsant, B. H. & DeKosky, S. T. (1999). The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Archives in General Psychiatry, 56, 261–6.
Clarke, T. B., Coffey, C. E., Hoffman, G. W. & Weiner, R. D. (1989). Continuation therapy for depression using outpatient electroconvulsive therapy. Convulsive Therapy, 5, 330–7.
Coffey, C. E., Weiner, R. D., Djang, W. T. et al. (1991). Brain anatomic effects of ECT: a prospective magnetic resonance imaging study. Archives in General Psychiatry, 48, 1013–21.
Cohen, D., Paillere-Martinot, M. L. & Basquin, M. (1997). Use of electroconvulsive therapy in adolescents. Convulsive Therapy, 13, 25–31.
Coleman, E. A., Sackeim, H. A., Prudic, J., Devanand, D. P., McElhiney, M. C. & Moody, B. J. (1996). Subjective memory complaints before and after electroconvulsive therapy. Biological Psychiatry, 39, 346–56.
Conca, A., Koppi, S., Konig, P., Swoboda, E. & Krecke, N. (1996). Transcranial magnetic stimulation: a novel antidepressive strategy? Neuropsychobiology, 34, 204–7.
Conwell, Y., Duberstein, P. R. & Caine, E. D. (2002). Risk factors for suicide in later life. Biological Psychiatry, 52, 193–204.
Copper, R. L., Goldenberg, R. L., Das, A. et al. (1996). The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks gestation. American Journal of Obstetrics and Gynecology, 175, 1286–92.
Coppen, A., Milln, P., Harwood, J. & Wood, K. (1985). Does the dexamethasone suppression test predict antidepressant treatment success? British Journal of Psychiatry, 146, 294–6.
Coryell, W. (1982). Hypothalamic-pituitary-adrenal axis abnormality and ECT response. Psychiatry Research, 6, 283–91.
Couturier, J. L. (2005). Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. Journal of Psychiatry and Neuroscience, 30, 83–90.
Currier, M. B., Murray, G. B. & Welch, C. C. (1992). Electroconvulsive therapy for post-stroke depressed geriatric patients. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 140–4.
Cutjar, P. & Wilson, D. (1999). The use of ECT in intellectual disability. Journal of Intellectual Disability Research, 43, 421–7.
Davis, J. M., Janicak, P. G., Sakkas, P., Gilmore, C. & Wang, Z. (1991). Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Therapy, 7, 111–20.
d'Elia, G. (1970). Unilateral electroconvulsive therapy. Acta Psychiatrica Scandinavica, 215 (Suppl.), 1–98.
Dalby, N. O., Tonder, N., Wolby, D. P., West, M., Finsen, B. & Bolwig, T. G. (1996). No loss of hippocampal hilar somatostatinergic neurons after repeated electroconvulsive shock: a combined stereological and in situ hybridization study. British Journal of Psychiatry, 169, 68–74.
Decina, P., Guthrie, E. B., Sackeim, H. A., Kahn, D. & Malitz, S. (1987). Continuation ECT in the management of relapses of major affective episodes. Acta Psychiatrica Scandinavica, 75, 559–62.
Devanand, D. P., Fitzsimons, L., Prudic, J. & Sackeim, H. A. (1995). Subjective side effects during electroconvulsive therapy. Convulsive Therapy, 11, 232–40.
Devanand, D. P., Decina, P., Sackeim, H. A., Hopkins, N., Novacenko, H. & Malitz, S. (1987). Serial dexamethasone suppression tests in initial suppressors and non-suppressors treated with electroconvulsive therapy. Biological Psychiatry, 22, 463–72.
Devanand, D. P., Sano, M., Tang, M. X. et al. (1996). Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Archives in General Psychiatry, 53, 175–82.
Devanand, D. P., Verma, A. K., Tirumalasetti, F. & Sackeim, H. A. (1991). Absence of cognitive impairment after more than 100 lifetime ECT treatments. American Journal of Psychiatry, 148, 929–32.
Dinan, T. G. & Barry, S. (1989). A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatrica Scandinavica, 80, 97–100.
Department of Health (1999). Electroconvulsive Therapy: Survey Covering the Period from January 1999 to March 1999. England. Bulletin 1999/22. London: Government Statistical Service.
Dombrovski, A. Y., Mulsant, B. H., Haskett, R. F., Prudic, J., Begley, A. E. & Sackeim, H. A. (2005). Predictors of remission after electroconvulsive therapy in unipolar depression. Journal of Clinical Psychiatry, 66, 1043–9.
Donahue, J. C. (2000). Electroconvulsive therapy and memory loss: anatomy of a debate. Journal of ECT, 16, 133–43.
Douyon, R., Serby, M., Klutchko, B. & Rotrosen, J. (1989). ECT and Parkinson's disease revisited: a “naturalistic” study. American Journal of Psychiatry, 146, 1451–5.
Duncan, A. J., Ungvari, G. S., Russell, R. J. & Seifert, A. (1990). Maintenance ECT in very old age. Annals of Clinical Psychiatry, 2, 139–44.
Dunn, C. G. & Quinlan, D. (1978). Indicators of ECT response and non-response in the treatment of depression. Journal of Clinical Psychiatry, 39, 620–2.
Ende, G., Braus, D. F., Walter, S., Walter, S., Weber-Fahr, W. & Henn, F. A. (2000). The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Archives in General Psychiatry, 57, 937–43.
Endler, N. S. (1988). The origins of electroconvulsive therapy (ECT). Convulsive Therapy, 4, 5–23.
Ferrill, M. J., Kehoe, W. A. & Jacisin, J. J. (1992). ECT during pregnancy: physiologic and pharmacologic considerations. Convulsive Therapy, 8, 186–200.
Field, T. M. (1998). Depressed Mothers and their Newborns. Paper presented at the 11th Biennial Conference on Infant Studies, Atlanta, GA.
Field, T., Diego, M., Hernandez-Reif, M., Schanberg, S. & Kuhn, C. (2002). Relative right versus left frontal EEG in neonates. Developmental Psychobiology, 41, 147–55.
Figiel, G. S., Epstein, C., McDonald, W. M. et al. (1998). The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 20–25.
Fink, M. (1979). Convulsive Therapy: Theory and Practice. New York: Raven Press.
Fink, M. (1984). Meduna and the origins of convulsive therapy. American Journal of Psychiatry, 141, 1034–41.
Fink, M. (1986). Neuroendocrine predictors of electroconvulsive therapy outcome. Dexamethasone suppression test and prolactin. Annals of the New York Academy of Sciences, 462, 30–6.
Fink, M., Kellner, C. & Sackeim, H. A. (1999). Intractable seizures, status epilepticus, and ECT. Journal of ECT, 15, 282–4.
Fink, M., Bailine, S. & Petrides, G. (2001). Electrode placement and electroconvulsive therapy: a search for the chimera. Archives of General Psychiatry, 58, 607–9.
Fink, M. & Taylor, M. A. (2003). Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge: Cambridge University Press.
Fink, M., Taylor, M. A. & Ghaziuddin, N. (2006). Catatonia in autistic spectrum disorders: a medical treatment algorithm. In Catatonia in Autism Spectrum Disorders, ed. D. M. Dhossche, L. Wing, M. Ohta & K-J. Neumarker, pp. 233–44. Amsterdam: Elsevier/Academic Press.
Fischer, P., Simanyi, M. & Danielczyk, W. (1990). Depression in dementia of the Alzheimer type and in multi-infarct dementia. American Journal of Psychiatry, 147, 1484–7.
Folkerts, H. (1996). The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. European Archives of Psychiatry and Clinical Neuroscience, 246, 155–64.
Folkerts, H. W., Michael, N., Tolle, R., Schonauer, K., Mucke, S. & Schulze-Monking, H. (1997). Electroconvulsive therapy vs. paroxetine in treatment-resistant depression – a randomized study. Acta Psychiatrica Scandinavica, 96, 334–42.
Fox, H. A. (2001). Extended continuation and maintenance ECT for long-lasting episodes of major depression. Journal of ECT, 17, 60–4.
Frances, A., Weiner, R. D. & Coffey, C. E. (1989). ECT for an elderly man with psychotic depression and concurrent dementia. Hospital and Community Psychiatry, 40, 237–38, 242.
Frankel, F. H. (1973). Electro-convulsive therapy in Massachusetts: a task force report. Massachusetts Journal of Mental Health, 3, 3–29.
Fantz, R. M., Markowitz, J. S. & Kellner, C. H. (1998). Sumatriptan for post-ECT headache. Journal of ECT, 14, 272–4.
Freeman, C. P. (2000). The ECT Handbook. London: Royal College of Psychiatrists.
Freeman, C. P. & Kendell, R. E. (1980). ECT: I. Patients' experiences and attitudes. British Journal of Psychiatry, 137, 8–16.
Freeman, C. P. L., Basson, J. V. & Crichton, A. (1978). Double-blind controlled trial of electroconvulsive therapy (ECT) and simulated ECT in depressive illness. Lancet, I, 738–40.
Frith, C. D., Stevens, M., Johnstone, E. C., Deakin, J. F., Lawler, P. & Crow, T. J. (1983). Effects of ECT and depression on various aspects of memory. British Journal of Psychiatry, 142, 610–17.
Gagne, G. G. Jr., Furman, M. J., Carpenter, L. L. & Price, L. H. (2000). Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. American Journal of Psychiatry, 157, 1960–5.
Gangadhar, B. N., Kapur, R. L. & Kalyanasundarum, S. (1982). Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. British Journal of Psychiatry, 141, 367–71.
Geoghegan, J. J. & Stevenson, G. H. (1949). Prophylactic electroshock. American Journal of Psychiatry, 105, 494–5.
George, M. S. & Wassermann, E. M. (1994). Rapid-rate transcranial magnetic stimulation and ECT. Convulsive Therapy, 10, 251–4.
George, M. S., Wassermann, E. M., Kimbrell, T. A. et al. (1997). Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. American Journal of Psychiatry, 154, 1752–6.
Ghaziuddin, N., Kaza, M., Ghazi, N., King, C., Walter, G. & Rey, J. M. (2001). Electroconvulsive therapy for minors: experiences and attitudes of child psychiatrists and psychologists. Journal of ECT, 17, 109–17.
Ghaziuddin, N., King, C. A., Naylor, M. W. et al. (1996). Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression. Journal of Child and Adolescent Psychopharmacology, 6, 259–71.
Glover, V. (1999). Maternal stress or anxiety during pregnancy and the development of the baby. Practising Midwife, 2, 20–2.
Glover, V., Teixeira, J., Gitau, R. & Fisk, N. (1998). Links between Antenatal Maternal Anxiety and the Fetus. Paper presented at the 11th Biennial Conference on Infant Studies, Atlanta, GA.
Goldstein, M. Z. & Jensfold, M. F. (1989). ECT treatment of an elderly mentally retarded man. Psychosomatic, 30, 104–6.
Gonzales, M. D. C., Palomar, M. & Rovira, R. (1997). Electroconvulsive therapy for status epilepticus. Annals of Internal Medicine, 127, 247–8.
Gormley, N., Cullen, C.. Walters, L., Philpot, M. & Lawlor, B. (1998). The safety and efficacy of electroconvulsive therapy in patients over age 75. International Journal of Geriatric Psychiatry, 13, 871–4.
Grant, J. E. & Mohan, S. N. (2001). Treatment of agitation and aggression in four demented patients using ECT. Journal of ECT, 17, 205–9.
Gregory, S., Shawcross, C. R. & Gill, D. (1985). The Nottingham ECT Study. A double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. British Journal of Psychiatry, 146, 520–4.
Griesemer, D. A., Kellner, C. H., Beale, M. D. & Smith, G. M. (1997). Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology, 49, 1389–92.
Grunhaus, L., Zelnik, T., Albala, A. A. et al. (1987). Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. Journal of Affective Disorders, 13, 233–40.
Grunhaus, L., Pande, A. C. & Haskett, R. F. (1990). Full and abbreviated courses of maintenance electroconvulsive therapy. Convulsive Therapy, 6, 130–8.
Grunhaus, L., Dolberg, O. & Lustig, M. (1995). Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. Journal of Psychiatric Research, 29, 165–72.
Grunhaus, L., Dannon, P. N., Schreiber, S. et al. (2000). Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of non-delusional major depressive disorder: an open study. Biological Psychiatry, 47, 314–24.
Grunhaus, L., Schreiber, S., Dolberg, O. T., Polak, D. & Dannon, P. N. (2003). A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biological Psychiatry, 53, 324–31.
Guze, B., Weinman, B. & Diamond, R. (1987). Use of ECT to treat bipolar depression in a mentally retarded with cerebral palsy. Convulsive Therapy, 3, 60–4.
Hall, W. D., Mant, A., Mitchell, P. B., Rendle, V. A., Hickie, I. B. & McManus, P. (2003). 1991–2000. Association between antidepressant prescribing and suicide in Australia, trend analysis. British Medical Journal, 326, 1008–11.
Hancock, R. D., Weber, S. L., Kaza, R. & Her, K. S. (1991). Changes in psychotropic drug use in long-term residents of an ICF/MR facility. American Journal of Mental Retardation, 96, 137–41.
Handforth, A. (1982). Postseizure inhibition of kindled seizures by electroconvulsive shock. Experimental Neurology, 78, 483–91.
Hawkins, J. M., Archer, K. J., Strakowski, S. M. & Keck, P. E. (1995). Somatic treatment of catatonia. International Journal of Psychiatry in Medicine, 25, 345–69.
Heath, E. S., Adams, A. & Wakeling, P. L. G. (1964). Short courses of ECT and simulated ECT in chronic schizophrenia. British Journal of Psychiatry, 110, 800–7.
Hedegaard, M., Henriksen, T. B., Secher, N. J., Hatch, M. C. & Sabroe, S. (1996). Do stressful life events affect duration of gestation and risk of preterm delivery? Epidemiology, 7, 339–45.
Heim, C. & Nemeroff, C. B. (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biological Psychiatry, 49, 1023–30.
Hermann, R. C., Ettner, S. L., Dorwart, R. A., Hoover, C. W. & Young, E. (1998). Characteristics of psychiatrists who perform ECT. American Journal of Psychiatry, 155, 889–94.
Hermann, R. C., Dorwart, R. A., Hoover, C. W. & Brody, J. (1995). Variation in ECT use in the United States. American Journal of Psychiatry, 152, 869–75.
Hickie, I., Mason, C., Parker, G. & Brodaty, H. (1996). Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. British Journal of Psychiatry, 169, 68–74.
Holsboer, F. (2001). Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorder, 62, 77–91.
Hoyle, N. R., Pratt, R. T. & Thomas, D. G. (1984). Effects of electroconvulsive therapy on serum myelin basic protein immunoreactivity. British Medical Journal, 288, 1110–11.
Hrdlicka, M., Moran, M., Vachutka, J. et al. (1996). EEG correlates of therapeutic effects of electroconvulsive therapy. Ceska a Slovenska Psychiatrie, 92, 32–40.
Husain, M. M., Meyer, D. E., Muttakin, M. H. & Weiner, M. (1993). Maintenance ECT for treatment of recurrent mania. American Journal of Psychiatry, 150, 985.
Husain, M. M., Rush, A. J., Fink, M. et al. (2004). Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. Journal of Clinical Psychiatry, 65, 485–91.
Isometsa, E. T., Henriksson, M. M., Heikkinen, M. E. & Lonnqvist, J. K. (1996). Completed suicide and recent electroconvulsive therapy in Finland. Convulsive Therapy, 12, 152–5.
Janakiramaiah, N., Gangadhar, B. N., Naga, V. et al. (2000). Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. Journal of Affective Disorders, 57, 255–9.
Janicak, P. G., Dowd, S. M., Martis, B. et al. (2002). Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biological Psychiatry, 51, 659–67.
Johnstone, E. C., Deakin, J. F., Lawler, P. et al. (1980). The Northwick Park electroconvulsive therapy trial. Lancet, 2, 1317–20.
Jones, B. P., Henderson, M. & Welch, C. A. (1988). Executive functions in unipolar depression before and after electroconvulsive therapy. International Journal of Neuroscience, 38, 287–97.
Kales, H. C., Dequardo, J. R. & Tandon, R. (1999). Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 23, 547–56.
Kalinowsky, L. B. & Kennedy, F. (1943). Observations in electric shock therapy applied to problems of epilepsy. Journal of Nervous Mental Disease, 98, 56–67.
Karliner, W. & Wehrheim, H. K. (1965). Maintenance convulsive treatments. American Journal of Psychiatry, 121, 1113–15.
Karvounis, S., Holt, G. & Hodgkiss, A. (1992). Outpatient ECT for depression in a man with moderate learning disability. British Journal of Psychiatry, 161, 426–7.
Katona, C. L., Aldridge, C. R., Roth, M. & Hyde, J. (1987). The dexamethasone suppression test and prediction of outcome in patients receiving ECT. British Journal of Psychiatry, 150, 315–18.
Kearns, A. (1987). Cotard's syndrome in a mentally retarded man. British Journal of Psychiatry, 150, 112–14.
Kellner, C. H. & Bernstein, H. J. (1993). ECT as a treatment for neurologic illness. In Clinical Science of Electroconvulsive Therapy, ed. C. E. Coffey, pp. 183–210. Washington, DC: American Psychiatric Press.
Kellner, C. H., Husain, M., Petrides, G., Fink, M. & Rummans, T. (2002). Comment on “Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial”. Biological Psychiatry, 52, 1032–3.
Kellner, C. H., Fink, M., Knapp, R. et al. (2005). Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. American Journal of Psychiatry, 162, 977–82.
Kennedy, R., Mittal, D. & O'Jile, J. (2003). Electroconvulsive therapy in movement disorders: an update. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 407–21.
Khan, A., Warner, H. A. & Brown, W. A. (2000). Symptom reduction and suicide risk inpatients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Archives in General Psychiatry, 57, 311–17.
Kho, K. H. (2002). Treatment of rapid cycling bipolar disorder in the acute and maintenance phase with ECT. Journal of ECT, 18, 159–61.
Kindler, S., Shapira, B., Hadjez, J., Abramowitz, M., Brom, D. & Lerer, B. (1991). Factors influencing response to bilateral electroconvulsive therapy in major depression. Convulsive Therapy, 7, 245–54.
Kramer, B. A. (1985). Use of ECT in California, 1977–1983. American Journal of Psychiatry, 142, 1190–2.
Kramer, B. A. (1999). A naturalistic review of maintenance ECT at a university setting. Journal of ECT, 15, 262–9.
Kramp, P. & Bolwig, T. G. (1981). Electroconvulsive therapy in acute delirious states. Comprehensive Psychiatry, 22, 368–71.
Krystal, A. D. & Coffey, C. E. (1997). Neuropsychiatric considerations in the use of electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 283–92.
Krystal, A. D., Weiner, R. D. & Coffey, C. E. (1995). The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 295–303.
Kutcher, S. & Robertson, H. A. (1995). Electroconvulsive therapy in treatment resistant bipolar youth. Journal of Child and Adolescent Psychopharmacology, 5, 167–75.
Kukopulos, A., Reginaldi, D., Tondo, L., Bernabei, A. & Caliari, B. (1977). Spontaneous length of depression and response to ECT. Psychological Medicine, 7, 625–9.
Kupchik, M., Spivak, B., Mester, R. et al. (2000). Combined electroconvulsive-clozapine therapy. Clinical Neuropharmacology, 23, 14–16.
Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H. & Ylikorkala, O. (2000). Depression and anxiety in early pregnancy and risk for preeclampsia. Obstetric Gynecology, 95, 487–90.
Lambourn, J. & Gill, D. (1978). A controlled comparison of simulated and real ECT. British Journal of Psychiatry, 133, 514–19.
Lauter, H. & Sauer, H. (1987). Electroconvulsive therapy: a German perspective. Convulsive Therapy, 3, 204–9.
Lazarus, A., Jaffe, R. & Dubin, W. (1990). Electroconvulsive therapy and major depression in Down's syndrome. Journal of Clinical Psychiatry, 51, 422–5.
Legendre, S. A., Stern, R. A., Solomon, D. A., Furman, M. J. & Smith, K. E. (2003). The influence of cognitive reserve on memory following electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 333–9.
Leung, M., Hollander, Y. & Brown, G. R. (2004). Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. Journal of Clinical Psychiatry, 64, 551–3.
Liang, R. A., Lam, R. W. & Ancill, R. J. (1988). ECT in the treatment of mixed depression and dementia. British Journal of Psychiatry, 152, 281–4.
Lindefors, N., Brodin, E. & Metsis, M. (1995). Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNa in rat hippocampus by electroconvulsive shock. Neuroscience, 65, 661–70.
Lipman, R. S., Backup, C., Bobrin, Y. et al. (1986). Dexamethasone suppression test as a predictor of response to electroconvulsive therapy. I. Inpatient treatment. Convulsive Therapy, 2, 151–60.
Lisanby, S. H., Bazil, C. E., Resor, S. R., Nobler, M. S., Finck, D. A. & Sackeim, H. A. (2001). ECT in the treatment of status epilepticus. Journal of ECT, 17, 210–15.
Lisanby, S. H., Maddox, J. H., Prudic, J., Devanand, D. P. & Sackeim, H. A. (2000). The effects of electroconvulsive therapy on memory of autobiographical and public events. Archives in General Psychiatry, 57, 581–90.
Loo, H., Galinowski, A., De Carvalho, W., Bourdel, M. C. & Poirier, M. F. (1991). Use of maintenance ECT for elderly depressed patients. American Journal of Psychiatry, 148, 810.
Lopez, J. F., Chalmers, D. T., Little, K. Y., Watson, S. J. & Bennett, A. E. (1998). Regulation of serotonin1 A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biological Psychiatry, 43, 547–73.
Magni, G., Fisman, M. & Helmes, E. (1988). Clinical correlates of ECT-resistant depression in the elderly. Journal of Clinical Psychiatry, 49, 405–7.
Mander, A. J., Whitfield, A., Kean, D., Smith, M. A., Douglas, R. H. & Kendell, R. E. (1987). Cerebral and brain stem changes after ECT revealed by nuclear magnetic resonance imaging. British Journal of Psychiatry, 151, 69–71.
Manly, D. T., Oakley, S. P. Jr & Bloch, R. M. (2000). Electroconvulsive therapy in old-old patients. American Journal of Geriatric Psychiatry, 8, 232–6.
Mann, S. C., Caroff, S. N., Bleier, H. R., Welz, W. K., Kling, M. A. & Hayashida, M. (1986). Lethal catatonia. American Journal of Psychiatry, 143, 1374–81.
Mann, S. C., Caroff, S. N., Bleier, H. R., Antelo, R. E. & Un, H. (1990). Electroconvulsive therapy of the lethal catatonia syndrome. Convulsive Therapy, 6, 239–47.
Mann, S. C., Caroff, S. N., Fricchione, G. L. & Greenstein, R. A. (2004). Malignant catatonia. In Catatonia: from Psychopathology to Neurobiology, ed. S. N. Caroff, S. C. Mann, A. Francais & G. L. Fricchione, pp. 105–19. Washington, DC: American Psychiatric Publishing, Inc.
Markowitz, J. S., Kellner, C. H., DeVane, C. L. et al. (2001). Intranasal sumatriptan in post-ECT headache: results of an open-label trial. Journal of ECT, 17, 280–3.
Martin, J. L., Barbanoj, M. J., Schlaepfer, T. E. et al. (2003). Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. British Journal of Psychiatry, 182, 480–91.
Mattes, J. A., Pettinati, H. M., Stephens, S., Robin, S. E. & Willis, K. W. (1990). A placebo-controlled evaluation of vasopressin for ECT-induced memory impairment. Biological Psychiatry, 27, 289–303.
McCall, W. V., Reboussin, D. M., Weiner, R. D. & Sackeim, H. A. (2000). Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Archives of General Psychiatry, 57, 438–44.
McDonald, I. M., Perkins, G., Marjerrison, G. & Podilsky, M. (1966). A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. American Journal of Psychiatry, 122, 1427–31.
McDonald, W. M. & Thompson, T. R. (2001). Treatment of mania in dementia with electroconvulsive therapy. Psychopharmacology Bulletin, 35, 72–82.
McElhiney, M. C., Moody, B. J., Steif, B. L., Prudic, J., Devanand, D. P. & Nobler, M. S. (1995). Autobiographical memory and mood effects of electroconvulsive therapy. Neuropsychology, 9, 501–17.
Meldrum, B. S. (1986). Neuropathological consequences of chemically and electrically induced seizures. Annals of the New York Academy of Sciences, 462, 186–93.
Merrill, R. D. (1990). ECT for a patient with profound mental retardation. American Journal of Psychiatry, 147, 256–7.
Miller, D. H., Clancy, J. & Cummings, F. (1953). A comparison between unidirectional current nonconvulsive electrical stimulation, alternating current electroshock and pentothal in chronic schizophrenia. American Journal of Psychiatry, 109, 617–20.
Miller, L. J. (1994). Use of electroconvulsive therapy during pregnancy. Hospital and Community Psychiatry, 45, 444–50.
Moise, F. N. & Petrides, G. (1996). Case study: electroconvulsive therapy in adolescents.[see comment]. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 312–18.
Moreno, E. M., Martin, M. J., Sanchez, V. J. & Vazquez, G. T. (1998). Electroconvulsive therapy in the first trimester of pregnancy. Journal of ECT, 14, 251–4.
Monroe, R. R., Jr (1991). Maintenance electroconvulsive therapy. Psychiatric Clinics of North America, 14, 947–60.
Mukherjee, S., Sackeim, H. A. & Lee, C. (1988). Unilateral ECT in the treatment of manic episodes. Convulsive Therapy, 4, 74–80.
Mukherjee, S., Sackeim, H. A. & Schnur, D. B. (1994). Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. American Journal of Psychiatry, 151, 169–76.
Mulsant, B. H., Haskett, R. F., Prudic, J. et al. (1997). Low use of neuroleptic drugs in the treatment of psychotic major depression. American Journal of Psychiatry, 154, 559–61.
Murray, G. B., Shea, V. & Conn, D. K. (1986). Electroconvulsive therapy for poststroke depression. Journal of Clinical Psychiatry, 47, 258–60.
Nibuya, M., Morinobu, S. & Duman, R. S. (1995). Regulation of BDNF and trkB mRNS in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience, 15, 7539–47.
Nobler, M. S., Sackeim, H. A., Solomou, M., Luber, B., Devanand, D. P. & Prudic, J. (1993). EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biological Psychiatry, 34, 321–30.
Nobler, M. S., Luber, B., Moeller, J. R. et al. (2000). Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. Journal of ECT, 16, 211–28.
O'Connell, B. K., Towfighi, J., Kofke, W. A. & Hawkins, R. A. (1988). Neuronal loss in mercaptopropionic acid-induced status epilepticus. Acta Neuropathologica, 77, 47–54.
O'Connor, M. K., Knapp, R., Husain, M. et al. (2001). The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. American Journal of Geriatric Psychiatry, 9, 382–90.
O'Connor, T. G., Heron, J., Golding, J., Beveridge, M. & Glover, V. (2002). Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and children. British Journal of Psychiatry, 180, 502–8.
Oms, A., Miro, E. & Rojo, J. E. (1998). Sumatriptan was effective in electroconvulsive therapy (ECT) headache. Anesthesiology, 89, 1291–2.
Pagnin, D., de Queiroz, V., Pini, S. & Cassano, G. B. (2004). Efficacy of ECT in depression: a meta-analytic review. Journal of ECT, 20, 13–20.
Pande, A. C., Grunhaus, L. J., Aisen, A. M. & Haskett, R. F. (1990). A preliminary magnetic resonance imaging study of ECT-treated depressed patients. Biological Psychiatry, 27, 91–3.
Parker, G., Hadzi-Pavlovic, D., Brodaty, H., Boyce, P., Mitchell, P., Wilhelm, K. & Hickie, I. (1992). Predicting the course of melancholic and nonmelancholic depression. A naturalistic comparison study. Journal of Nervous and Mental Disease, 180, 693–702.
Pascual-Leone, A., Rubio, B., Pallardo, F. & Catala, M. D. (1996). Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet, 348, 233–7.
Perera, T. D., Luber, B., Nobler, M. S., Prudic, J., Anderson, C. & Sackeim, H. A. (2004). Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects. Neuropsychopharmacology, 29, 813–25.
Petrides, G., Dhossche, D., Fink, M. & Francis, A. (1994). Continuation ECT: relapse prevention in affective disorders. Convulsive Therapy, 10, 189–94.
Petrides, G., Fink, M., Husain, M. M. et al. (2001). ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. Journal of ECT, 17, 244–53.
Petrides, G., Malur, C. & Fink, M. (2004). Convulsive therapy. In Catatonia: from Psychopathology to Neurobiology, ed. S. N. Caroff, S. C. Mann & G. L. Fricchione, pp. 151–60. Washington, DC: American Psychiatric Publishing, Inc.
Philbrick, K. L. & Rummans, T. A. (1994). Malignant catatonia. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 1–13.
Poindexter, A. R. (1989). Psychotropic drug patterns in a large ICF/MR facility: a ten-year experience. American Journal of Mental Retardation, 93, 624–6.
Post, R. M., Weiss, S. R. B. & Pert, A. (1988). Cocaine-induced behavioral sensitizations and kindling: implications for emergence of psychopathology and seizures. Annals of the New York Academy of Sciences, 537, 292–308.
Post, R. M., Putnam, F., Contel, N. R. & Goldman, B. (1984). Electroconvulsive seizures inhibit amygdala kindling: implications for mechanisms of action in affective illness. Epilepsia, 25, 234–9.
Pridmore, S., Bruno, R., Turnier-Shea, Y., Red, P. & Rybak, M. (2000). Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. International Journal of Neuropharmacology, 3, 129–34.
Prudic, J. & Sackeim, H. A. (1999). Electroconvulsive therapy and suicide risk. Journal of Clinical Psychiatry, 60 (Suppl. 2), 104–10.
Prudic, J., Sackeim, H. A. & Devanand, D. P. (1990). Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Research, 31, 287–96.
Prudic, J., Haskett, R. F., Mulsant, B. et al. (1996). Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry, 153, 985–92.
Prudic, J., Olfson, M., Marcus, S. C., Fuller, R. B. & Sackeim, H. A. (2004). Effectiveness of electroconvulsive therapy in community settings. Biological Psychiatry, 55, 301–12.
Puri, B. K., Langa, A., Coleman, R. M. & Singh, I. (1992). The clinical efficacy of maintenance electroconvulsive therapy in a patient with a mild mental handicap. British Journal of Psychiatry, 161, 707–9.
Rami-Gonzales, L., Salamero, M., Boget, T., Catalan, R., Ferrer, J. & Bernardo (2003). Pattern of cognitive dysfunction in depressive patients during maintenance electroconvulsive therapy. Psychiatry in Medicine, 33, 345–50.
Rasmussen, K. G. Jr, Russell, J. C., Kung, S., Rummans, T. A., Rae-Stuart, E. & O'Connor, M. K. (2003). Electroconvulsive therapy for patients with major depression and probable Lewy body dementia. Journal of ECT, 19, 103–9.
Regenold, W. T., Weintraub, D. & Taller, A. (1998). Electroconvulsive therapy for epilepsy and major depression. American Journal of Geriatric Psychiatry, 6, 180–3.
Reisner, A. D. (2003). The electroconvulsive therapy controversy: evidence and ethics. Neuropsychological Review, 13, 199–219.
Rey, J. M. & Walter, G. (1997). Half a century of ECT use in young people. American Journal of Psychiatry, 154, 595–602.
Rifkin, A. (1988). ECT versus tricyclic antidepressants in depression: a review of the evidence. Journal of Clinical Psychiatry, 49, 3–7.
Roberts, J. K. A. (1986). Neuropsychiatric complications of mental retardation. Psychiatric Clinics of North America, 9, 647–57.
Robinson, R. G., Bolduc, P. L. & Price, T. R. (1987). Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke, 18, 837–943.
Roccaforte, W. H., Wengel, S. P. & Burke, W. J. (2000). ECT for screaming in dementia. American Journal of Geriatric Psychiatry, 8, 177.
Rosenberg, J. & Pettinati, H. M. (1984). Differential memory complaints after bilateral and unilateral ECT. Amerian Journal of Psychiatry, 141, 1071–4.
Rossi, A., Stratta, P., Nistico, R., Sabatini, M. D., Di Michele, V. & Casacchia, M. (1990). Visuospatial impairment in depression: a controlled ECT study. Acta Psychiatrica Scandinavica, 81, 245–9.
Roy, A. & Draper, R. (1995). Suicide among psychiatric hospital in-patients. Psychological Medicine, 25, 199–202.
Roy, C. R. & Overdyk, F. J. (1997). The adult patient. In Patient Safety in Anesthetic Practice, ed. R. C. Morell & J. H. Eichorn. St. Louis, MI: Churchill Livingstone.
Sackeim, H. A. (1986). Acute cognitive side effects of ECT. Psychopharmacological Bulletin, 22, 482–548.
Sackeim, H. A. (1992). The cognitive effects of electroconvulsive therapy. In Cognitive Disorders: Pathophysiology and Treatment, ed. W. H. Moos, E. R. Gamzu & L. J. Thal. New York: Marcel Dekker.
Sackheim, H. A. (1999). The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. Journal of ECT, 15, 5–26.
Sackeim, H. A., Decina, P., Prohovnik, I., Malitz, S. & Resor, S. R. (1983). Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biological Psychiatry, 18, 1301–10.
Sackeim, H. A., Portnoy, S., Neeley, P., Steif, B. L., Decina, P. & Malitz, S. (1987). Cognitive consequences of low-dose electroconvulsive therapy. Annals of the New York Academy of Sciences, 462, 326–40.
Sackeim, H. A., Decina, P., Kanzler, M., Kerr, B. & Malitz, S. (1987). Effects of electrode placement on the efficacy of titrated, low-dose ECT. American Journal of Psychiatry, 144, 1449–55.
Sackeim, H. A., Freeman, J., McElhiney, M. C., Coleman, E., Prudic, J. & Devanand, D. P. (1992). Effects of major depression on estimates of intelligence. Journal of Clinical and Experimental Neuropsychology, 14, 268–88.
Sackeim, H. A., Prudic, J., Devanand, D. P. et al. (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine, 328, 839–46.
Sackeim, H. A., Prudic, J., Devanand, D. P. (2000). A prospective, randomized, double-blind comparison of bilateral and right unilateral ECT at different stimulus intensities. Archives of General Psychiatry, 57, 425–34.
Sackeim, H. A., Haskett, R. F., Mulsant, B. H. et al. (2001). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. Journal of the American Medical Association, 285, 1299–307.
Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57, 925–35.
Shiwach, R. S., Reid, W. H. & Carmody, T. J. (2001). An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–1998. Psychiatric Services, 52, 1095–7.
Schneekloth. T. D., Rummans, T. A. & Logan, K. M. (1993). Electroconvulsive therapy in adolescents. Convulsive Therapy, 9, 158–66.
Schnur, D. B., Mukherjee, S., Silver, J., Degreef, G. & Lee, C. (1989). Electroconvulsive therapy in the treatment of episodic aggressive dyscontrol in psychotic patients. Convulsive Therapy, 5, 353–61.
Schwarz, T., Loewenstein, J. & Isenberg, K. E. (1995). Maintenance ECT: indications and outcome. Convulsive Therapy, 11, 14–23.
Scott, A. I. & Turnbull, L. W. (1990). Do repeated courses of ECT cause brain damage detectable by MRI? American Journal of Psychiatry, 147, 371–2.
Scott, B. W., Wojtowicz, J. M. & Burnham, W. M. (2000). Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Experimental Neurology, 165, 231–6.
Serra, M., Pisul, M. G., Dazzi, L., Purdy, R. H. & Biggio, G. (2002). Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine. Journal of Psychopharmacology, 16, 133–8.
Sharma, V. (1999). Retrospective controlled study of inpatient ECT; does it prevent suicide? Journal of Affective Disorders, 56, 183–7.
Sharma, V. (2001). The effect of electroconvulsive therapy on suicide risk in patients with mood disorders. Canadian Journal of Psychiatry, 46, 704–9.
Shulman, R. B. (2003). Maintenance ECT in the treatment of PD. Therapy improves psychotic symptoms, physical function. Geriatrics, 58, 43–5.
Sikdar, S., Kulhara, P., Avasthi, A. & Singh, H. (1994). Combined chlorpromazine and electroconvulsive therapy in mania. British Journal of Psychiatry, 164, 806–10.
Small, J. G., Klapper, M. H., Kellams, J. J. et al. (1988). Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry, 45, 727–32.
Smith, M. A., Zhang, L. X., Lyons, W. E. & Mamounas, L. A. (1997). Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. NeuroReport, 8, 1829–34.
Sobin, C., Sackeim, H. A., Prudic, J., Devanand, D. P., Moody, B. J. & McElhiney, M. C. (1995). Predictors of retrograde amnesia following ECT. American Journal of Psychiatry, 152, 995–1001.
Squire, L. R., Cohen, N. & Zouzounis, J. (1984). Preserved amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Archives of General Psychiatry, 38, 89–95.
Squire, L. R. & Slater, P. C. (1983). Electroconvulsive therapy and complaints of memory dysfunction: a prospective three-year follow-up study. British Journal of Psychiatry, 142, 1–8.
Strober, M., Rao, U., DeAntonio, M. et al. (1998). Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. Biological Psychiatry, 43, 335–8.
Suppes, T., Webb, A., Carmody, T. et al. (1996). Is postictal electrical silence a predictor of response to electroconvulsive therapy? Journal of Affective Disorders, 41, 55–8.
Suzuki, K., Awata, S. & Matsuoka, H. (2003). Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. Journal of ECT, 19, 73–80.
Swartz, C. M. (1989). Safety and ECT stimulus electrodes: I. Heat liberation at the electrode skin interface. Convulsive Therapy, 5, 171–5.
Swartz, C. M. (1994). Asymmetric bilateral right frontotemporal left frontal stimulus electrode placement for electroconvulsive therapy. Neuropsychobiology, 29, 174–8.
Takaoka, K. & Takata, T. (2003). Catatonia in childhood and adolescence. Psychiatry and Clinical Neuroscience, 57, 129–37.
Tang, W. K. & Ungvari, G. S. (2003). Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27, 373–9.
Tanney, B. L. (1986). Electroconvulsive therapy and suicide. Suicide and Life Threatening Behavior, 16, 116–40.
Taylor, M. A. (1982). Indications for electroconvulsive therapy. In Electroconvulsive Therapy: Biological Foundations and Clinical Applications, ed. R. Abrams & W. B. Essman, pp. 7–40. New York: Spectrum Publications.
Taylor, M. A. (2001). Use of suprathreshold electroconvulsive therapy. Archives of General Psychiatry, 58, 607.
Taylor, M. A. & Abrams, R. (1985). Short-term cognitive effects of unilateral and bilateral ECT. British Journal of Psychiatry, 146, 308–11.
Taylor, M. A. & Fink, M. (2006). Melancholia: The Diagnosis, Pathophysiology, and Treatment of Depressive Illness. Cambridge: Cambridge University Press.
Taylor, P. J. & Fleminger, J. J. (1980). ECT for schizophrenia. Lancet, I, 380–82.
Tew, J. D., Jr, Mulsant, B. H., Haskett, R. F. et al. (1999). Acute efficacy of ECT in the treatment of major depression in the old-old. American Journal of Psychiatry, 156, 1865–70.
Thienhaus, O. J., Margletta, S. & Bennett, J. A. (1990). A study of the clinical efficacy of maintenance ECT. Journal of Clinical Psychiatry, 51, 141–4.
Thompson, J. W., Weiner, R. D. & Myers, C. P. (1994). Use of ECT in the United States in 1975, 1980, and 1986. American Journal of Psychiatry, 151, 1657–61.
Thornton, J. E., Mulsant, B. H., Dealy, R. & Reynolds, C. F. (1990). Retrospective study of maintenance electroconvulsive therapy in a university-based psychiatry practice. Convulsive Therapy, 6, 121–9.
Thuppal, M. & Fink, M. (1999). Electroconvulsive therapy and mental retardation. Journal of ECT, 15, 140–9.
Tomac, T. A., Rummans, T. A., Pileggi, T. S. & Li, H. (1997). Safety and efficacy of electroconvulsive therapy in patients over age 85. American Journal of Geriatric Psychiatry, 5, 126–30.
Tondo, L., Baldessarini, R. J., Hennen, J., Floris, G., Silvetti, F. & Tohen, M. (1998). Lithium treatment and risk of suicidal behavior in bipolar disorder patients. Journal of Clinical Psychiatry, 59, 405–14.
Trollor, J. N. & Sachdev, P. S. (1999). Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Australia and New Zealand Journal of Psychiatry, 33, 650–9.
Tsao, C. I., Jain, S., Gibson, R. H., Guedet, P. J. & Lehrmann, J. A. (2004). Maintenance ECT for recurrent medication-refractory mania. Journal of ECT, 20, 118–19.
Tsuang, M. T., Dempsey, G. M. & Fleming, J. A. (1979). Can ECT prevent premature death and suicide in ‘schizoaffective’ patients? Journal of Affective Disorders, 1, 167–71.
UK ECT Review Group & Geddes, J. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet, 361, 799–808.
Ukpong, D. I., Makanjuola, R. O. & Morakinyo, O. (2002). A controlled trial of modified electroconvulsive therapy in schizophrenia in a Nigerian teaching hospital. West African Journal of Medicine, 21, 237–40.
Vaidya, N. A., Maableshwarkar, A. R. & Shahid, R. (2003). Continuation and maintenance ECT in treatment-resistant bipolar disorder. Journal of ECT, 19, 10–16.
Vaidya, V. A., Terwilliger, R. Z. & Duman, R. S. (2000). Alterations in heavy and light neurofilament proteins in hippocampus following chronic ECS administration, Synapse, 35, 137–43.
Van der Wurff, F. B., Stek, M. L., Hoogendijk, W. J. G. & Beekman, A. T. F. (2003). The efficacy and safety of ECT in depressed older adults, a literature review. International Journal of Geriatric Psychiatry, 18, 894–904.
Vanelle, J. M., Loo, H., Galinowski, A. et al. (1994). Maintenance ECT in intractable manic-depressive disorders. Convulsive Therapy, 10, 195–205.
Viparelli, U. & Viparelli, G. (1992). ECT and grand-mal epilepsy. Convulsive Therapy, 8, 39–42.
Vothknecht, S., Kho, K. H., van Schaick, H. W., Zwinderman, A. H., Middelkoop, H. & Blansjaar, B. A. (2003). Effects of maintenance electroconvulsant therapy on cognitive functions. Journal of ECT, 19, 151–7.
Walker, R. & Swartz, C. M. (1994). Electroconvulsive therapy during high-risk pregnancy. General Hospital Psychiatry, 16, 348–53.
Walter, G., Rey, J. M. & Starling, J. (1997). Experience, knowledge and attitudes of child psychiatrists regarding electroconvulsive therapy in the young. Australian and New Zealand Journal of Psychiatry, 31, 676–81.
Walter, G., Rey, J. M. & Mitchell, P. B. (1999). Practitioner review: electroconvulsive therapy in adolescents. Journal of Child Psychology and Psychiatry and Allied Disciplines, 40, 325–34.
Weiner, R. D. (1984), Does electroconvulsive therapy cause brain damage? Behavioral and Brain Sciences, 7, 1–53.
Weiner, S. J., Ward, T. N. & Ravaris, C. L. (1994). Headache and electroconvulsive therapy. Headache, 34, 155–9.
Weintraub, D. & Lippmann, S. B. (2000). Electroconvulsive therapy in the acute poststroke period. Journal of ECT, 16, 415–18.
Weintraub, D. & Lippmann, S. B. (2001). ECT for major depression and mania with advanced dementia. Journal of ECT, 17, 65–7.
Wengel, S. P., Burke, W. J., Pfeiffer, R. F., Roccaforte, W. H. & Paige, S. R. (1998). Maintenance electroconvulsive therapy for intractable Parkinson's disease. American Journal of Geriatric Psychiatry, 6, 263–9.
West, E. D. (1981). Electroconvulsive therapy in depression: a double blind controlled trial. British Medical Journal, 282, 355–7.
Zachrisson, O. C., Balldin, J., Ekman, R. et al. (2000). No evident neuronal damage after electroconvulsive therapy. Psychiatry Research, 96, 157–65.
Zuckerman, B., Bauchner, H., Parker, S. & Cabral, H. (1990). Maternal depressive symptoms during pregnancy, and newborn irritability. Journal of Developmental and Behavioral Pediatrics, 11, 190–4.
Zyss, T., Gorka, Z., Kowalska, M. & Vetulani, J. (1997). Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. Biological Psychiatry, 42, 920–4.

Reference Title: REFERENCES

Reference Type: reference-list

Abrams, R., Swartz, C. M. & Vedak, C. (1991). Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Archives of General Psychiatry, 48, 746–8.
Alonso, P., Pujol, J., Cardoner, N. et al. (2001). Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 1143–5.
Amar, A. P., Heck, C. N., Levy, M. L. et al. (1998). An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome. Neurosurgery, 43, 1265–80.
American Psychiatric Association (2001). The Practice of ECT: Recommendations for Treatment, Training and Privileging, 2nd edn. Washington, DC: American Psychiatric Press.
Aouizerate, B., Cuny, E., Martin-Guehl, C. et al. (2004). Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. Journal of Neurosurgery, 101, 682–6.
Avery, D. H., Holtzheimer, P. E., Fawaz, W. (2006). A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biological Psychiatry, 59, 187–94.
Awata, S., Konno, M., Kawashima, R. et al. (2002). Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy. Psychiatry and Clinical Neuroscience, 56, 31–40.
Bailey, P. & Bremer, F. (1938). A sensory cortical representation of the vagus nerve. Journal of Neurophysiology, 405–12.
Bailine, S. H., Rifkin, A., Kayne, E. et al. (2000). Comparison of bifrontal and bitemporal ECT for major depression. American Journal of Psychiatry, 157, 121–3.
Barker, A. T., Jalinous, R. & Freeston, I. L. (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet, 1, 1106–7.
Belmaker, R. H. & Grisaru, N. (1999). Antibipolar potential for transcranial magnetic stimulation. Bipolar Disorder, 1, 71–2.
Benabid, A. L., Pollak, P., Gao, D. et al. (1996). Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. Journal of Neurosurgery, 84, 203–14.
Benabid, A. L., Pollak, P., Gervason, C. et al. (1991). Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet, 337, 403–6.
Benabid, A. L., Pollak, P., Louveau, A., Henry, S. & de Rougemont, J. (1987). Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Applied Neurophysiology, 50, 344–6.
Benbow, S. M. (2005). Adverse effects of ECT. In The ECT Handbook, 2nd edn, ed. A. Scott. London: Royal College of Psychiatrists.
Bohning, D. E., Lomarev, M. P., Denslow, S., Nahas, Z., Shastri, A. & George, M. S. (2001). Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. Investigative Radiology, 36, 470–9.
Brasil-Neto, J. P., Cohen, L. G., Panizza, M., Nilsson, J., Roth, B. J. & Hallett, M. (1992). Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. Journal of Clinical Neurophysiology, 9, 132–6.
Burt, T., Lisanby, S. H. & Sackeim, H. A. (2002). Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. International Journal of Neuropsychopharmacology, 5, 73–103.
Carpenter, L. L., Moreno, F. A., Kling, M. A. et al. (2004). Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry, 56, 418–26.
Chen, R., Classen, J., Gerloff, C. et al. (1997). Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology, 48, 1398–403.
Cohen, E., Bernardo, M., Masana, J. et al. (1999). Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. Journal of Neurology, Neurosurgery and Psychiatry, 67, 129–30.
Cohen, H., Kaplan, Z., Kotler, M., Kouperman, I., Moisa, R. & Grisaru, N. (2004). Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. American Journal of Psychiatry, 161, 515–24.
Conway, C. R., Chibnall, J. T., Li, X. & George, M. S. (2002). Changes in brain metabolism in response to chronic vagus nerve stimulation in depression. Biological Psychiatry, 51, 8S–544.
Coubes, P., Roubertie, A., Vayssiere, N., Hemm, S. & Echenne, B. (2000). Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet, 355, 2220–1.
d'Alfonso, A. A., Aleman, A., Kessels, R. P. et al. (2002). Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. Journal of Neuropsychiatry and Clinical Neuroscience, 14, 77–9.
Dannon, P. N., Dolberg, O. T., Schreiber, S. & Grunhaus, L. (2002). Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals – preliminary report. Biological Psychiatry, 51, 687–90.
Dell, P. & Olson, R. (1951). Projections secondaires mesencéphaliques, diencéphaliques et amygdaliennes des afférents viscérales vagales. Comptes Rendus de Société de Biologie, 145, 1088–91.
Delva, N. J., Brunet, D., Hawken, E. R., Kesteven, R. M., Lawson, J. S. & Waldron, J. J. (2000). Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. Journal of ECT, 16, 361–9.
Devinsky, O., Morrell, M. J. & Vogt, B. A. (1995). Contributions of anterior cingulated cortex to behaviour. Brain, 11, 8279–306.
Devous, M. D. (2001). Effects of VNS on regional cerebral blood flow in depressed subjects. Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression. Satellite Symposium in conjunction with the 7th World Congress of Biological Psychiatry. Berlin, Germany.
Driscoll, D. A. (1970). An investigation of a theoretical model of the human head with application to current flow calculations and EEG interpretation. Ph.D. Thesis, University of Vermont.
Elger, G., Hoppe, C., Falkai, P., Rush, A. J. & Elger, C. E. (2000). Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Research, 42, 203–10.
Epstein, C. M. (1990). Localizing the site of magnetic brain stimulation in humans. Neurology, 40, 666–70.
Feinsod, M., Kreinin, B., Chistyakov, A. & Klein, E. (1998). Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depression and Anxiety, 7, 65–8.
Fitzgerald, P. B., Brown, T. L., Marston, N. A., Daskalakis, Z. J., De Castella, A. & Kulkarni, J. (2003). Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Archives of General Psychiatry, 60, 1002–8.
Fitzgerald, P. B., Benitez, J., Daskalakis, J. Z. et al. (2005). A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology, 25, 358–62.
Fregni, F., Boggio, P. S., Nitsche, M., Marcolin, M. A., Rigonatti, S. P. & Pascual-Leone, A. (2006). Treatment of major depression with transcranial direct current stimulation. Bipolar Disorders, 8, 203–4.
Gabriels, L., Cosyns, P., Nuttin, B., Demeulemeester, H. & Gybels, J. (2003). Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatrica Scandinavica, 107, 275–82.
Garcia-Toro, M., Salva Coll, J., Crespi Font, M. et al. (2002). Panic disorder and transcranial magnetic stimulation. Actas Espagnola de Psiquiatria, 30, 221–4.
Geddes, L. A. & Baker, L. E. (1967). The specific resistance of biological material – a compendium of data for the biomedical engineer and physiologist. Medical and Biological Engineering, 5, 271–93.
Geller, V., Grisaru, N., Abarbanel, J. M., Lemberg, T. & Belmaker, R. H. (1997). Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 21, 105–10.
George, M. S. & Wassermann, E. M. (1994). Rapid-rate transcranial magnetic stimulation and ECT. Convulsive Therapy, 10, 251–4.
George, M. S., Post, R. M., Ketter, T. A., Kimbrell, T. A. & Speer, A. M. (1997). Neural mechanisms of mood disorders. Current Review of Mood and Anxiety Disorders, 1, 71–83.
George, M. S., Lisanby, S. H. & Sackeim, H. A. (1999). Transcranial magnetic stimulation: applications in neuropsychiatry. Archives of General Psychiatry, 56, 300–11.
George, M. S., Nahas, Z., Molloy, M. et al. (2000). A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry, 48, 962–70.
George, M. S., Rush, A. J., Marangell, L. B. et al. (2005). One-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry, 58, 364–73.
Gershon, A. A., Dannon, P. N. & Grunhaus, L. (2003). Transcranial magnetic stimulation in the treatment of depression. American Journal of Psychiatry, 160, 835–45.
Grisaru, N., Chudakov, B., Yaroslavsky, Y. & Belmaker, R. H. (1998). Catatonia treated with transcranial magnetic stimulation. American Journal of Psychiatry, 155, 1630.
Gottesfeld, B. H., Lesse, S. M. & Herskovitz, H. (1944). Studies in subconvulsive electric shock therapy effect of varied electrode applications. Journal of Nervous and Mental Disorders, 99, 56–64.
Greenberg, B. D., George, M. S., Martin, J. D. et al. (1997). Effects of prefrontal repetitive transcranial magnetic stimulation (rTMS) in obsessive-compulsive disorder: a preliminary study. American Journal of Psychiatry, 154, 867–9.
Greenberg, B. D., Ziemann, U., Harmon, A., Murphy, D. L. & Wassermann, E. M. (1998). Decreased neuronal inhibition in cerebral cortex in obsessive-compulsive disorder on transcranial magnetic stimulation. Lancet, 352, 881–2.
Greenberg, B. D., Ziemann, U., Cora-Locatelli, G. et al. (2000). Altered cortical excitability in obsessive-compulsive disorder. Neurology, 54, 142–7.
Greenberg, B. D., Price, L. H., Rauch, S. L. (2003). Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurgery Clinics of North America, 14, 199–212.
Gross, R. E. & Lozano, A. M. (2000). Advances in neurostimulation for movement disorders. Neurology Research, 22, 247–58.
Grunhaus, L., Dannon, P. N., Schreiber, S. et al. (2000). Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biological Psychiatry, 47, 314–24.
Hajak, G., Marienhagen, J., Langguth, B., Werner, S., Binder, H. & Eichhammer, P. (2004). High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychological Medicine, 34, 1157–63.
Harden, C. L., Pulver, M. C., Nikolov, B., Halper, J. P. & Labar, D. R. (1999). Effect of vagus nerve stimulation on mood in adult epilepsy patients. Neurology, 52 (Suppl. 2), A238-P03122.
Hargrove, E. A., Bennett, A. E. & Ford, F. R. (1953). The value of subconvulsive electrostimulation in the treatment of some emotional disorders. American Journal of Psychiatry, 109, 612–16.
Hayes, K. J. (1950). The current path in ECS. Archives of Neurology and Psychiatry, 63, 102–9.
Henry, M. E., Schmidt, M. E., Matochik, J. A., Stoddard, E. P. & Potter, W. Z. (2001). The effects of ECT on brain glucose: a pilot FDG PET study. Journal of ECT, 17, 33–40.
Henry, T. R., Votaw, J. R., Pennell, P. B. et al. (1999). Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology, 52, 1166–73.
Herwig, U., Lampe, Y., Juengling, F. D. et al. (2003). Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. Journal of Psychiatric Research, 37, 267–75.
Hodaie, M., Wennberg, R. A., Dostrovsky, J. O. & Lozano, A. M. (2002). Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia, 43, 603–8.
Hoffman, R. E., Boutros, N. N., Berman, R. M. et al. (1999). Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biological Psychiatry, 46, 130–2.
Hoffman, R. E., Boutros, N. N., Hu, S., Berman, R. M., Krystal, J. H. & Charney, D. S. (2000). Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet, 355, 1073–5.
Hoffman, R. E., Hawkins, K. A., Gueorguieva, R. et al. (2003). Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry, 60, 49–56.
Hoffman, R. E., Gueorguieva, R., Hawkins, K. A. et al. (2005). Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biological Psychiatry, 58, 97–104.
Holi, M. M., Eronen, M., Toivonen, K., Toivonen, P., Marttunen, M. & Naukkarinen, H. (2004). Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophrenia Bulletin, 30, 429–34.
Holtzheimer, P. E. 3rd, Russo, J. & Avery, D. H. (2001). A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacological Bulletin, 35, 149–69.
Hummel, F., Celnik, P., Giraux, P. et al. (2005). Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain, 128, 490–9.
Iyer, M. B., Mattu, M. A., Grafman, J., Lomarev, M., Sato, M. & Wassermann, E. (2005). Safety and cognitive effects of frontal DC brain polarization in healthy individuals. Neurology, 64, 872–5.
Jandl, M., Bittner, R., Sack, A. et al. (2004). Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. Journal of Neural Transmission, 112, 955–67.
Janicak, P. G., Dowd, S. M., Martis, B. et al. (2002). Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomised trial. Biological Psychiatry, 51, 659–67.
Jobe, P. C., Dailey, J. W. & Wernicke, J. F. (1999). A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Critical Reviews in Neurobiology, 13, 317–56.
Kaptsan, A., Yaroslavsky, Y., Applebaum, J., Belmaker, R. H. & Grisaru, N. (2003). Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disorder, 5, 36–9.
Kauffmann, C. D., Cheema, M. A. & Miller, B. E. (2004). Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depression and Anxiety, 19, 59–62.
Kimbrell, T. A., Little, J. T., Dunn, R. T. et al. (1999). Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry, 46, 1603–13.
Klein, E., Kolsky, Y., Puyerovsky, M., Koren, D., Chistyakov, A. & Feinsod, M. (1999). Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biological Psychiatry, 46, 1451–4.
Klein, E., Kreinin, I., Chistyakov, A. et al. (1999). Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Archives of General Psychiatry, 56, 315–20.
Kosel, M., Frick, C., Lisanby, S. H., Fisch, H. U. & Schlaepfer, T. E. (2003). Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology, 28, 2045–8.
Krahl, S. E., Clark, K. B., Smith, D. C. & Browning, R. A. (1998). Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia, 39, 709–14.
Lang, N., Siebner, H. R., Ward, N. S. et al. (2005). How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain? European Journal of Neuroscience, 22, 495–504.
Law, S. K. (1993). Thickness and resistivity variations over the upper surface of the human skull. Brain Topography, 6, 99–109.
Lerer, B., Shapira, B., Calev, A. et al. (1995). Antidepressant and cognitive effects of twice- versus three-times-weekly ECT. American Journal of Psychiatry, 152, 564–70.
Liebetanz, D., Nitsche, M., Tergau, F. & Paulus, W. (2002). Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain, 125, 2238–47.
Lisanby, S. H., Luber, B. L., Schroeder, C. et al. (1998a). rTMS in primates: intracerebral measurement of rTMS and ECS induced voltage in vivo. Electroencephalography and Clinical Neurophysiology, 107, 79P.
Lisanby, S. H., Luber, B., Schroeder, C. et al. (1998b). Intracerebral measurement of rTMS and ECS induced voltage in vivo. Biological Psychiatry, 43, 100S.
Lisanby, S. H., Maddox, J. H., Prudic, J., Devanand, D. P. & Sackeim, H. A. (2000). The effects of electroconvulsive therapy on memory of autobiographical and public events. Archives of General Psychiatry, 57, 581–90.
Lisanby, S. H. & Sackeim, H. A. (2000). TMS in major depression. In Transcranial Magnetic Stimulation (TMS): Applications in Neuropsychiatry, ed. M. S. George & R. H. Belmaker, pp. 185–200. Washington, DC: American Psychiatric Press.
Lisanby, S. H., Luber, B., Fincle, A. D., Schroeder, C. & Sackeim, H. A. (2001a). Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. [Erratum appears in Archives of General Psychiatry, (2001) 58(5), 515]. Archives of General Psychiatry, 58, 199–200.
Lisanby, S. H., Schlaepfer, T. E., Fisch, H. U. & Sackeim, H. A. (2001b). Magnetic seizure therapy of major depression. Archives of General Psychiatry, 58, 303–5.
Lisanby, S. H. & Sackeim, H. A. (2002). Transcranial magnetic stimulation and electroconvulsive therapy: similarities and differences. In Handbook of Transcranial Magnetic Stimulation, ed. A. Pascual-Leone, N. Davey, J. Rothwell, E. Wassermann & B. K. Puri, pp. 376–95. London: Arnold Publishers.
Lisanby, S. H., Luber, B., Schlaepfer, T. E. & Sackeim, H. A. (2003a). Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology, 28, 1852–65.
Lisanby, S., Husain, M., Morales, O. G. et al. (2003b). Controlled clinical trial of the antidepressant efficacy of magnetic seizure therapy in the treatment of major depression. ACNP Annual Meeting Abstracts, 166.
Lisanby, S. H. (2004). Magnetic seizure therapy: development of a novel convulsive technique. In Brain Stimulation in Psychiatric Treatment, ed. S. H. Lisanby, pp. 77–116. Arlington, VA: American Psychiatric Publishing.
Lomarev, M., Denslow, S., Nahas, Z., Chae, J. H., George, M. S. & Bohning, D. E. (2002). Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. Journal of Psychiatric Research, 36, 219–27.
Luber, B., Nobler, M. S., Moeller, J. R. et al. (2000). Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. Journal of ECT, 16, 229–43.
Maccabee, P. J., Amassian, V. E., Eberle, L. P. et al. (1991). Measurement of the electric field induced in inhomogeneous volume conductors by magnetic coils: application to human spinal neurogeometry. Electroencephalography and Clinical Neurophysiology, 81, 224–37.
Maccabee, P. J., Eberle, L., Amassian, V. E., Cracco, R. Q., Rudell, A. & Jayachandra, M. (1990). Spatial distribution of the electric field induced in volume by round and figure ‘8’ magnetic coils: relevance to activation of sensory nerve fibers. Electroencephalography and Clinical Neurophysiology, 76, 131–41.
Mantovani, A., Lisanby, S. H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P. & Rossi, S. (2006). Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). International Journal of Neuropsychopharmacology, 9, 95–100.
Mantovani, A., Lisanby, S. H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P. & Rossi, S. (2007). Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. Journal of Affective Disorders, in Press.
Martin, J. L., Barbanoj, M. J., Schlaepfer, T. E. et al. (2002). Transcranial magnetic stimulation for treating depression. Cochrane Database System Review, 2, CD003493.
Martin, J. L., Barbanoj, M. J., Schlaepfer, T. E., Thompson, E., Perez, V. & Kulisevsky, J. (2003). Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. British Journal of Psychiatry, 182, 480–91.
Mayberg, H. S., Lozano, A. M., Voon, V. et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45, 651–60.
McCall, W. V., Reboussin, D. M., Weiner, R. D. & Sackeim, H. A. (2000). Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Archives of General Psychiatry, 57, 438–44.
McCann, U. D., Kimbrell, T. A., Morgan, C. M. et al. (1998). Repetitive transcranial magnetic stimulation for post-traumatic stress disorder. Archives of General Psychiatry, 55, 276–9.
McElhiney, M. C., Moody, B. J., Steif, B. L. et al. (1995). Autobiographical memory and mood: effects of electroconvulsive therapy. Neuropsychology, 9, 501–17.
McIntosh, A. M., Semple, D., Tasker, K. et al. (2004). Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Research, 127, 9–17.
McIntyre, C. C., Savasta, M., Kerkerian-Le Goff, L. & Vitek, J. L. (2004). Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clinical Neurophysiology, 115, 1239–48.
Michael, N. & Erfurth, A. (2004). Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. Journal of Affective Disorder, 78, 253–7.
Mills, K. R., Boniface, S. J. & Schubert, M. (1992). Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalography and Clinical Neurophysiology, 85, 17–21.
Morales, O., Luber, B., Kwan, E., Ellsasser, R., Sackeim, H. A. & Lisanby, S. H. (2003). Prolactin response to convulsive therapy: Magnetic seizure therapy (MST) versus electroconvulsive shock (ECS) in nonhuman primates. Journal of ECT, 19, 58A.
Nahas, Z., Marangell, L. B., Husain, M. M. et al. (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry, 66, 1097–104.
Ng, C., Schweitzer, I., Alexopoulos, P. et al. (2000). Efficacy and cognitive effects of right unilateral electroconvulsive therapy. Journal of ECT, 16, 370–9.
Nitsche, M. A. (2002). Transcranial direct current stimulation: a new treatment for depression? Bipolar Disorders, 4, 98–9.
Nobler, M. S., Oquendo, M. A., Kegeles, L. S., Campbell, C., Sackeim, H. A. & Mann, J. J. (2001). Decreased regional brain metabolism after ECT. American Journal of Psychiatry, 158, 305–8.
Nobler, M. S., Sackeim, H. A., Prohovnik, I. et al. (1994). Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Archives of General Psychiatry, 51, 884–97.
Obeso, J. A., Olanow, C. W., Rodriguez-Oroz, M. C., Krack, P., Kumar, R. & Lang, A. E. (2001). Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. New England Journal of Medicine, 345, 956–63.
Padberg, F., Zwanzger, P., Thoma, H. et al. (1999). Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy- refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Research, 88, 163–71.
Pascual-Leone, A., Houser, C. M., Reese, K. et al. (1993). Safety of rapid-rate transcranial magnetic stimulation in normal volunteers. Electroencephalography and Clinical Neurophysiology, 89, 120–30.
Pascual-Leone, A., Rubio, B., Pallardo, F. & Catala, M. D. (1996). Beneficial effects of rapid-rate transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in drug resistant depression. Lancet, 248, 233–7.
Penry, J. K. & Dean, J. C. (1990). Prevention of intractable partial seizures by intermittent vagal nerve stimulation in humans: preliminary results. Epilepsy, 31, S40–S43.
Poulet, E., Brunelin, J., Bediou, B. et al. (2005). Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biological Psychiatry, 57, 188–91.
Pridmore, S., Rybak, M., Turnier-Shea, P., Reid, P., Bruno, R. & Couper, D. (1999). A naturalistic study of response in melancholia to transcranial magnetic stimulation (TMS). German Journal of Psychiatry, 2, 13–21.
Prudic, J., Peyser, S. & Sackeim, H. A. (2000). Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. Journal of ECT, 16, 121–32.
Redfearn, J. W., Lippold, O. C. & Costain, R. (1964). A preliminary account of the clinical effects of polarizing the brain in certain psychiatric disorders. British Journal of Psychiatry, 110, 773–85.
Rollnik, J. D., Huber, T. J., Mogk, H. et al. (2000). High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport, 11, 4013–15.
Rosenberg, P. B., Mehndiratta, R. B., Mehndiratta, Y. P., Wamer, A., Rosse, R. B. & Balish, M. (2002). Repetitive transcranial magnetic stimulation treatment of comorbid posttraumatic stress disorder and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 270–6.
Rossi, S., Bartalini, S., Ulivelli, M. et al. (2005). Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. Biological Psychiatry, 57, 16–20.
Rush, A. J., Marangell, L. B., Sackeim, H. A. et al. (2005a). Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biological Psychiatry, 58, 347–54.
Rush, A. J., Sackeim, H. A., Marangell, L. B. et al. (2005b). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biological Psychiatry, 58, 355–63.
Rush, S. & Driscoll, D. (1968). Current distribution in the brain from surface electrodes. Anesthesie et analgesie, 47, 717–23.
Saba, G., Rocamora, J. F., Kalalou, K. et al. (2002). Catatonia and transcranial magnetic stimulation. American Journal of Psychiatry, 159, 1794.
Sachdev, P. S., McBride, R., Loo, C. K., Mitchell, P. B., Malhi, G. S. & Croker, V. M. (2001). Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. Journal of Clinical Psychiatry, 62, 981–4.
Sachdev, P., Loo, C., Mitchell, P. & Malhi, G. (2005). Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry and Clinical Neuroscience, 59, 354–7.
Sackeim, H. A. (1992). The cognitive effects of electroconvulsive therapy. In Cognitive Disorders: Pathophysiology and Treatment, ed. W. H. Moos, E. R. Gamzu & L. J. Thal, pp. 183–228. New York: Marcel Dekker.
Sackeim, H. (1994). Magnetic stimulation therapy and ECT. Convulsive Therapy, 10, 255–8.
Sackeim, H. A., Portnoy, S., Neeley, P., Steif, B. L., Decina, P. & Malitz, S. (1986). Cognitive consequences of low-dosage electroconvulsive therapy. Annals of the New York Academy of Sciences, 462, 326–40.
Sackeim, H. A., Prudic, J., Devanand, D. P. et al. (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine, 328, 839–46.
Sackeim, H. A., Luber, B., Katzman, G. P. et al. (1996). The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Archives of General Psychiatry, 53, 814–24.
Sackeim, H. A., Prudic, J., Devanand, D. P. et al. (2000). A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry, 57, 425–34.
Sackeim, H. A., Keilp, J. G., Rush, A. J. et al. (2001b). The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 53–62.
Sackeim, H. A., Rush, A. J., George, M. S. et al. (2001a). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology, 25, 713–28.
Schachter, S. C. & Saper, C. B. (1998). Vagus nerve stimulation. Epilepsia, 39, 677–86.
Schmidek, H. H. & Sweet, W. H., ed. (1995). Operative Neurosurgical Techniques, 4th edn. Philadelphia, PA: WB Saunders Co.
Schonfeldt-Lecuona, C., Gron, G., Walter, H. et al. (2004). Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport, 15, 1669–73.
Silbersweig, D. A., Stern, E., Frith, C. et al. (1995). A functional neuroanatomy of hallucinations in schizophrenia. Nature, 378, 176–9.
Smitt, J. W. & Wegener, C. F. (1944). On electric convulsive therapy with particular regard to a parietal application of electrodes, controlled by intracerebral voltage measurements. Acta Psychiatrica Neurologica, 19, 529–49.
Sobin, C., Sackeim, H. A., Prudic, J., Devanand, D. P., Moody, B. J. & McEthiney, M. C. (1995). Predictors of retrograde amnesia following ECT. American Journal of Psychiatry, 152, 995–1001.
Triggs, W. J., McCoy, K. J., Greer, R. et al. (1999). Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biological Psychiatry, 45, 1440–6.
Ulett, G., Smith, K. & Gleser, G. (1956). Evaluation of convulsive and subconvulsive shock therapies utilizing a control group. American Journal of Psychiatry, 112, 795–802.
Uthman, B. M., Wilder, B. J., Penry, J. K. et al. (1993). Treatment of epilepsy by stimulation of vagus nerve. Neurology, 43, 1338–45.
Van Bockstaele, E. J., Peoples, J. & Valentino, R. J. (1999). Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biological Psychiatry, 46, 1352–63.
Wassermann, E. M. & Lisanby, S. H. (2001). Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clinical Neurophysiology, 112, 1367–77.
Yianni, J., Bain, P., Giladi, N. et al. (2003). Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit. Movement Disorders, 18, 436–42.
Zabara, J. (1985). Time course of seizure control to brief, repetitive stimuli. Epilepsia, 26, 518.
Zald, D. H. & Kim, S. W. (1996). Anatomy and function of the orbital frontal cortex: II. Function and relevance to obsessive–compulsive disorder. Journal of Neuropsychiatry and Clinical Neuroscience, 82, 49–61.
Zwanzger, P., Minov, C., Ella, R. et al. (2002). Transcranial magnetic stimulation for panic. American Journal of Psychiatry, 159, 315–16.

Reference Title: REFERENCES

Reference Type: reference-list

Ablon, J. S. & Jones, E. E. (1998). How expert clinicians' prototypes of an ideal treatment correlate with outcome in psychodynamic and cognitive-behavior therapy. Psychotherapy Research, 8, 71–83.
Ablon, J. S. & Jones, E. E. (1999). Psychotherapy process in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Journal of Consulting and Clinical Psychology, 67, 64–75.
Ablon, J. S. & Jones, E. E. (2002). Validity of controlled cinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry, 159, 775–83.
Ackerman, S. J. & Hilsenroth, M. J. (2001). A review of therapist characteristics and techniques negatively impacting the therapeutic alliance. Psychotherapy: Theory, Research, Practice, Training, 38, 171–85.
Ackerman, S. J. & Hilsenroth, M. J. (2003). A review of therapist characteristics and techniques positively impacting the therapeutic alliance. Clinical Psychology Review, 23, 1–33.
Agras, W. S., Walsh, T., Fairburn, C. G., Wilson, G. T. & Kraemer, H. C. (2000). A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Archives of General Psychiatry, 57, 459–66.
Alexander, F. & French, T. (1946). Psychoanalytic Therapy. New York: Ronald.
Anderson, E. M. & Lambert, M. J. (2001). A survival analysis of clinically significant change in outpatient psychotherapy. Journal of Clinical Psychology, 57, 875–88.
Atkins, D. C. & Christensen, A. (2001). Is professional training worth the bother? A review of the impact of psychotherapy training on client outcome. Australian Psychologist, 36, 122–30.
Barber, J. P., Connolly, M. B., Crits-Christoph, P., Gladis, L. & Siqueland, L. (2000). Alliance predicts patients' outcome beyond in-treatment change in symptoms. Journal of Consulting and Clinical Psychology, 68, 1027–32.
Barber, J. P., Luborsky, L., Crits-Christoph, P. et al. (1999). Therapeutic alliance as a predictor of outcome in treatment of cocaine dependence. Psychotherapy Research, 9, 54–73.
Barkham, M., Rees, A., Shapiro, D. A. et al. (1996). Outcomes of time-limited psychotherapy in applied settings: replicating the Second Sheffield Psychotherapy Project. Journal of Consulting and Clinical Psychology, 64, 1079–85.
Bateman, A. W. & Fonagy, P. (1999). The effectiveness of partial hospitalization in the treatment of borderline personality disorder – a randomised controlled trial. American Journal of Psychiatry, 156, 1563–9.
Bateman, A. W. & Fonagy, P. (2001). Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. American Journal of Psychiatry, 158, 36–42.
Baucom, D. H., Shoham, V., Mueser, K. T., Daiuto, A. D. & Stickle, T. R. (1998). Empirically supported couple and family interventions for marital distress and adult mental health problems. Journal of Consulting and Clinical Psychology, 66, 53–88.
Bass, J., Neugebauer, R., Clougherty, K. F. et al. (2006). Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. British Journal of Psychiatry, 188, 567–73.
Beach, S. R., Fincham, F. D. & Katz, J. (1998). Marital therapy in the treatment of depression: toward a third generation of therapy and research. Clinical Psychology Review, 18, 635–61.
Beck, T. (1986). Cognitive Therapy and the Emotional Disorders. New York: Basic Books.
Bennett, K. J., Lipman, E. L., Racine, Y. & Offord, D. R. (1998). Annotation: Do measures of externalising behaviour in normal populations predict later outcome? Implications for targeted interventions to prevent conduct disorder. Journal of Child Psychology and Psychiatry, 39, 1059–70.
Beutler, L., Malik, M., Alimohamed, S. et al. (2004). Therapist variables. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, ed. M. Lambert, pp. 227–306. New York: Wiley.
Beutler, L. E., Machado, P. P. P. & Neufeldt, S. A. (1994). Therapist variables. In Handbook of Psychotherapy and Behavior Change, 4th edn, ed. A. E. Bergin & S. L. Garfield. New York: Wiley.
Bloom, P. (2004). Descartes' Baby. New York: Basic Books.
Bolton, P., Bass, J., Neugebauer, R. et al. (2003). Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. Journal of the American Medical Association, 289, 3117–124.
Bovasso, G. B., Eaton, W. W. & Armenian, H. K. (1999). The long-term outcomes of mental health treatment in a population-based study. Journal of Consulting and Clinical Psychology, 67, 529–38.
Buckley, P., Karasu, T. B. & Charles, E. (1981). Psychotherapists view their personal therapy. Psychotherapy, 18, 299–305.
Chambless, D. L. & Ollendick, T. H. (2001). Empirically supported psychological interventions: controversies and evidence. Annual Review of Psychology, 52, 685–713.
Chilvers, R., Harrison, G., Sipos, A. & Barley, M. (2002). Evidence into practice: application of psychological models of change in evidence-based implementation. British Journal of Psychiatry, 181, 99–101.
Clarkin, J. & Levy, K. L. (2004a). The influence of client variables on psychotherapy. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, 5h edn, ed. M. Lambert, pp. 227–308. New York: Wiley.
Clarkin, J. F. & Levy, K. N. (2004b). The influence of client variables on psychotherapy. In Bergin & Garfield's Handbook of Psychotherapy and Behavior Change, 5th edn, ed. M. Lambert, pp. 194–226. New York: Wiley.
Cohen, L. H., Sargent, M. M. & Sechrest, L. B. (1986). Use of psychotherapy research by professional psychologists. American Psychologist, 41, 198–206.
Connolly, M. B., Crits-Christoph, P., Shappell, S., Barber, J. P., Luborsky, L. & Shaffer, C. (1999). Relation of transference interpretations to outcome in the early sessions of brief supportive-expressive psychotherapy. Psychotherapy Research, 9, 485–95.
Crits-Christoph, P. & Siqueland, L. (1996). Psychosocial treatment for drug abuse: selected review and recommendations for national health care. Archives of General Psychiatry, 53, 749–56.
Cummings, E. M. & Cicchetti, D. (1990). Towards a transactional model of relations between attachment and depression. In Attachment in the Preschool Years: Theory, Research, and Intervention, ed. D. Cicchetti, M. T. Greenberg & E. M. Cummings, pp. 339–72. Chicago, IL: University of Chicago Press.
Cummings, N. A. (1987). The future of psychotherapy: one psychologist's perspective. American Journal of Psychotherapy, 61, 349–60.
Cummings, N. A. (1991). Brief intermittent therapy throughout the life cycle. In Psychotherapy in Managed Health Care: The Optimal Use of Time and Resources, ed. C. S. Austad & W. H. Berman, pp. 35–45. Washington, DC: American Psychological Association.
Davanloo, H. (Ed.). (1978). Basic Principles and Techniques in Short-Term Dynamic Psychotherapy. New York: Spectrum Publications.
Davison, C. G. (1998). Being bolder with the boulder model: the challenge of education and training in empirically supported treatments. Journal of Consulting and Clinical Psychology, 66, 163–7.
DeRubeis, R. J. & Feeley, M. (1990). Determinants of change in cognitive therapy for depression. Cognitive Therapy and Research, 14, 469–82.
Doidge, N., Simon, B., Brauer, L. et al. (2002). Psychoanalytic patients in the U.S., Canada, and Australia: I. DSM-III-R disorders, indications, previous treatment, medications, and length of treatment. Journal of the American Psychoanalytic Association, 50, 575–614.
Dozier, M., Cue, K. & Barnett, L. (1994). Clinicians as caregivers: role of attachment organization in treatment. Journal of Consulting and Clinical Psychology, 62, 793–800.
Eames, V. & Roth, A. D. (2000). Patient attachment orientation and the early working alliance – a study of patient and therapist reports of alliance quality and ruptures. Psychotherapy Research, 10, 421–34.
Elkin, I. (1994). The NIMH treatment of depression collaborative research program: where we began and where we are. In Handbook of Psychotherapy and Behaviour Change, ed. A. E. Bergin & S. L. Garfield, pp. 114–39. New York: Wiley.
Eysenck, H. (1952). The effects of psychotherapy: an evaluation. Journal of Consulting Psychology, 16, 319–24.
Eysenck, H. (1969). The Effects of Psychotherapy. New York: Science House.
Feeley, M., DeRubeis, R. J. & Gelfand, L. A. (1999). The temporal relation of adherence and alliance to symptom change in cognitive therapy for depression. Journal of Consulting and Clinical Psychology, 67, 578–82.
Fonagy, P. & Slade, P. (1982). Punishment vs negative reinforcement in the aversive conditioning of auditory hallucinations. Behaviour Research and Therapy, 20, 483–92.
Frank, E., Grochocinski, V. J., Spanier, C. A. et al. (2000). Interpersonal psychotherapy and antidepressant medication: evaluation of a sequential treatment strategy in women with recurrent major depression. Journal of Clinical Psychiatry, 61, 51–7.
Frank, E., Kupfer, D. J., Perel, J. M. et al. (1990). Three year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093–9.
Frank, J. D. & Frank, J. B. (1991). Persuasion and Healing. Baltimore, MD: Johns Hopkins University Press.
Gabbard, G. O., Takahashi, T., Davidson, J., Bauman-Bork, M. & Ensroth, K. (1991). A psychodynamic perspective on the clinical impact of insurance review. American Journal of Psychiatry, 148, 318–23.
Gabbard, G. O., Gunderson, J. G. & Fonagy, P. (2002). The place of psychoanalytic treatments within psychiatry. Archives of General Psychiatry, 59, 505–10.
Garfield, S. L. (1994). Research on client variables in psychotherapy. In Handbook of Psychotherapy and Behavior Change, ed. S. L. Garfield & A. E. Bergin, pp. 190–228. New York: Wiley.
Gaston, L. (1991). Reliability and criterion-related validity of the California Psychotherapy Alliance Scales-Patient Version. Psychological Assessment, 3, 68–74.
Gaston, L., Marmar, C. R., Gallagher, D. & Thomson, L. W. (1991). Alliance prediction of outcome beyond in-treatment symptomatic change as psychotherapy progresses. Psychotherapy Research, 1, 104–12.
Gloaguen, V., Cottraux, J., Cucherat, M. & Blackburn, I. (1998). A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders, 49, 59–72.
Greenberg, L. S. (Ed.). (2002). Emotion-focused Therapy: Coaching Clients to Work through their Feelings. Washington, DC: American Psychological Association.
Hansen, N. B. & Lambert, M. J. (2003). An evaluation of the dose-response relationship in naturalistic treatment settings using survival analysis. Mental Health Services Research, 5, 1–12.
Hayes, A. M., Castonguay, L. G. & Goldfried, M. R. (1996). Effectiveness of targeting the vulnerability factors of depression in cognitive therapy. Journal of Consulting and Clinical Psychology, 64, 623–7.
Henry, R. W., Schacht, T. E., Strupp, H. H. et al. (1993). Effects of training in time-limited psychotherapy: mediators of therapists responses to training. Journal of Consulting and Clinical Psychology, 61, 441–7.
Higgitt, A. & Fonagy, P. (2002). Clinical effectiveness. British Journal of Psychiatry, 181, 170–4.
Hilsenroth, M. J., Ackerman, S. J., Clemence, A. J., Strassle, C. G. & Handler, L. (2002). Effects of structured clinician training on patient and therapist perspectives of alliance early in psychotherapy. Psychotherapy: Theory, Research, Practice, Training, 39, 309–23.
Hoglend, P. (1993). Personality disorders and long-term outcome after brief dynamic psychotherapy. Journal of Personality Disorders, 7, 168–81.
Horvath, A. O. & Simmonds, B. D. (1991). Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Consulting and Clinical Psychology, 38, 139–49.
Horwitz, L. (1974). Clinical Prediction in Psychotherapy. New York: Aronson.
Howard, K. I., Kopta, S. M., Krause, M. S. & Orlinsky, D. E. (1986). The dose-effect relationship in psychotherapy. Special Issue: Psychotherapy research. American Psychologist, 41, 159–64.
Howard, R. C. (1999). Treatment of anxiety disorders: Does specialty training help? Professional Psychology: Research and Practice, 30, 470–3.
Kadera, S. W., Lambert, M. J. & Andrews, A. A. (1996). How much therapy is really enough? A session-by-session analysis of the psychotherapy dose-effect relationship. Journal of Psychotherapy: Practice and Research, 5, 1–20.
Kernberg, O. F., Coyne, L., Appelbaum, A., Horwitz, L. & Voth, H. (1972). Final report of the Menninger Psychotherapy Research Project. Bulletin of the Menninger Clinic, 36, 1–275.
Kingdon, D., Turkington, D. & John, C. (1994). Cognitive behaviour therapy of schizophrenia. British Journal of Psychiatry, 164, 581–7.
Klein, D. N., Schwartz, J. E., Santiago, N. J. et al. (2003). Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. Journal of Consulting and Clinical Psychology, 71, 997–1006.
Klerman, G. L. & Weissman, M. M. (Eds) (1993). New Applications of the Interpersonal Therapy of Depression. Washington, DC: American Psychiatric Press.
Koerner, K. & Linehan, M. M. (2000). Research on dialectical behavior therapy for patients with borderline personality disorder. Psychiatric Clinics of North America, 23, 151–67.
Kolvin, I., MacMillan, A. & Wrate, R. M. (1988). Psychotherapy is effective. Journal of the Royal Society of Medicine, 81, 261–6.
Kopta, S. M., Howard, K. I., Lowry, J. L. & Beutler, L. E. (1994). Patterns of symptomatic recovery in psychotherapy. Journal of Consulting and Clinical Psychology, 62, 1009–16.
Kupfer, D. J., Frank, E., Perel, J. M. et al. (1992). Five year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry, 49, 769–73.
Lambert, M. (ed.) (2004). Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. New York: Wiley.
Lambert, M. J., Bergin, A. E. & Garfield, S. L. (2004). Introduction and historical overview. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, ed. M. Lambert, pp. 3–15. New York: Wiley.
Leichsenring, F. (2001). Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach. Clinical Psychology Review, 21, 401–19.
Leichsenring, F., Rabung, S. & Leibing, E. (2004). The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Archives of General Psychiatry, 61, 1208–16.
Linehan, M. M. (1993). Dialectical Behavioral Therapy of Borderline Personality Disorder. New York: Guilford Press.
Linehan, M. M., Comtois, K. A., Murray, A. M. et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–66.
Lipsey, M. W. & Wilson, D. B. (1993). The effficacy of psychological, educational, and behavioral treatment; confirmation from metaanalysis. American Psychologist, 48, 1181–209.
Luborsky, L. (1984). Principles of Psychoanalytic Psychotherapy: A Manual for Supportive-Expressive (SE) Treatment. New York: Basic Books.
Luborsky, L. & Crits-Christoph, P. (1990). Understanding Transference: the Core Conflict Relationship Theme Method. New York: Basic Books.
Luborsky, L., Crits-Christoph, P., McLellan, T. et al. (1986). Do therapists vary much in their success? Findings from four outcome studies. American Journal of Orthopsychiatry, 51, 501–12.
Luborsky, L., Crits-Christoph, P., Mintz, J. & Auerbach, A. (1988). Who will Benefit from Psychotherapy? Predicting Therapeutic Outcomes. New York: Basic Books.
Luborsky, L., McLellan, A. T., Diguer, L., Woody, G. & Seligman, D. (1997). The psychotherapist matters: comparison of outcome across twenty-two therapists and seven patient samples. Clinical Psychology: Science and Practice, 4, 53–65.
Luborsky, L. Singer, B. & Luborsky, L. (1975). Comparative studies of psychotherapy: is is true that “everyone has won and all shall have prizes”? Archives of Genernal Psychiatry, 41, 165–80.
Malan, D. H. (1976). Toward the Validation of Dynamic Psychotherapy: A Replication. New York: Plenum Press.
Malan, D. H. (1979). Individual Psychotherapy and the Science of Psychodynamics. Boston: Butterworth.
Mallinckrodt, B., Gantt, D. & Coble, H. (1995). Attachment patterns in the psychotherapy relationship: development of a client attachment to the therapist scale. Journal of Counselling Psychology, 42, 307–17.
Mann, J. (1973). Time-limited Psychotherapy. Cambridge, MA: Harvard University Press.
Martin, D. J., Garske, J. P. & Davis, M. K. (2000). Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consulting Clinical Psychology, 68, 438–50.
Martin, S. D., Martin, E., Rai, S. S., Richardson, M. A. & Royall, R. (2001). Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Archives of General Psychiatry, 58, 641–8.
McDermut, W., Miller, I. W. & Brown, R. A. (2001). The efficacy of group psychotherapy for depression: a meta-analysis and review of the empirical research. Clinical Psychology: Science and Practice, 8, 98–116.
Miranda, J. & Borkovec, T. D. (1999). Reaffirming science in psychotherapy research. Journal of Clinical Psychology, 55, 191–200.
Monsen, J. T., Odland, T., Faugli, A., Daee, E. & Eilertsen, D. E. (1995). Personality disorders: changes and stability after intensive psychotherapy focusing on affect consciousness. Psychotherapy Research, 5, 33–48.
Morrow-Bradley, C. & Elliott, R. (1986). Utilization of psychotherapy research by practicing psychotherapists. American Psychologist, 41, 188–97.
Nathan, P. E. & Gorman, J. M. (2002). A Guide to Treatments that Work. New York: Oxford University Press.
Orlinksy, D. E., Ronnestad, M. H. & Willutski, U. (2004). Fifty years of psychotherapy process-outcome research: continuity and change. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, ed. M. Lambert, pp. 307–90. New York: Wiley.
Piper, W. E., Azim, H. A., Joyce, A. S. & McCallum, M. (1991). Transference interpretations, therapeutic alliance, and outcome in short-term individual psychotherapy. Archives of General Psychiatry, 48, 946–53.
Propst, A., Paris, J. & Rosberger, Z. (1994). Do therapist experience, diagnosis and functional level predict outcome in short-term psychotherapy? Canadian Journal of Psychiatry, 39, 178–83.
Raw, S. D. (1993). Does psychotherapy research teach us anything about psychotherapy? Behavior Therapist, March, 75–6.
Rector, N. A. & Beck, A. T. (2001). Cognitive behavioral therapy for schizophrenia: an empirical review. Journal of Nervous and Mental Disease, 189, 278–87.
Rockland, L. H. (1992). Supportive Therapy for Borderline Patients: A Dynamic Approach. New York: Guilford Press.
Rosenzweig, S. (1936). Some implicit common factors in diverse methods of psychotherapy. American Journal of Orthopsychiatry, 6, 412–15.
Roth, A. & Parry, G. (1997). The implications of psychotherapy research for clinical practice and service development: lessons and limitations. Journal of Mental Health, 6, 367–80.
Rubino, G., Barker, C., Roth, A. D. & Fearon, P. (2000). Therapist empathy and depth of interpretation in response to potential alliance ruptures: the role of therapist and patient attachment styles. Psychotherapy Research, 10, 408–20.
Ryan, E. R. (1985). Predicting the quality of alliance in the initial psychotherapy interview. Journal of Nervous and Mental Disease, 12, 717–25.
Ryle, A. (1990). Cognitive Analytic Therapy: Active Participation in Change. Chichester: Wiley.
Ryle, A. (1995). Research relating to CAT. In Cognitive Analytic Therapy: Developments in theory and practice, ed. A. Ryle, pp. 175–89. Chichester: Wiley.
Sackett, D. L., Rosenberg, W. M., Gray, J. A. M., Haynes, R. B. & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn't. British Medical Journal, 312, 71–2.
Safran, J. D. & Muran, J. C. (1996). The resolution of ruptures in the therapeutic alliance. Journal of Consulting and Clinical Psychology, 55, 379–84.
Safran, J. D. & Muran, J. C. (2000). Negotiating the Therapeutic Alliance. New York: Guilford Press.
Safran, J. D., Crocker, P., McMain, S. & Murray, P. (1990). The therapeutic alliance rupture as a therapy event for empirical investigation. Psychotherapy, 27, 154–65.
Sanchez, L. M. & Turner, S. M. (2003). Practising psychology in the era of managed care. Implications for practice and training. American Psychologist, 58, 116–29.
Satterfield, W. A. & Lyddon, W. J. (1998). Client attachment and the working alliance. Counselling Psychology Quarterly, 11, 407–15.
Schulberg, H. C., Block, M. R., Madonia, M. J. et al. (1996). Treating major depression in primary care practice. Eight-month clinical outcomes. Archives of General Psychiatry, 53, 913–19.
Seligman, M. E. P. (1995). The effectiveness of psychotherapy: the Consumer Report study. American Psychologist, 50, 965–74.
Shadish, W. R., Matt, G. E., Navarro, A. M. et al. (1997). Evidence that therapy works in clinically representative conditions. Journal of Consulting and Clinical Psychology, 65, 355–65.
Shea, M. T., Pilkonis, P. A., Beckham, E. et al. (1990). Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. American Journal of Psychiatry, 147, 711–18.
Sheldon, T. A., Song, F. & Davey-Smith, G. (1993). Critical appraisal of the medical literature: how to assess whether health care interventions do more good than harm. In Purchasing and Providing Cost Effective Health Care, ed. M. F. Drummond & A. Maynard, pp. 31–48. London: Churchill Livingstone.
Shorter, E. (1998). A History of Psychiatry. New York: Wiley.
Sifneos, P. E. (1972). Short-Term Psychotherapy and Emotional Crisis. Cambridge, MA: Harvard University Press.
Smith, M. L. & Glass, G. V. (1977). Meta-analysis of psychotherapy outcome studies. American Psychologist, 32, 752–60.
Smith, M. L., Glass, G. V. & Miller, T. I. (1980). The Benefits of Psychotherapy. Baltimore, MD: Johns Hopkins University Press.
Stein, D. M. & Lambert, M. J. (1995). Graduate training in psychotherapy: are therapy outcomes enhanced? Journal of Consulting and Clinical Psychology, 63, 182–96.
Stevenson, J. & Meares, R. (1992). An outcome study of psychotherapy for patients with borderline personality disorder. American Journal of Psychiatry, 149, 358–62.
Stiles, W. B., Leach, C., Barkham, M. et al. (2003). Early sudden gains in psychotherapy under routine clinic conditions: practice-based evidence. Journal of Consulting and Clinical Psychology, 71, 14–21.
Strupp, H. & Hadley, S. (1979). Specific vs. non-specific factors in psychotherapy. Archives of General Psychiatry, 36, 1125–36.
Strupp, H. H. & Binder, J. L. (1984). Psychotherapy in a New Key: A Guide to Time-limited Dynamic Psychotherapy. New York: Basic Books.
Strupp, H. H., Fox, R. E. & Lesser, K. (1969). Patients View Their Psychotherapy. Baltimore, MD: Johns Hopkins University Press.
Suinn, R. M. (1993). Psychotherapy: can the practitioner learn from the researcher? Behavior Therapist, February, 47–9.
Sullivan, H. S. (1953). The Interpersonal Theory of Psychiatry. New York: Norton.
Tang, T. Z. & DeRubeis, R. J. (1999). Sudden gains and critical sessions in cognitive-behavioral therapy for depression. Journal of Consulting and Clinical Psychology, 67, 894–904.
Tang, T. Z., Luborsky, L. & Andrusyna, T. (2002). Sudden gains in recovering from depression: are they also found in psychotherapies other than cognitive-behavioral therapy? Journal of Consulting and Clinical Psychology, 70, 444–7.
Tyrell, C. L., Dozier, M., Teague, G. B. & Fallott, R. B. (1999). Effective treatment relationships for persons with severe psychiatric disorders: the importance of attachment states of mind. Journal of Consulting and Clinical Psychology, 67, 725–33.
Vaillant, G. E. (1977). Adaptation to Life. Cambridge, MA: Little Brown.
Wachtel, P. L. (1977). Psychoanalysis and Behavior Therapy. New York: Basic Books.
Wallerstein, R. S. (1990). Psychoanalysis: the common ground [see comments]. International Journal of Psychoanalysis, 71, 3–20.
Wampold, B., Minami, T., Baskin, T. & Callen-Tierney, S. (2002). A meta-(re)analysis of the effects of cognitive therapy versus ‘other therapies’ for depression. Journal of Affective Disorders, 68, 159–65.
Wampold, B. E. (2001). The Great Psychotherapy Debate: Models, Methods, and Findings. Mahwah, NJ: Laurence Erlbaum.
Wampold, B. E., Mondin, G. W., Moody, M., Stich, F., Benson, K. & Ahn, H. (1997). A meta-analysis of outcome studies comparing bona fide psychotherapies: empiricially, “all must have prizes”. Psychological Bulletin, 122, 203–15.
Weissman, M. M. & Markowitz, J. (1994). Interpersonal psychotherapy – current status. Archives of General Psychiatry, 51, 599–606.
Weisz, J. R., Donenberg, G. R., Han, S. S. & Kauneckis, D. (1995). Child and adolescent psychotherapy outcomes in experiments versus clinics: why the disparity? Journal of Abnormal Child Psychology, 23, 83–106.
Weisz, J. R., Weiss, B., Han, S. S., Granger, D. A. & Morton, T. (1995). Effects of psychotherapy with children and adolescents revisited: a meta-analysis of treatment outcome studies. Psychological Bulletin, 117, 450–68.
Westen, D. (1998). The scientific legacy of Sigmund Freud: towards a psychodynamically informed psychological science. Psychological Bulletin, 124, 360–70.
Westen, D. & Morrison, K. (2001). A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology, 69, 875–99.
Westen, D., Novotny, C. M. & Thompson-Brenner, H. (2004). The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychology Bulletin, 130, 631–63.
Wierzbicki, M. & Pekarik, G. (1993). A meta-analysis of psychotherapy dropout. Professional Psychology: Research and Practice, 24, 190–5.
Wilfley, D. E., Welch, R. R., Stein, R. I. et al. (2002). A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of General Psychiatry, 59, 713–21.
Winston, A., Laikin, M., Pollack, J., Samstag, L. W., McCullough, L. & Muran, J. C. (1994). Short-term dynamic psychotherapy of personality disorders. American Journal of Psychiatry, 15, 190–4.
Young, J. E., Klosko, J. S. & Weishaar, M. E. (2003). Schema Therapy: A Practitioner's Guide. New York: Guilford Press.
Young, J. E. & Lindemann, M. D. (1992). An integrative schema-focused model for personality disorders. Journal of Cognitive Psychotherapy, 6, 11–23.

Reference Title: REFERENCES

Reference Type: reference-list

Apodaca, T. & Miller, W. (2003). A meta-analysis of the effectiveness of bibliotherapy for alcohol problems. Journal of Clinical Psychology, 59, 289–304.
Appleby, L., Morriss, R., Gask, L. et al. (2000). An educational intervention for front-line health professionals in the assessment and management of suicidal patients (the STORM Project). Psychological Medicine, 30, 805–12.
Baer, L. & Greist, J. H. (1997). An interactive computer-administered self-assessment and self-help program for behavior therapy. Journal of Clinical Psychiatry, 58 Suppl. 12, 23–8.
Black, D. W., Blum, N., Pfohl, B. & St. John, D. (2004). The STEPPS group treatment program for outpatients with borderline personality disorder. Journal of Contemporary Psychotherapy, 34, 193–210.
Blum, N., Pfohl, B., St. John, D., Monahan, P. & Black, D. W. (2002). STEPPS: a cognitive-behavioral systems-based group treatment for outpatients with borderline personality disorder – a preliminary report. Comprehensive Psychiatry, 43, 301–10.
Bower, P., Richards, D. & Lovell, K. (2001). The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review. British Journal of General Practice, 51, 838–45.
Burland, J. (1998). Family-to-family: a trauma and recovery model of family education. New Directions for Mental Health Services, 77, 33–44.
Burns, T., Millar, E., Garland, C., Kendrick, T., Chisolm, B. & Ross, F. (1998). Randomized controlled trial of teaching practice nurses to carry out structured assessments of patients receiving depot antipsychotic medication. British Journal of General Practice, 48, 1845–8.
Chien, W-T., Chan, S. W. C. & Thompson, D. R. (2006). Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. British Journal of Psychiatry, 189, 41–9.
Christensen, H., Griffiths, K. M. & Jorm, A. F. (2004). Delivering interventions for depression by using the internet: randomised controlled trial. British Medical Journal, 328, 265–8.
Colom, F., Vieta, E., Martinez-Aran, A. et al. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–7.
Coodin, S. & Chisholm, F. (2001). Teaching in a new key: effects of a co-taught seminar on medical students' attitudes towards schizophrenia. Psychiatric Rehabilitation Journal, 24, 299–302.
Corrigan, P. W., River, L. P., Lundin, R. K. et al. (2001). Three strategies for changing attributions about severe mental illness. Schizophrenia Bulletin, 27, 187–95.
Dixon, L., Lucksted, A., Stewart, B. et al. (2004). Outcomes of the peer-taught 12-week family-to-family education program for severe mental illness. Acta Psychiatrica Scandinavica, 109, 207–15.
Dixon, L., Stewart, B., Burland, J., Delahanty, J., Lucksted, A. & Hoffman, M. (2001). Pilot study of the effectiveness of the family-to-family education program. Psychiatric Services, 52, 965–7.
Dowrick, C., Dunn, G., Ayuso-Mateos, J. et al. (2000). Problem solving treatment and group psychoeducation for depression: multicentre randomised controlled trial. British Medical Journal, 321, 1450–4.
Eisen, M., Zellman, G. L. & Murray, D. M. (2003). Evaluating the Lions-Quest “Skills for Adolescence” drug education program. Second-year behavior outcomes. Addictive Behaviors, 28, 883–97.
Falloon, J. R., Coverdale, J. H., Laidlaw, T. M., Merry, S., Kidd, R. R. & Morosini, P. (1998). Early intervention for schizophrenic disorders: implementing optimal strategies in routine clinical services. British Journal of Psychiatry, 172 Suppl. 33, 33–8.
Falvo, D. R. (1994). Effective Patient Education. A Guide to Increased Compliance. Gaithersburg, MD: Aspen Publication Inc.
Fisher, B. & Gilbert, D. (2001). Patient involvement and clinical effectiveness. In New Beginnings: Towards Patient and Public Involvement in Primary Health Care, ed. S. Gillam & F. Brooks, pp. 119–31. London: King's Fund.
Gask, L., Usherwood, T., Thompson, H. & Williams, B. (1998). Evaluation of a training package in the assessment and management of depression in primary care. Medical Education, 32, 190–8.
Gask, L., Rogers, A., Oliver, D., May, C. & Roland, M. (2003). Qualitative study of patients' perceptions of the quality of care in general practice. British Journal of General Practice, 53, 278–83.
Gask, L., Dowrick, C., Dixon, C. et al. (2004). A pragmatic cluster randomised controlled trial of an educational intervention for general practitioners in the assessment and management of depression. Psychological Medicine, 34, 63–72.
Gilbody, S., Whitty, P., Grimshaw, J. & Thomas, R. (2003). Educational and organizational interventions to improve the management of depression in primary care: a systematic review. Journal of the American Medical Association, 289, 3145–51.
Gonzalez-Pinto, A., Gonzalez, C., Enjuto, S. et al. (2004). Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update. Acta Psychiatrica Scandinavica, 109, 83–90.
Greist, J. H., Marks, I. M., Baer, L. et al. (1998). Self-treatment for obsessive-compulsive disorder using a manual and a computerized telephone interview: A US-UK study. MD Computing, 15, 149–57.
Hegerl, U., Althaus, D. & Stefanek J. (2003). Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiatry, 36, 288–91.
Herz, M. I., Lamberti, J. S., Minz, J. et al. (2000). A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry, 57, 277–83.
Hoffman, P., Buteau, E., Hooley, J. M., Fruzzetti, A. E. & Bruce M. L. (2003a). Family members' knowledge about borderline personality disorder: correspondence with their levels of depression, burden, distress, and expressed emotion. Family Process, 42, 469–78.
Hoffman, P. D., Fruzzetti, A. E., Buteau, E. et al. (2003b). Family connections: a dialectical support and educational approach for families of persons with borderline personality disorder. Paper presented at the meeting of the International Society for the Investigation and Teaching of Dialectical Behavior Therapy, Boston, MA, November 2003.
Huband, N., Duggan, C., Evans, C. et al. (2007). Social problem-solving plus psychoeducation for adults with personality disorder. Pragmatic randomised controlled trial. British Journal of Psychiatry, 190, 307–13.
Hunkeler, E. M., Meresman, J. F., Hargreaves, W. A. et al. (2000). Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Archives of Family Medicine, 9, 700–8.
Johannessen, J. O., McGlashan, T. H., Larsen, T. K. et al. (2001). Early detection strategies for untreated first-episode psychosis. Schizophrenia Research, 51, 39–46.
Jorm, A. F., Griffiths, K. M., Christensen, H., Parslow, R. A. & Rogers, B. (2004). Actions taken to cope with depression at different levels of severity: a community survey. Psychological Medicine, 34, 293–9.
Kaminer, Y., Burleson, J. A. & Goldberger, R. (2002). Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. Journal of Nervous and Mental Disease, 190, 737–45.
King, M., Davidson, O., Taylor, F., Haines, A., Sharp, D. & Turner, R. (2002). Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. British Medical Journal, 324, 947–50.
Lewinsohn, P. (1989). The Coping with Depression Course: review and future directions. Canadian Journal of Behavioural Science, 21, 470–93.
Lewinsohn, P., Hoberman, H., Teri, L. & Hautzinger, M. (1985). An integrative theory of depression. In Theoretical Issues in Behaviour Therapy, ed. S. Reiss & R. Bootzin, pp. 331–59. New York: Academic Press.
Katon, W., von Korff, M., Lin, E. et al. (1995) Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Journal of the American Medical Association, 273, 1026–31.
Katon, W., Von Korff, M., Lin, E. & Simon G. (2001). Rethinking practitioner roles in chronic illness: the specialist, primary care physician and the practice nurse. General Hospital Psychiatry, 23, 138–44.
Kendrick, T., Burns, T. & Freeling, P. (1995). Randomised controlled trial of teaching general practitioners to carry our structured assessments of their long term mentally ill patients. British Medical Journal, 311, 93–8.
Kendrick, T., Stevens, L., Bryant, A. et al. (2001). Hampshire Depression Project: changes in the process of care and cost consequences. British Journal of General Practice, 51, 911–13.
Kopelowicz, A., Zarate, R., Gonzalez Smith, V., Mintz, J. & Liberman, R. P. (2003). Disease management in Latinos with schizophrenia: a family assisted, skills training approach. Schizophrenia Bulletin, 29, 211–27.
Marks, I. M., Mataix-Cols, D., Kenwright, M., Cameron, R., Hirsch, S. & Geda, L. (2003). Pragmatic evaluation of computer aided self-help for anxiety and depression. British Journal of Psychiatry, 183, 57–65.
Martinez-Aran, A., Vieta, E., Reinares, M. (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry, 161, 262–70.
McCann, T. V. & Clark, E. (2004). Advancing self-determination with young adults who have schizophrenia. Journal of Psychiatric and Mental Health Nursing, 11, 12–20.
McFarlane, W. R., Dixon, L., Lukens, E. & Lucksted, A. (2003). Family psychoeducation and schizophrenia: a review of the literature. Journal of Marital and Family Therapy, 29, 223–45.
Macpherson, R., Jerrom, B. & Hughes, A. (1996). A controlled study of education about drug treatment in schizophrenia. British Journal of Psychiatry, 168, 709–17.
Muñoz, R. & Ying, Y. (1993). The Prevention of Depression: Research and Practice Baltimore, MD: Johns Hopkins University Press.
Nazareth, I., King, M. & Tai, S. S. (1996). Monitoring psychosis in general practice: a controlled trial. British Medical Journal, 169, 475–82.
Paykel, E. S., Hart, D. & Priest, R. G. (1998). Changes in public attitudes to depression during the Defeat Depression Campaign. British Journal of Psychiatry, 173, 519–22.
Pekkala, E. & Merinder, L. (2004). Psychoeducation for schizophrenia (Cochrane Review). In The Cochrane Library, 1 Chichester, UK: John Wiley & Sons, Ltd.
Penn, D. L., Kommana, S., Mansfield, M. & Link, B. G. (1999). Dispelling the stigma of schizophrenia: II. The impact of information on dangerousness. Schizophrenia Bulletin, 25, 437–46.
Perry, A., Tarrier, N., Morris, R., McCarthy, E. & Limb, K. (1999). Randomised controlled trial of the efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal, 318, 149–53.
Ran, M. S., Xiang, M. Z., Chan, C. L. et al. (2003). Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia – a randomised controlled trial. Social Psychiatry and Psychiatric Epidemiology, 38, 69–75.
Rankin, S. H. & Stallings, K. D. (1996). Patient Education: Issues, Principles, Practices. Philadelphia, PA: Lippincott-Raven.
Rost, K., Nutting, P., Smith, J., Elliott, C. & Dickinson, M. (2002). Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care. British Medical Journal, 325, 934–7.
Rutz, W., Walinder, J., Eberhard, G. et al. (1989). An education programme for depressive disorders on Gotland: background and evaluation. Acta Psychiatrica Scandinavica, 79, 19–26.
Schoenbaum, M., Unutzer, J., Sherbourne, C. et al. (2001). Cost-effectiveness of practice-initiated quality improvements for depression: results of a randomized controlled trial. Journal of the American Medical Association, 286, 1325–30.
Schulze, B., Richter-Werling, M., Matschinger, H. & Angermeyer, M. C. (2003). Crazy? So what! Effects of a school project on students' attitudes towards people with schizophrenia. Acta Psychiatrica Scandinavica, 107, 142–50.
Simon, C. E., Von Korff, M., Rutter, C. & Wagner, M. (2000). Randomised trial on monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. British Medical Journal, 320, 550–4.
Solomon, P. (1996). Moving from psychoeducation to family education for families of adults with serious mental illness. Psychiatric Services, 47, 1364–70.
Stuart, H. (2003). Stigma and the daily news: evaluation of a newspaper intervention. Canadian Journal of Psychiatry, 48, 651–6.
Thompson, C., Kinmonth, A. L., Stevens, L. (2000). Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet, 355, 185–91.
Unutzer, J., Katon, W., Callahan, C. et al. (2002). Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. Journal of the American Medical Association, 288, 2836–45.
Wagner, E. T., Austin, B. T. & Von Korff, M. (1996). Organizing care for patients with chronic illness. Milbank Quarterly, 74, 511–44.
Wells, K., Sherbourne, C., Schoenbaum, M. et al. (2000). Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. Journal of the American Medical Association, 283, 212–20.
Wykurz, G. & Kelly, D. (2002). Developing the role of patients as teachers: literature review. British Medical Journal, 325, 818–23.
Zygmunt, A., Olfson, M., Boyer, C. A. & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159, 1653–64.

Reference Title: REFERENCES

Reference Type: reference-list

Adams, P. B., Lawson, S., Sanigorski, A. & Sinclair, A. J. (1996). Arachidonic to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 31 (suppl.), 157–61.
Allen, J. J. B., Schnyer, R. N. & Hitt, S. K. (1998). The efficacy of acupuncture in the treatment of major depression in women. Psychological Science, 9, 397–401.
Astin, J. A. Why patients use alternative medicine. Journal of the American Medical Association, 279, 1548–53.
Avants, S. K., Margolin, A., Holford, T. R. & Kosten, T. R. (2000). A randomized controlled trial of auricular acupuncture for cocaine dependence. Archives of Internal Medicine, 160, 2305–12.
Babcock, T., Helton, W. S. & Espat, N. J. (2000). Eicosapentaenoic acid (EPA): an anti-inflammatory − 3 fat with potential clinical applications. Nutrition, 16, 1116–18.
Becker-Carus, C., Heyden, T. & Kelle, A. (1985). Die Wirksamkeit von Akupunktur und Einstellungs-Entspannungstraining zur Behandlung primarer Schlafstorungen. Zeitschrift für Klinische Psychologie und Psychopathologie, 33, 161–72.
Bell, K. M., Potkin, S. G., Carreon, D. & Plon, L. (1994). S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurologica Scandinavica, Suppl. 154, 15–18.
Berg, B. J., Volpicelli, J. R., Alterman, A. I. & O'Brien, C. P. (1991). The relationship between endogenous opioids and alcohol drinking: the opioid compensation hypothesis. In Novel Pharmacological Interventions for Alcoholism, ed. C. A. Naranjo & E. M. Sellars. New York: Springer-Verlag.
Biber, A., Fischer, H., Romer, A. & Chatterjee, C. C. (1998). Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry, 31(Suppl.), 36–43.
Bilia, A. R., Bergonzi, M. C., Morgenni, F., Mazzi, G. & Vincieri, F. F. (2001). Evaluation of chemical stability of St. John's wort commercial extract and some preparations. International Journal of Pharmaceuticals, 213, 199–208.
Bisset, N. G. & Wichtl, M. (ed.) (1994). Valerianae radix. In Herbal Drugs and Phytopharmaceuticals, pp. 513–16. Stuttgart: Medpharm GmbH Scientific Publishers.
Bladt, S. & Wagner, H. (1994). Inhibition of MAO by fractions and constituents of hypericum extract. Journal of Geriatric Psychiatry and Neurology, 7(Suppl. 1), S57–9.
Blumenthal, M. (2002). Kava safety questioned due to case reports of liver toxicity. HerbalGram, 55, 26–32.
Bombardelli, E. & Morazzoni, P. (1995). Hypericum perforatum. Fitoterapia, 66, 43–68.
Bottiglieri, T. & Hyland, K. (1994). S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurologica Scandinavica, Suppl. 154, 19–26.
Bove, G. M. (1998). Acute neuropathy after exposure to sun in a patient treated with St. John's wort. Lancet, 352, 1121–2 (Letter).
Bressa, G. M. (1994). S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurologica Scandinavica, Suppl. 154, 7–14.
Brockmöller, J., Reum, T., Bauer, S., Kerb, R., Hübner, W.-D. & Roots, I. (1997). Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry, 30 (Suppl.), 94–101.
Bruinsma, K. A. & Taren, D. L. (2000). Dieting, essential fatty acid intake, and depression. Nutrition Review, 58, 98–108.
Budzinski, J. W., Foster, B. C., Vandenhoek, S. & Arnason, J. T. (2000). An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine, 7, 273–82.
Buguet, A., Sartre, M. & LeKerneau, J. (1995). Continuous nocturnal automassage of an acupuncture point modifies sleep in healthy subjects. Neurophysiologie Clinique, 25, 78–83.
Bullock, M. L., Culliton, P. D. & Olander, R. T. (1989). Controlled trial of acupuncture for severe recidivist alcoholism. Lancet, 8652, 1435–9.
Bullock, M. L., Kiresuk, T. J., Pheley, A. M. et al. (1999). Auricular acupuncture in the treatment of cocaine abuse. Journal of Substance Abuse and Treatment, 16, 31–8.
Butterweck, V., Nahrstedt, A., Evans, J. (2002). In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs. Psychopharmacology, 162, 193–202.
Butterweck, V., Christoffel, V., Nahrstedt, A., Petereit, F., Spengler, B. & Winterhoff, H. (2003). Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Life Science, 73, 627–39.
Calder, P. C. (1997). n-3 polyunsaturated fatty acids and cytokine production in health and disease. Annals of Nutrition and Metabolism, 41, 203–34.
Cantoni, G. L. (1953). S-Adenosylmethionine: a new intermediate formed enzymatically from L-methionine and adenosine-triphosphate. Journal of Biological Chemistry, 204, 403–16.
Cawte, J. (1985).Psychoactive substances of the south seas: betel, kava and pituri. Australia and New Zealand Journal of Psychiatry, 19, 83–7.
Chatterjee, S. S., Nšldner, M., Koch, E. & Erdelmeier, C. (1998). Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry, 31 (Suppl.), 7–15.
Chavez, M. L. & Chavez, P. I. (1997). Saint John's wort. Hospital Pharmacy, 32, 1621–32.
Chen, M. L., Lin, L. C., Wu, S. C. & Lin, J. G. (1999). Effectiveness of acupressure in improving the quality of sleep of institutionalised residents. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 54A, M389–94.
Chan, T. Y. K. (1998). An assessment of the delayed effects associated with valerian overdose. International Journal of Clinical Pharmacology and Therapy, 36, 569 (letter).
Clement-Jones, V., McLoughlin, L., Lowry, P. J., Besser, G. M., Rees, L. H. & Wen, H. L. (1979). Acupuncture in heroin addicts; changes in Met-enkephalin and beta-endorphin in blood and cerebrospinal fluid. Lancet, 2 (8139), 380–3.
Cott, J. M. (1997). In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry, 30 (Suppl.), 108–12.
Culliton, P. D., Boucher, T. A. & Carlson, G. A. (1997). Substance misuse. In Mind-Body Medicine. A Clinicians's Guide to Psychoneuroimmunology, ed. A. Watkins, pp. 221–50. Churchill Livingstone, Edinburgh.
Dannawi, M. (2002). Possible serotonin syndrome after combination of buspirone and St. John's wort. Journal of Psychopharmacology, 16, 401 (Letter).
De Los Reyes, G. C. & Koda, R. T. (2002). Determining hyperforin and hypericin content in eight brands of St. John's wort. American Journal of Health Systems and Pharmacy, 59, 545–7.
Delion, S., Chalon, S., Herault, J., Fuilloteau, D., Besnard, J. C. & Durand, G. (1994). Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats. Journal of Nutrition, 124, 2466–75.
Dello Buono, M., Urciuoli, O., Marietta, P., Padoani, W. & De Leo, D. (2001). Alternative medicine in a sample of 655 community-dwelling elderly. Journal of Psychosomatic Research, 50, 147–54.
Duffield, A. M., Jamieson, D. D., Lidgard, R. O., Duffield, P. H. & Bourne, D. J. (1989). Identification of some human urinary metabolites of the intoxicating beverage kava. Journal of Chromatography, 475, 273–81.
Durr, D., Stieger, B., Kullak-Ublick, G. A. et al. (2000). St. John's wort induces intestinal p-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clinical Pharmacology and Therapeutics, 68, 598–604.
Eich, H., Agelink, M. W., Lehmann, E., Lemmer, W. & Klieser, E. (2000). Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study. Fortschritte des Neurologie-Psychiatrie, 68, 137–44.
Eisenberg, D. M., Davis, R. B. & Ettner, S. L. (1998). Trends in alternative medicine use in the United States. Journal of the American Medical Association, 280, 246–52.
Ernst, E. (2001). The Desktop Guide to Complementary and Alternative Medicine. Edinburgh: Mosby.
Ernst, E. (1997). Acupuncture as a symptomatic treatment of osteoarthritis. A systematic review. Scandinavian Journal of Rheumatology, 26, 444–7.
Ernst, E. & White, A. R. (1998). Acupuncture for back pain. A meta-analysis of randomized controlled trials. Archives of Internal Medicine, 158, 2235–41.
Fava, M., Alpert, J., Nierenberg, A. A. et al. (2005). A double-blind, randomized trial of St. John's wort, fluoxetine, and placebo in major depressive disorder. Journal of Clinical Psychopharmacology, 25, 441–7.
Fetrow, C. W. & Avila, J. R. (2001). Efficacy of the dietary supplement S-adenosyl-L-methionine. Annals of Pharmacotherapy, 35, 1414–25.
Foster, S. & Tyler, V. E. (1999). Tyler's Honest Herbal. A Sensible Guide to the Use of Herbs and Related Remedies, 4th edn. New York: Hayworth Herbal Press.
Fox, E. J. & Melzack, R. (1976). Transcutaneous electrical stimulation of acupuncture; comparison of treatment for low back pain. Pain, 2, 141–8.
Frangou, S., Lewis, M. & McCrone, P. (2006). Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. British Journal of Psychiatry, 188, 46–50.
Friedel, H. A., Goa, Kl. & Benfield, P. (1989). S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs, 38, 389–416.
Garges, H. P., Varia, I. & Doraiswamy, P. M. (1998). Cardiac complications and delirium associated with valerian root withdrawal. Journal of the American Medical Association, 280, 1566–7 (letter).
Gaster, B. & Holroyd, J. (2000). St. John's wort for depression. Archives of Internal Medicine, 160, 152–6.
Glass, J. R., Sproule, B. A., Herrmann, N., Streiner, D. & Busto, U. E. (2003). Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects. Journal of Clinical Psychopharmacology, 23, 260–8.
Han, J. S. & Terenius, L. (1982). Neurochemical basis of acupuncture analgesia. Annual Review of Pharmacology and Toxicology, 22, 193–220.
Han, J. S. (1986). Electroacupuncture: an alternative to antidepressants for treating affective diseases? International Journal of Neuroscience, 29, 79–92.
Center for Disease Control (2002). Hepatic toxicity possibly associated with kava-containing products–United States, Germany, and Switzerland, 1999–2002. Morbidity and Mortality Weekly Report, 51, 1065–7.
Hibbeln, J. R. (1998). Fish consumption and major depression. Lancet, 351, 1213 (letter).
Horrocks, L. A. & Yeo, Y. K. (1999). Health benefits of docosahexanoic acid (DHA). Pharmacological Research, 40, 211–25.
Houghton, P. J. (1999). The scientific basis for the reputed activity of valerian. Journal of Pharmaceutical Pharmacology, 51, 505–12.
House of Lords Select Committee on Science and Technology (2000). 6th Report, Session 1999–2000. Complementary and Alternative Medicine. London: House of Lords.
Hypericum Depression Trial Study Group (2002). Effect of Hypericum perforatum (St. John's wort) in major depressive disorder. A randomized controlled trial. Journal of the American Medical Association, 287, 1807–14.
Jacobson, J. M., Feinman, L., Liebes, L. et al. (2001). Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrobial Agents and Chemotherapy, 45, 517–24.
Jensen, A. G., Hansen, S. H. & Nielsen, E. (2001). Adhyperforin as a contributor to the effect of Hypericum performaturm L. in biochemical models of antidepressant activity. Life Science, 68, 1593–605.
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E. & Mitchell, A. A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States. Journal of the American Medical Association, 287, 337–44.
Kelley, D. S., Taylor, P. C., Nelson, G. J. et al. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids, 34, 317–24.
Kosten, T. R., Kreck, M. J., Ragunath, J. & Kleber, H. B. (1986). A preliminary study of beta-endorphin during chronic naltrexon maintenance treatment in ex-opiate addicts. Life Science, 31, 55–9.
Lewith, G. T. & Lewith, N. R. (1980). Modern Chinese Acupuncture. Wellingborough, UK: Thorsons Publishers.
Lewith, G. T. & Kenyon, J. N. (1984). Physiological and psychological explanations for the mechanism of acupuncture as a treatment for chronic pain. Social Science and Medicine, 19, 1367–78.
Lewith, G. T. & Vincent, C. (1995). The evaluation of the clinical effects of acupuncture. A problem reassessed and a framework for future research. Pain Forum, 4, 29–39.
Linde, K. & Jonas, W. B. (1998). Meta-analysis of homoeopathy trials. Lancet, 351, 367–8.
Linde, K. & Mulrow, C. D. (2004). St. John's wort for depression. Cochrane Systematic Database of Reviews, 3. Oxford: Update Software Ltd.
Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W. & Melchart, D. (1996). St. John's wort for depression – an overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 253–8.
Linde, K., Berner, M., Egger, M. & Mulrow, C. (2005). St. John's wort for depression. Meta-analysis of randomised controlled trials. British Journal of Psychiatry, 186, 11–17.
Luo, H., Jia, Y., Wu, X. & Dai, W. (1990). Electro-acupuncture in the treatment of depressive psychosis. International Journal of Clinical Acupuncture, 1, 7–13.
Luo, H., Jia, Y. & Zhan, L. (1985). Electro-acupuncture vs amitriptyline in the treatment of depressive states. Journal of Traditional Chinese Medicine, 5, 3–8.
MacLennan, A. H., Wilson, D. H. & Taylor, A. W. (1996). Prevalence and cost of alternative medicine in Australia. Lancet, 347, 569–73.
MacPherson, H., Thomas, K., Walters, S. & Fitter, M. (2001). The York acupuncture safety study: prospective survey of 34000 treatments by traditional acupuncturists. British Medical Journal, 323, 486–7.
Maes, M. & Meltzer, H. Y. M. (1995). The serotonin hypothesis of major depression. In Psychopharmacology, The Fourth Generation of Progress, ed. F. E. Bloom & D. J. Kupfer, pp. 933–41. New York: Raven Press.
Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H. & Meltzer, H. Y. (1999). Lowered 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research, 85, 275–91.
Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R. & Meltzer, H. Y. (1996). Fatty acid composition in major depression: decreased 3 fractions in cholesteryl esters and increased C20:46/C20:53 ratio in cholesteryl esters and phospholipids. Journal of Affective Disease, 38, 35–46.
Marangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F. S. & Puryear, L. J. (2003). A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Archives of General Psychiatry, 160, 996–8.
Melzack, R. & Wall, P. D. (1965). Pain mechanisms, a new theory. Science, 150, 971–9.
Meydani, S. N., Endres, S., Woods, M. M. et al. (1991). Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation; comparison between young and older women. Journal of Nutrition, 121, 547–55.
Meydani, S. N., Lichtenstein, A. H., Cornwall, S. et al. (1993). Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. Journal of Clinical Investigation, 92, 105–13.
Montakab, H. (1999). Acupuncture and insomnia. Forsch Komplementarmed, 1 (Suppl.), 29–31.
Morris, C. A. & Avorn, J. (2003). Internet marketing of herbal products. Journal of the American Medical Association, 290, 1505–9.
Moses, E. L. & Mallinger, A. G. (2000). St. John's wort: three cases of possible mania induction. Journal of Clinical Psychopharmacology, 20, 115–17 (Letter).
Natural Medicines Comprehensive Database. Kava (2004). http://www.naturaldatabase.com/monograph.
Natural Medicines Comprehensive Database. SAMe (2004). http://www.naturaldatabase.com/monograph.
Natural Medicines Comprehensive Database. St. John's wort (2004). http://www.naturaldatabase.com/monograph.
Natural Medicines Comprehensive Database. Valerian (2004). http://www.naturaldatabase.com/monograph.
Norton, S. A. & Ruze, P. (1994). Kava dermopathy. Journal of the American Academy of Dermatology, 31, 89–97.
O'Breasail, A. M. & Argouarch, S. (1998). Hypomania and St. John's wort. Canadian Journal of Psychiatry, 43, 746–7 (Letter).
Patel, S., Robinson, R. & Burk, M. (2002). Hypertensive crisis associated with St. John's wort. American Journal of Medicine, 112, 507–8 (Letter).
Peet, M. & Horrobin, D. F. (2002). A dose-ranging study of the effects of ethyl-eicosapentanoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry, 59, 913–19.
Pepping, J. (1999a). Kava: Piper methysticum. American Journal of Health-System Pharmacy, 56, 957–60.
Pepping, J. (1999b). Omega-3 essential fatty acids. American Journal of Health-System Pharmacy, 56, 719–24.
Pittler, M. H. & Ernst, E. (2003). Kava extract for treating anxiety (Cochrane Review). In The Cochrane Library, Issue 4. Chichester: John Wiley & Sons.
Plushner, S. L. (2000). Valerian: Valeriana officinalis. American Journal of Health-System Pharmacy, 57, 328–35.
Pomeranz, B. & Chiu, D. (1976). Naloxone blocks acupuncture analgesia and causes hyperalgesia: endorphin is implicated. Life Science, 19, 1757–62.
Review of Natural Products, efacts. Kava, 2003. http://efactsweb.com.
Review of Natural Products, efacts. St. John's wort, 2000. http://efactsweb.com.
Richard, A. J., Montoya, I. D., Nelson, R. & Spencer, R. T. (1995). Effectiveness of adjunct therapies in crack cocaine treatment. Journal of Substance Abuse Treatment, 12, 401–13.
Roschke, J., Wolf, C., Muller, M. J. et al. (2000). The benefit from whole body acupuncture in major depression. Journal of Affective Disorders, 57, 73–81.
Roy, R., Tiller, W. A., Bell, I. & Hoover, M. R. (2005). The structure of liquid water; novel insights from materials research; potential relevance to homeopathy. Materials Research and Innovations, 9, 93–124.
Russman, S., Lauterburg, B. H. & Helbling, A. (2001). Kava hepatotoxicity. Annals of Internal Medicine, 135, 68–9 (letter).
Ruze, P. (1990). Kava-induced dermopathy: a niacin deficiency? Lancet, 335, 1442–5.
Schwartz, M., Saitz, R., Mulvey, K. et al. (1999). The value of acupuncture detoxification programs in a substance abuse treatment system. Journal of Substance Abuse Treatment, 17, 305–12.
Schaffer, D. M., Gordon, N. P., Jensen, C. D. & Avins, A. L. (2003). Nonvitamin, nonmineral supplement use over a 12-month period by adult members of a large health maintenance organization. Journal of the American Dietetic Association, 103, 1500–5.
Shelton, R. C., Keller, M. B., Gelenberg, A. et al. (2001). Effectiveness of St. John's wort in major depression, a randomized controlled trial. Journal of the American Medical Association, 285, 1978–86.
Singer, A., Wonnemann, M. & Müller, W. E. (1999). Hyperforin, a major antidepressant constituent of St. John's wort, inhibits serotonin uptake by elevating free intracellular Na+. Journal of Pharmacology and Experimental and Therapeutics, 290, 1363–8.
Sirvent, T. M., Walker, L., Vance, N. & Gibson, D. M. (2002). Variation in hypericins from wild populations of Hypericum perforatum L. in the Pacific northwest of the U.S.A. Economic Botany, 56, 41–8.
Staffeldt, B., Kerb, R., Brockmüller, J., Ploch, M. & Roots, I. (1994). Pharmacokinetics of hypericin and pseudohypericin after oral intake of the Hypericum perforatum extract LI 160 in healthy volunteers. Journal of Geriatric Psychiatry and Neurology, 7 (Suppl. 1), S47–53.
Steiner, R. P., May, D. L. & Davis, A. W. (1982). Acupuncture therapy for the treatment of tobacco smoking addiction. American Journal of Chinese Medicine, 10, 107–21.
Stevinson, C. & Ernst, E. (2000). Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine, 1, 91–9.
Stevinson, C., Huntley, A. & Ernst, E. (2002). A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety, 25, 251–61.
Stoll, A. L., Severus, W. E., Freeman, M. P. et al. (1999). Omega 3 fatty acids in bipolar disorder. A preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 407–12.
Strahl, S., Ehret, V., Dahm, H. H. & Maier, K. P. (1998). Necrotizing hepatitis after taking herbal remedies (in Dutch). Deutsche Medizinische Wochenschrift, 123, 1410–14.
Stramentinoli, G., Gualano, M. & Galli-Kienle, M. (1979). Intestinal absorption of S-adenosyl-L-methionine. Journal of Pharmacology Experimental Therapeutics, 209, 323–6.
Stramentinoli, G. (1987). Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics. American Journal of Medicine, 83, 35–42.
Su, K.-P., Huang, S.-Y., Chiu, C.-C. & Shen, W. W. (2003). Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Journal of Neuropsychopharmacology, 13, 267–71.
Thiede, H. M. & Walper, A. (1994). Inhibition of MAO and COMT by hypericum extracts and hypericin. Journal of Geriatric Psychiatry and Neurology, 7 (Suppl. 1), S54–6.
Travell, J. & Rinzler, S. H. (1946). Relief of cardiac pain by local block of somatic trigger areas. Proceedings of the Society of Experimental and Biological Medicine, 63, 480–2.
Van Tulder, M. W., Cherkin, D. C., Berman, B., Lao, L. & Koes, B. V. (1999). Acupuncture for low back pain. Cochrane Database of Systematic Reviews. Oxford: Update Software Ltd.
Vickers, A. J. (1996). Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. Journal of the Royal Society of Medicine, 89, 303–11.
Washburn, A. M., Fullilove, R. E., Fullilove, M. T. et al. (1993). Acupuncture heroin detoxification: a single-blind clinical trial. Journal of Substance Abuse Treatment, 10, 345–51.
Wells, E. A., Jackson, R., Dias, O. R. et al. (1995). Acupuncture as an adjunct to methadone treatment services. American Journal of Addiction, 4, 169–214.
Wen, H. & Cheung, S. (1973). Treatment of drug addiction by acupuncture and electrical stimulation. Asian Journal of Medicine, 9, 138–41.
Wen, H. & Teo, S. (1975). Experience in the treatment of drug addiction by electro-acupuncture. Modern Medicine in Asia, 11, 23–4.
Wheatley, D. (2001). Kava and valerian in the treatment of stress-induced insomnia. Phytotherapy Research, 15, 549–51.
Whiskey, E., Werneke, U. & Taylor, D. (2001). A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. International Journal of Clinical Psychopharmacology, 16, 239–52.
White, A. R., Rampes, H. & Ernst, E. (2002). Acupuncture for smoking cessation. Cochrane Database of Systematic Reviews, 4. Chichester: John Wiley & Sons Ltd.
White, P., Lewith, G. T., Berman, B. & Birch, S. (2002). Reviews of acupuncture for chronic neck pain: pitfalls in conducting systematic reviews. Rheumatology, 41, 1224–31.
Woelk, H., Burkard, G. & Grunwald, J. (1994). Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients. Journal of Geriatric Psychiatry and Neurology, 7 (Suppl. 1), S34–8.
Yang, X. (1994). Clinical observation on needling extra channel points in treatment of mental depression. Journal of Traditional Chinese Medicine, 14, 14–18.
Zullino, D. & Borgeat, F. (2003). Hypertension induced by St. John's wort. Pharmacopsychiatry, 36, 32 (Letter).

Reference Title: REFERENCES

Reference Type: reference-list

Barton, R. (1959). Institutional Neurosis. Bristol: John Wright.
Bass, J., Neugebauer, R., Clougherty, K. F. et al. (2006). Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. British Journal of Psychiatry, 188, 567–73.
Bierer, J. (1959). Theory and practice of psychiatric day hospitals. Lancet, 2, 901–2.
Bindman, J., Beck, A., Glover, G. et al. (1999). Evaluating mental health policy in England – Care Programme Approach and supervision registers. British Journal of Psychiatry, 175, 327–30.
Bolton, P., Bass, J., Neugebauer, R. et al. (2003). Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. Journal of the American Medical Association, 289, 3117–24.
Burns, T., Creed, F., Fahy, T., Thompson, S., Tyrer, P. & White, I. (1999). Intensive versus standard case management for severe psychotic illness: a randomised trial. Lancet, 353, 2185–9.
Burns, T., Fioritti, A., Holloway, F., Malm, U. & Rössler, W. (2001). Case management and assertive community treatment in Europe. Psychiatric Services, 52, 631–6.
Campbell, M., Fitzpatrick, R., Haines, A., Sandercock, P., Spiegelhalter, D. & Tyrer, P. (2000). A framework for the design and evaluation of complex interventions to improve health. British Medical Journal, 321, 694–6.
Cameron, D. E. (1947). The day hospital. Modern Hospital, 69, 60–2.
Caplan, G. (1951). A public-health approach to child psychiatry: an introductory account of an experiment. Mental Hygiene, 35, 235–49.
Caplan, G. (1980). An approach to preventive intervention in child psychiatry. Canadian Journal of Psychiatry, 25, 671–82.
Carr, V. J., Lewin, T. J., Reid, A. L. A., Walton, J. M. & Faehrmann, C. (1997). An evaluation of the effectiveness of a consultation-liaison psychiatry service in general practice. Australian and New Zealand Journal of Psychiatry, 31, 714–25.
Cook, C. (2004). Oral history: Sir Richard Doll. Journal of Public Health, 26, 327–36.
Dixon, L. & Goldman, H. (2004). Forty years of progress in community mental health: the role of evidence-based practices. Administration and Policy in Mental Health, 31, 381–92.
Early, D. F. (1975). Sheltered groups in open industry. A new approach to training and to employment. Lancet, i, 1370–3.
Emmanuel, J. S., McGee, A., Ukoumunne, O. C. & Tyrer, P. (2002). A randomised controlled trial of enhanced key-worker liaison psychiatry in general practice. Social Psychiatry and Psychiatric Epidemiology, 37, 261–6.
Farrar, S., Kates, N., Crustolo, A. M. & Nikolaou, L. (2001). Integrated model for mental health care – are health care providers satisfied with it? Canadian Family Physician, 47, 2483–8.
Fiander, M., Burns, T., McHugo, G. J. & Drake, R. E. (2003). Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA. British Journal of Psychiatry, 182, 248–54.
Gask, L., Sibbald, B. & Creed, F. (1997). Evaluating models of working at the interface between mental health services and primary care. British Journal of Psychiatry, 170, 6–11.
Geddes, J. & Goodwin, G. (2001). Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials. British Journal of Psychiatry, 178, 191–4.
Glover, G., Arts, G. & Suresh Babu, K. (2006). Crisis resolution/home treatment teams and psychiatric admission rates in England. British Journal of Psychiatry, 189, 441–5.
Goffman, E. (1961) Asylums. New York: Doubleday.
Goldberg, D., Jackson, G., Gater, R., Campbell, M. & Jennett, N. (1996). The treatment of common mental disorders by a community team based in primary care: a cost effectiveness study. Psychological Medicine, 26, 487–92.
Goldman, H. H., Regier, D. A., Taube, C. A., Redick, R. W. & Bass, R. D. (1980). Community mental health centers and the treatment of severe mental disorder. American Journal of Psychiatry, 137, 83–6.
Haigh, R. (1999). The quintessence of a therapeutic environment: five universal qualities. In Therapeutic Communities: Past, Present and future, ed. P. Campbell & R. Haigh, pp. 246–57. London: Jessica Kingsley.
Harrison-Read, P., Lucas, B., Tyrer, P. (2002). Heavy users of acute psychiatric beds: randomised controlled trial of enhanced community management in an outer London borough. Psychological Medicine, 32, 413–26.
Hassiotis, A., Ukoumunne, O. C., Byford, S. et al. (2001). Intellectual functioning and outcome of patients with severe psychotic illness randomised to intensive case management: report from the UK700 case management trial. British Journal of Psychiatry, 178, 166–71.
Holloway, F. & Carson, J. (1998). Intensive case management for the severely mentally ill: controlled trial. British Journal of Psychiatry, 172, 19–22.
Hoult, J. (1986) Community care of the acutely mentally ill. British Journal of Psychiatry, 149, 137–44.
Hoult, J., Reynolds, I., Charbonneau-Powis, M., Weekes, P. & Briggs, J. (1983). Psychiatric hospital versus community treatment: the results of a randomised trial. Australian and New Zealand Journal of Psychiatry, 17, 160–7.
Issakidis, C., Sanderson, K., Teesson, M., Johnston, S. & Buhrich, N. (1999). Intensive case management in Australia: a randomized controlled trial. Acta Psychiatrica Scandinavica, 99, 360–7.
Jackson, G., Gater, R., Goldberg, D., Tantam, D., Loftus, L. & Taylor, H. (1993). A new community mental health team based in primary care: a description of the service and the effect on service use in the first year. British Journal of Psychiatry, 162, 375–84.
Johnson, S., Nolan, F., Pilling, S. (2005). Randomised controlled trial of acute mental health care by a specialist crisis team: the north Islington crisis study. British Medical Journal, 331, 599–602.
Kidd, H. B. (1965). Industrial units in psychiatric hospitals. British Journal of Psychiatry, 111, 1205–9.
Killaspy, H., Bebbington, P., Blizard, R. et al. (2006). The REACT study: randomised evaluation of assertive community treatment in north London. British Medical Journal, 332, 815–20.
King, R. (2006). Intensive case management: a critical re-appraisal of the scientific evidence for effectiveness. Administration and Policy in Mental Health, 33, 529–35.
Lamont, A., Ukoumunne, O., Tyrer, P. et al. (2000). The geographic mobility of severely mentally ill residents in London. Social Psychiatry and Psychiatric Epidemiology, 35, 164–9.
Marshall, M., Lockwood, A., Gray, A. & Green, R. (1997). Assertive community treatment. Schizophrenia Module of the Cochrane Database of Systematic Reviews. Oxford: Update Software Ltd.
Marshall, M. & Creed, F. (2000). Assertive community treatment – is it the future of community care in the UK? International Review of Psychiatry, 12, 191–6.
Marshall, M., Crowther, R., Almaraz-Serrano, A. M. & Tyrer, P. (2001a). Day hospital versus out-patient care for psychiatric disorders. Cochrane Database of Systematic Reviews, 3, CD003240. Oxford: Update Software Ltd.
Marshall, M., Crowther, R., Almaraz Serrano, A. et al. (2001b). Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Health Technology Assessment, 5, 1–75.
Marwaha, S. & Johnson, S. (2004). Schizophrenia and employment: a review. Social Psychiatry and Psychiatric Epidemiology, 39, 337–49.
Metcalfe, C., White, I. R., Weaver, T. et al. (2005). Intensive case management for severe psychotic illness: is there a general benefit for patients with complex needs? A secondary analysis of the UK700 trial data. Social Psychiatry and Psychiatric Epidemiology, 40, 718–24.
Morrisey, J. P. & Goldman, H. H. (1984). Cycles of reform in the care of the chronically mentally ill. Hospital and Community Psychiatry, 35, 785–93.
Ngoma, M. C., Prince, M. & Mann, A. (2003). Common mental disorders among those attending primary health clinics and traditional healers in urban Tanzania. British Journal of Psychiatry, 183, 349–55.
Nzimakwe, D. (1996). Primary health care in South Africa: private practice nurse practitioners and traditional healers form partnerships. Journal of Academic Nursing Practice, 8, 311–16.
Phelan, M., Slade, M., Thornicroft, G. et al. (1995). The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry, 167, 589–95.
Priebe, S., Jones, G., McCabe, R. et al. (2006) Effectiveness and costs of acute day hospital treatment compared with conventional in-patient care: randomised controlled trial. British Journal of Psychiatry, 188, 243–9.
Pullen, I. M. & Yellowlees, A. J. (1988). Scottish psychiatrists in primary health-care settings. a silent majority. British Journal of Psychiatry, 153, 663–6.
Puri, B. K., Hall, A. D., Reefat, R., Mayer, R. & Tyrer, P. (1996). General practitoners' views of an open referral system to a community mental health service. Acta Psychiatrica Scandinavica, 94, 133–6.
Resnick, S. G., Fontana, A., Lehman, A. F. & Rosenheck, R. A. (2005). An empirical conceptualization of the recovery orientation. Schizophrenia Research, 75, 119–28.
Rosie, J. S., Azim, H. F., Piper, W. E. & Joyce, A. S. (1995). Effective psychiatric day treatment: historical lessons. Psychiatric Services, 46, 1019–26.
Ruggeri, M., Leese, M., Thornicroft, G., Bisoffi, G. & Tansella, M. (2000). Definition and prevalence of severe and persistent mental illness. British Journal of Psychiatry, 177, 149–55.
Rutter, D. & Tyrer, P. (2003). The value of therapeutic communities in the treatment of personality disorder: a suitable place for treatment? Journal of Psychiatric Practice, 9, 291–302.
Schinnar, A. P., Rothbard, A. B., Kanter, R. & Jung, Y. S. (1990). An empirical literature review of definitions of severe and persistent mental illness. American Journal of Psychiatry, 147, 1602–8.
Schwarz, D. & Lellouch, J. (1967). Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases, 20, 637–48.
Shipley, K., Hilborn, B., Hansell, A., Tyrer, J. & Tyrer, P. (2000). Patient satisfaction: a valid measure of quality of care in a psychiatric service. Acta Psychiatrica Scandinavica, 101, 330–3.
Simmonds, S., Coid, J., Joseph, P., Marriott, S. & Tyrer, P. (2001). Community mental health team management in severe mental illness: a systematic review. British Journal of Psychiatry, 178, 497–502.
Slade, M., McCrone, P., Kuipers, E., Leese, M., Cahill, S. & Parabiaghi, A. (2006). Use of standardised outcome measures in adult mental health services: randomised controlled trial. British Journal of Psychiatry, 189, 330–6.
Stein, L. I. & Diamond, R. J. (1985). A program for difficult-to-treat patients. In New Directions for Mental Health Services, 26, ed. L. I. Stein & M. A. Test. San Francisco, CA: Jossey-Bass.
Stein, L. I. & Test, M. A. (1980). Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry, 37, 392–7.
Stein, L. I. & Santos, A. B. (1998). Assertive Community Treatment of Persons with Severe Mental Illness. London: WW Norton.
Stein, L. I. & Santos, A. B. (1998). Assertive Community Treatment of Persons with Severe Mental Illness. New York: Norton.
Strathdee, G. & Williams, P. (1984). A survey of psychiatrists in primary care: the silent growth of a new service. Journal of the Royal College of General Practitioners, 34, 615–18.
Tempest, M. (2006). The Future of the NHS. London: XPL Publishing.
Tooth, G. C. & Brooke, E. M. (1961). Trends in the mental hospital population and their effect on future planning. Lancet, i, 710–13.
Tyrer, P. (1999). What is the future of assertive community treatment? Epidemiologia e Psichiatrica Sociale, 8, 16–18.
Tyrer, P. (2007). The future of specialist community teams in the care of those with severe mental illness. Epidemiologia e Psichiatria Sociale, 16, 225–30.
Tyrer, P., Ferguson, B. & Wadsworth, J. (1990). Liaison psychiatry in general practice: the comprehensive collaborative model. Acta Psychiatrica Scandinavica, 81, 359–63.
Tyrer, P., Morgan, J., Van Horn, E. et al. (1995). A randomised controlled study of close monitoring of vulnerable psychiatric patients. Lancet, 345, 756–9.
Tyrer, P., Balod, A., Germanavicius, A., McDonald, A., Varadan, M. & Thomas, J. (2007). Perceptions of assertive community treatment in the UK and Lithuania. International Journal of Social Psychiatry (in press).
Ukoumunne, O. C., Gulliford, M. C., Chinn, S., Sterne, J. A. C., Burney, P. G. J. & Donner, A. (1999). Methods in health service research. Evaluation of health interventions at area and organisation level. British Medical Journal, 319, 376–9.
Weaver, T., Renton, A., Tyrer, P. & Ritchie, J. (1996). Combining qualitative data with randomised controlled trials is often useful. British Medical Journal, 313, 629.
Weisbrod, B. A., Test, M. A. & Stein, L. I. (1980). Alternatives to mental hospital treatment: II. Economic benefit-cost analysis. Archives of General Psychiatry, 37, 400–5.
Wells, J. S. (2006). Hospital-based industrial therapy units and the people who work within them – an Irish case analysis using a soft-systems approach. Journal of Psychiatric Mental Health Nursing, 13, 139–47.

Reference Title: REFERENCES

Reference Type: reference-list

Adams, F., Fernandez, F. & Andersson, B. (1986). Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics, 27 (Suppl. 1), 33–7.
Aizawa, K., Kanai, T., Saikawa, Y. et al. (2002). A novel approach to the prevention of post-operative delirium in the elderly after gastrointestinal surgery. Surgery Today, 32, 310–14.
Akechi, T., Uchitomi, Y., Okamura, H. et al. (1996). Usage of haloperidol for delirium in cancer patients. Support Care Cancer, 4, 390–2.
American Psychiatric Association (1999). Practice guideline for the treatment of patients with delirium. American Journal of Psychiatry, 156 (May suppl.), 1–20.
Bayindir, O., Akpinar, B., Can, E. et al. (2000). The use of 5-HT3 receptor antagonist ondansetron for the treatment of postcardiotomy delirium. Journal of Cardiothoracic and Vascular Anesthesia, 14, 288–92.
Blitzstein, S. M. & Brandt, G. T. (1997). Extrapyramidal symptoms from intravenous haloperidol in the treatment of delirium. American Journal of Psychiatry, 154, 1474–5.
Breitbart, W., Marotta, R., Platt, M. et al. (1996). A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. American Journal of Psychiatry, 153, 231–7.
Breitbart, W., Tremblay, A. & Gibson, C. (2002). An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics, 43, 175–82.
Britton, A. & Russell, R. (2004). Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment. Cochrane Database of Systematic Reviews, 2, CD000395.
Brown, T. M. & Boyle, M. F. (2002). Delirium. British Medical Journal, 325, 644–7.
Budd, S. & Brown, W. (1974). Effect of a reorientation technique on postcardiotomy delirium. Nursing Research, 23, 341–8.
Carnes, M., Howell, T., Rosenberg, M. et al. (2003). Physicians vary in approaches to the clinical management of delirium. Journal of the American Geriatrics Society, 51, 234–9.
Chatham, M. A. (1978). The effect of family involvement on patients' manifestations of postcardiotomy psychosis. Heart & Lung, 7, 995–9.
Cole, M. G. (2004). Delirium in elderly patients. American Journal of Geriatric Psychiatry, 12, 7–21.
Cole, M. G., Primeau, F. J., Bailey, R. F. et al. (1994). Systematic intervention for elderly inpatients with delirium: a randomized trial. Canadian Medical Association Journal, 151, 965–70.
Cole, M. G., McCusker, J., Bellavance, F. et al. (2002). Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trail. Canadian Medical Association Journal, 167, 753–9.
Coppen, A., Gupta, R., Montgomery, S. et al. (1976). Mianserin hydrochloride: a novel antidepressant. British Journal of Psychiatry, 129, 342–5.
Davis, J. M., Janicak, P. G., Sakkas, P. et al. (1991). Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Therapy, 7, 111–20.
Dudley, W. H. & Williams, J. G. (1972). Electroconvulsive therapy in delirium tremens. Comprehensive Psychiatry, 13, 357–60.
Dugovic, C. & Adrien, J. (1991). 5-HT receptors involved in sleep regulation. In Biological Psychiatry, Vol. 2, ed. G. K. Racagni, N. Brunllo & T. Fukuda, pp. 710–12. Amsterdam: Elsevier.
Fernandez, F. & Levy, J. K. (1989). Management of delirium in terminally ill AIDS patients. International Journal of Psychiatry in Medicine, 19, 165–72.
Fischer, P. (2001). Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor. Journal of Clinical Psychopharmacology, 21, 118.
Foreman, M. D., Mion, L. C., Tryostad, L. et al. (1999). Standard of practice protocol: acute confusion/delirium. Geriatric Nursing, 20, 147–52.
Gagnon, B., Low, G., Schreier, G. et al. (2005). Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. Journal of Psychiatry and Neuroscience, 30, 100–7.
Gustafson, Y., Brannstrom, B., Berggren, D. et al. (1991). A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures. Journal of the American Geriatrics Society, 39, 655–62.
Hales, R. E. & Yudofsky, S. C., ed. (2003). Textbook of Clinical Psychiatry. American Psychiatric Publishing Inc.
Han, C. & Kim, Y. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics, 45, 297–301.
Hanania, M. & Kitain, E. (2002). Melatonin for treatment and prevention of post-operative delirium. Anesthesia and Analgesia, 94, 338–9.
Horikawa, N., Yamazaki, T., Miyamoto, K. et al. (2003). Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. General Hospital Psychiatry, 25, 289–92.
Jacobi, J., Fraser, G. L., Coursin, D. B. et al. (2002). Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Critical Care Medicine, 30, 119–41.
Kalisvaart, C. J., Boelaarts, L., DeJonghe, J. F. et al. (2004). Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine. Nederlands Tijdschrift voor Geneeskunde, 148, 1501–4 (in Dutch).
Kim, K. Y., Bader, G. M., Kotlyar, V. et al. (2003). Treatment of delirium in older adults with quetiapine. Journal of Geriatric Psychiatry and Neurology, 16, 29–31.
Kim, K., Pae, C., Chae, J. et al. (2001). An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry and Clinical Neurosciences, 55, 515–19.
Leso, L. & Schwartz, T. L. (2002). Ziprasidone treatment of delirium. Psychosomatics, 43, 61–2.
Liu, C., Juang, Y., Liang, H. et al. (2004). Efficacy of risperidone in treating the hyperactive symptoms of delirium. International Clinical Psychopharmacology, 19, 165–8.
Marshall, R. J. (1983). The pharmacology of mianserin – an update. British Journal of Clinical Pharmacology, 15, 263S–8S.
Meagher, D. J., O'Hanlon, D., O'Mahoney, E. & Casey, P. R. (1996). The use of environmental strategies and psychotropic medication in the management of delirium. British Journal of Psychiatry, 168, 512–15.
Menza, M. A., Murray, G. B., Holmes, V. F. et al. (1987). Decreased extrapyramidal symptoms with intravenous haloperidol. Journal of Clinical Psychiatry, 48, 278–80.
Menza, M. A., Murray, G. B., Holmes, V. F. et al. (1988). Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart and Lung, 17, 238–41.
Meyers, B. J. & Van Ojen, R. L. (2004). The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness. Nederlands Tijdschrift voor Geneeskunde, 148, 1738–41 (in Dutch).
Milisen, K., Foreman, M. D., Abraham, I. L. et al. (2001). A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. Journal of the American Geriatrics Society, 49, 523–32.
Morita, T., Otani, H., Tsunoda, J. et al. (2000). Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer, 8, 134–7.
Moulaert, P. (1989). Treatment of nonspecific delirium with IV haloperidol in surgical intensive care patients. Acta Anaesthesiologica Belgica, 40, 183–6.
Nakamura, J., Uchimura, N. & Yamada, S. (1997a). Does plasma free-3-methoxy-4-hydroxyphenyl (ethylene) glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. International Clinical Psychopharmacology, 12, 147–52.
Nakamura, J., Uchimura, N., Yamada, S. et al. (1997b). Mianserin suppositories in the treatment of post-operative delirium. Human Psychopharmacology, 12, 595–9.
Okamoto, Y., Matsuoka, Y., Sasaki, T. et al. (1999). Trazodone in the treatment of delirium. Journal of Clinical Psychopharmacology, 19, 280–2.
Olofsson, S. M., Weitzner, M. A., Valentine, A. D. et al. (1996). A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer, 4, 351–7.
Parellada, E., Baeza, I., de Pablo, J. et al. (2004). Risperidone in the treatment of patients with delirium. Journal of Clinical Psychiatry, 65, 348–53.
Pinder, R. M. (1983). Antidepressants and α-adrenoreceptors. In Clinical Pharmacology in Psychiatry: Bridging the Experimental–Therapeutic Gap, ed. L. Gram, pp. 268–87. London: Macmillan.
Platt, M. M., Breitbart, W., Smith, M. et al. (1994). Efficacy of neuroleptics for hypoactive delirium. Journal of Neuropsychiatry, 6, 66–7.
Ravona-Springer, R., Ramit, M. D., Ornah, T. et al. (1998). Delirium in elderly patients treated with risperidone: a report of three cases. Journal of Clinical Psychopharmacology, 18, 171–2.
Resnick, M. & Burton, B. T. (1984). Droperidol vs. haloperidol in the initial management of acutely agitated patients. Journal of Clinical Psychiatry, 45, 298–9.
Riker, R. R., Fraser, G. L., Gilles, L. et al. (1997). Movement disorders associated with withdrawal from high-dose intravenous haloperidol therapy in delirious ICU patients. Chest, 111, 1778–81.
Robertson, B., Karlsson, I., Eriksson, L. et al. (1996). An atypical neuroleptic drug in the treatment of behavioural disturbances and psychotic symptoms in elderly people. Dementia, 7, 142–6.
Sanders, K. M., Stern, T. A., O'Gara, P. T. et al. (1992). Delirium during intra-aortic balloon pump therapy. Psychosomatics, 33, 35–44.
Sasaki, Y., Matsuyama, T., Inoue, S. et al. (2003). A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. Journal of Clinical Psychiatry, 64, 1316–21.
Scheftner, W. A. & Shulman, R. B. (1992). Treatment choice in neuroleptic malignant syndrome. Convulsive Therapy, 8, 267–79.
Schwartz, T. L. & Masand, P. S. (2000). Treatment of delirium with quetiapine. Primary Care Companion Journal of Clinical Psychiatry, 2, 10–12.
Seneff, M. G. & Mathews, R. A. (1995). Use of haloperidol infusions to control delirium in critically ill adults. Annals of Pharmacotherapy, 29, 690–3.
Sipahimalani, A., Sime, R. M. & Masand, P. S. (1997). Treatment of delirium with risperidone. International Journal of Geriatric Psychopharmacology, 1, 24–6.
Sipahimalani, A. & Masand, P. S. (1998). Olanzapine in the treatment of delirium. Psychosomatics, 39, 422–30.
Skrobik, Y. (2002). Haloperidol should be used sparingly. Critical Care Medicine, 30, 2613–14.
Skrobik, Y. K., Bergeron, N., Dumont, M. et al. (2004). Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Medicine, 30, 444–9.
Someya, T., Endo, Hara, T. et al. (2001). A survey on the drug therapy for delirium. Psychiatry and Clinical Neurosciences, 55, 397–401.
Stiefel, F., Fainsinger, R. & Bruera, E. (1992). Acute confusional states in patients with advanced cancer. Journal of Pain and Symptom Management, 7, 94–8.
Tauscher, J., Tauscher-Wisniewski, D. & Kasper, S. (2000). Treatment of patients with delirium. American Journal of Psychiatry, 157, 1711.
Tei, Y., Morita, T., Inoue, S. et al. (2004). Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient. Psychosomatics, 45, 450–1.
Thomas, H., Schwartz, E. & Petrilli, R. (1992). Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Annals of Emergency Medicine, 21, 407–13.
Trzepacz, P. T., Ho, V. & Mallavarapu, H. (1996). Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia. Psychosomatics, 37, 299–301.
Trzepacz, P. T. (2000). Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Seminars in Clinical Neuropsychiatry, 5, 132–48.
Uchiyama, M., Tanaka, K., Isse, K. et al. (1996). Efficacy of mianserin on symptoms of delirium in the aged: an open trial study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 20, 651–6.
Van der Mast, R. C. & Fekkes, D. (2000). Serotonin and amino acids: partners in delirium pathophysiology. Seminars in Clinical Neuropsychiatry, 5, 125–31.
Wengel, S. P., Roccaforte, W. H. & Burke, W. J. (1998). Donepezil improves symptoms of delirium in dementia: implications for future research. Journal of Geriatric Psychiatry and Neurology, 11, 159–61.
Wengel, S. P., Burke, W. J. & Roccaforte, W. H. (1999). Donepezil for post-operative delirium associated with Alzheimer's disease. Journal of the American Geriatric Society, 47, 379–80.
Williams, M. A., Campbell, E. B., Raynor, W. J. et al. (1985). Reducing acute confusional states in elderly patients with hip fractures. Research in Nursing and Health, 8, 329–37.
Young, C. C. & Lujan, E. (2004). Intravenous ziprasidone for treatment of delirium in the intensive care unit. Anesthesiology, 101, 794–5.

Reference Title: REFERENCES

Reference Type: reference-list

Affleck, J. W., Aitken, R. C. B., Hunter, J. A. A. et al. (1988). Rehabilitation status: a measure of medicosocial dysfunction. Lancet, I, 230–3.
Aitken, L., Simpson, S. & Burns, A. (1999). Personality change in dementia. International Psychogeriatrics, 11, 263–71.
Allen-Burge, R., Stevens, A. & Burgio, L. (1999). Effective behavioural interventions for decreasing dementia-related challenging behaviour in nursing homes. International Journal of Geriatric Psychiatry, 14, 213–28.
Allen, N. H., Gordon, S., Hope, T. & Burns, A. (1996). Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD). British Journal of Psychiatry, 169, 293–307.
Allman, P. (1992). Drug treatment of emotionalism following brain damage (letter). Journal of the Royal Society of Medicine, 85, 423–4.
Amella, E. (2004). Feeding and hydration issues for older adults with dementia. Nursing Clinics of North America, 39, 607–23.
American Geriatrics Society and American Association for Geriatric Psychiatry (2003). Consensus statement on improving the quality of mental health care in US nursing homes: management of depression and behavioural symptoms associated with dementia. Journal of the American Geriatric Society, 51, 1287–98.
American Psychiatric Association (1997). Practice Guidelines for the treatment of patients with Alzheimer's disease and other dementias of late life. American Journal of Psychiatry, 154, (suppl).
Ancill, R. J., Carlyle, W. W., Liang, R. A. & Holliday, S. G. (1991). Agitation in the demented elderly: a role for benzodiazepines? International Clinical Psychopharmacology, 6, 141–6.
Ancoli-Israel, S., Martin, J. L., Gehrman, P. et al. (2003). Effect of light on agitation in institutionalized patients with severe Alzheimer disease. American Journal of Geriatric Psychiatry, 11, 194–203.
Areosa, S. A., Sherriff, F. & McShane, R. (2005). Memantine for dementia. Cochrane Database of Systematic Reviews, CD003154. Oxford: Update Software Ltd.
Arnold, S. E. (1993). Estrogen for refractory aggression after traumatic brain injury. American Journal of Psychiatry, 150, 1564–5.
Aronson, M. K., Post, D. C. & Guastadisegni, P. (1993). Dementia, agitation, and care in the nursing home. Journal of the American Geriatric Society, 41, 507–12.
Ashton, D. (1993). Therapeutic work of reminiscence with the elderly. British Journal of Nursing, 2, 894–8.
Auchus, A. & Bissey-Black, C. (1997). Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 9, 591–3.
Azouvi, P., Jokic, C., Attal, N. et al. (1999). Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Injury, 13, 797–804.
Baines, S., Saxby, P. & Ehlert, K. (1987). Reality orientation and reminiscence therapy: a controlled cross-over study of elderly confused people. British Journal of Psychiatry, 151, 222–31.
Ballard, C., Margallo-Lana, M., Juszczak, E. et al. (2005). Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. British Medical Journal, 330, 874.
Ballard, C., Powell, I., James, I. et al. (2002). Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities. International Journal of Geriatric Psychiatry, 17, 140–5.
Baumgarten, M., Backer, P. & Gauthier, S. (1990). Validity and reliability of the Dementia Behaviour Disturbance Scale. Journal of the American Geriatric Society, 38, 221–6.
Beber, C. R. (1965). Management of behaviour in the institutionalized aged. Diseases of the Nervous System, 26, 591–5.
Beck, C., Vogelpohl, T., Rasin, J. et al. (2002). Effects of behavioural interventions on disruptive behaviour and affect in demented nursing home residents. Nursing Research, 51, 219–28.
Beck, A. T., Epstein, N., Harrision, R. P. & Emery, G. (1983). Development of the Sociotropy-Autonomy Scale: A Measure of Personality Factors in Psychopathology. Philadelphia: Center For Cognitive Therapy, University of Pennsylvania.
Behavioural and endocrinological evaluation of music therapy for elderly patients with dementia Nursing and Health Sciences (2004), 6, 11–18.
Bellus, S. B., Stewart, D., Vergo, J. G. et al. (1996). The use of lithium in the treatment of aggressive behaviours with two brain-injured individuals in a state psychiatric hospital. Brain Injury, 10, 849–60.
Berger, G. L., Bernhardt, T., Schramm, U. et al. (2004). No effects of a combination of caregivers support group and memory training/music therapy in dementia patients from a memory clinic population. International Journal of Geriatric Psychiatry, 19, 223–31.
Bird, M., Alexopoulos, P. & Adamowicz, J. (1995). Success and failure in five case studies: use of cued recall to ameliorate behaviour problems in senile dementia. International Journal of Geriatric Psychiatry, 20, 305–31.
Bird, M. J. (2000). Psychosocial rehabilitation for problems arising from cognitive deficits in dementia. In Cognitive Rehabilitation in Old Age, ed. R. D. Hill, L. Blackman & A. S. Neely, pp. 843–5. Oxford: Oxford University Press.
Birks, J. S. & Harvey, R. (2003). Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews, CD001190. Oxford: Update Software Ltd.
Bourgeois, S. & Vezina, J. (1998). L'extinction des comportements agressifs d'une personne agee souffrant de demence [Extinction for reducing aggressive behaviours in an older adult with dementia]. Revue Francophone de Clinique Comportementale et Cognitive, 2, 1–5.
Bourgeois, M. S., Burgio, L. D., Schulz, R., Beach, S. & Palmer, B. (1997). Modifying repetitive verbalizations of community-dwelling patients with AD. Gerontologist, 37, 30–9.
Brandt, J., Campodonico, J., Rich, J. et al. (1998). Adjustment to residential placement in Alzheimer's disease patients: does premorbid personality matter? International Journal of Geriatric Psychiatry, 13, 509–15.
Brink, C. (1980). Urinary continence/incontinence: Assessing the problem. Geriatric Nursing, 1, 241–5.
Britton, K. R. (1998). Medroxyprogesterone in the treatment of aggressive hypersexual behaviour in traumatic brain injury. Brain Injury, 12, 703–7.
Brodaty, H., Draper, B., Saab, D. et al. (2001). Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504–12.
Brodaty, H., Ames, D., Snowdon, J. et al. (2003). A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. Journal of Clinical Psychiatry, 64, 134–43.
Brook, P., Degun, G. & Mather, M. (1975). Reality orientation, a therapy for psychogeriatric patients: a controlled study. British Journal of Psychiatry, 127, 42–5.
Brooke, M. M., Patterson, D. R., Questad, K. A. et al. (1992). The treatment of agitation during initial hospitalization after traumatic brain injury. Archives of Physical Medical Rehabilitation, 73, 917–21.
Burgener, S., Bakas, T., Murray, C., Dunahee, J. & Tossey, S. (1998). Effective caregiving approaches for patients with Alzheimer's disease. Geriatric Nursing, 19, 121–6.
Burgio, L. (1996). Interventions for the behavioural complications of Alzheimer's disease: behavioural approaches. International Journal of Psychogeriatrics, 8 (Suppl. 1), 45–52.
Burgio, L. D., Scilley, K., Hardin, J. M. et al. (1994). Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation. Journal of Gerontology, 49, P230–9.
Burke, W. J., Dewan, V., Wengel, S. P., Roccaforte, W. H., Nadolny, G. C. & Folks, D. G. (1997). The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. International Journal of Geriatric Psychiatry, 12, 519–25.
Burke, W. J., Folks, D. G., Roccaforte, W. H. & Wengel, S. P. (1994). Serotonin reuptake inhibitors for the treatment of coexisting depression and psychosis in dementia of the Alzheimer type. American Journal of Geriatric Psychiatry, 2, 352–4.
Burns, A., Folstein, S., Brandt, J. & Folstein, M. (1990). Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. Journal of Nervous and Mental Disease, 178, 20–6.
Calvanio, R., Burke, D. T., Hyun Jung Kim et al. (2000). Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury. Brain Injury, 14, 933–42.
Camberg, L., Woods, P., Ooi, W. L. et al. (1999). Evaluation of simulated presence: a personalized approach to enhance well-being in persons with Alzheimer's disease. Journal of the American Geriatric Society, 47, 446–52.
Cantillon, M., Brunswick, R., Molina, D. & Bahro, M. (1996). Buspirone vs. haloperidol. A double-blind trial for agitation in a nursing home population with Alzheimer's disease. American Journal of Geriatric Psychiatry, 4, 263–7.
Carlson, D., Fleming, K., Smith, G. & Evans, J. (1995). Management of dementia-related behavioural disturbances: a nonpharmacologic approach. Mayo Clinic Proceedings, 70, 1108–15.
Carstensen, L. L. & Fremouw, W. J. (1981). The demonstration of a behavioural intervention for late life paranoia. Gerontologist, 21, 329–33.
Chan, W. C., Lam, L. C., Choy, C. N., Leung, V. P., Li, S. W. & Chiu, H. F. (2001). A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. International Journal of Geriatric Psychiatry, 16, 1156–62.
Chaterjee, A., Strauss, M., Smyth, K. & Whitehouse, P. (1992). Personality changes in Alzheimer's disease. Archives of Neurology, 49, 486–91.
Chatham Showalter, P. E. & Kimmel, D. N. (2000). Agitated symptom response to divalproax following acute brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 395–7.
Chatham Showalter, P. E. (1996). Carbamazepine for combativeness in acute traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 8, 96–9.
Chatham Showalter, P. E. & Netsky Kimmel, D. (2000). Stimulating consciousness and cognition following severe brain injury: a new potential clinical use for lamotrigine. Brain Injury, 14, 997–1001.
Chesrow, E., Kaplitz, S., Veltra, H. & Breme, J. (1965). Blind study of oxazepam in the management of geriatric patients with behavioural problems. Clinical Medicine, 71, 1001–5.
Cheston, R. (1998). Psychotherapy and dementia: a review of the literature. British Journal of Medical Psychology, 71, 211–31.
Christensen, D. B. & Benfield, W. R. (1998). Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. Journal of the American Geriatric Society, 46, 620–5.
Clare, L., Woods, R. T., Moniz Cook, E. D., Orrell, M. & Spector, A. (2003). Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews, CD003260. Oxford: Update Software Ltd.
Clark, M. E., Lipe, A. W. & Bilbrey, M. (1998). Use of music to decrease aggressive behaviours in people with dementia. Journal of Gerontology Nursing, 24, 10–17.
Coccaro, E. F., Kramer, E., Zemishlany, Z. et al. (1990). Pharmacologic treatment of noncognitive behavioural disturbances in elderly demented patients. American Journal of Psychiatry, 147, 1640–5.
Cohen, G. D. (1988). One psychiatrist's view. In Treatment for the AlzheimerPatient: The Long Haul, ed. L. Jarvik & C. Winograd, pp. 96–104. New York: Springer.
Cohen-Mansfield, J. (1986). Agitated behaviours in the elderly: II. Preliminary results in the cognitively deteriorated. Journal of the American Geriatric Society, 34, 722–7.
Cohen-Mansfield, J. & Billig, N. (1986). Agitated behaviours in the elderly: 1. A conceptual review. Journal of the American Geriatric Society, 34, 711–21.
Cohen-Mansfield, J. & Werner, P. (1997). Typology of disruptive vocalizations in older persons suffering from dementia. International Journal of Geriatric Psychiatry, 12, 1079–91.
Cohen-Mansfield, J., Werner, P. (1998a). Longitudinal changes in behavioural problems in old age: A study in an adult day care population. Journal of Gerontology, Biological Sciences, Medical Sciences, 53, M65–71.
Cohen-Mansfield, J. & Werner, P. (1998b). The effects of an enhanced environment on nursing home residents who pace. The Gerontologist, 38, 199–208.
Cohen-Mansfield, J., Marx, M. & Rosenthal, A. (1989). A description of agitation in the nursing home. Journal of Gerontology, 44, M77–84.
Cohen-Mansfield, J., Werner, P. & Marx M. S. (1990). Screaming in nursing home residents. Journal of the American Geriatric Society, 38, 785–92.
Cohen-Mansfield, J., Man, M. & Werner, P. (1992). Agitation in Elderly Persons: An Integrative Report of Findings in a Nursing Home. International Psychogeriatrics, 4 (Suppl.), 221–40.
Colenda, C., Cohen, W., McCall, W. & Rosenquist, P. (1997). Phototherapy for patients with Alzheimer's disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Disease and Associated Disorders, 11, 175–8.
Colenda, C. C. & Hamer, R. M. (1991). Antecedents and interventions for aggressive behaviour of patients at a geropsychiatric state hospital. Hospital and Community Psychiatry, 42, 287–92.
Cooper, A. J. (1987). Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. Journal of the Clinical Psychiatry, 48, 368–70.
Covington, J. S. (1975). Alleviating agitation, apprehension, and related symptoms in geriatric patients: a double-blind comparison of a phenothiazine and a benzodiazepine. South Medical Journal, 68, 719–24.
Craig, T. J. (1982). An epidemiologic study of problems associated with violence among psychiatric inpatients. American Journal of Psychiatry, 139, 1262–6.
Cummings, J. L., Street, J., Masterman, D. & Clark, W. S. (2002). Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders, 13, 67–73.
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. & Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308–14.
Cutler, N. R., Haxby, J., Kay, A. D. et al. (1985). Evaluation of zimeldine in Alzheimer's disease: cognitive and biochemical measures. Archives of Neurology, 42, 744–8.
Cuvo, A. J. (1976). Decreasing repetitive behaviour in an institutionalized mentally retarded resident. Mental Retardation, 24, 22–5.
De Deyn, P. P., Carrasco, M. M., Deberdt, W. et al. (2004). Olanzapine versus placebo in the treatment of psychosis with or without associated behavioural disturbances in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry, 19, 115–26.
De Deyn, P. P., Katz, I. R., Brodaty, H., Lyons, B., Greenspan, A. & Burns, A. (2005). Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clinical Neurology and Neurosurgery, 107, 497–508.
De Deyn, P. P., Rabheru, K., Rasmussen, A. et al. (1999). A randomized trial of risperidone, placebo, and haloperidol for behavioural symptoms of dementia. Neurology, 53, 946–55.
De Klerk-Rubin, V. (1995). A safe and friendly place to share feelings. Journal of Dementia Care, May/June, 22–24.
De Young, S., Just, G. & Harrison, R. (2002). Decreasing aggressive, agitated or disruptive behaviour: participation in a behaviour management unit. Journal of Gerontology Nursing, 28, 22–31.
Deb, S., Lyons I. & Koutzoukis, C. (1999a). Neurobehavioural symptoms one year after a head injury. British Journal of Psychiatry, 174, 360–5.
Deb, S., Lyons, I., Koutzoukis, C., Ali, I. & Mccarthy, G. (1999b). Rate of psychiatric illness one year after traumatic brain injury. American Journal of Psychiatry, 156, 374–8.
Dehlin, O., Hedenrud, B., Jansson, P. & Nörgård, J. (1985). A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatrica Scandinavica, 71, 190–6.
Den Boer, J. A., Bosker, F. J. & Slaap, B. R. (2000). Serotonergic drugs in the treatment of depressive and anxiety disorders. Human Psychopharmacology, 15, 315–36.
Denny, A. (1997). Quiet music: an intervention for mealtime agitation? Journal of Gerontology Nursing, 52A, M369–77.
Devanand, D., Jacobs, D., Tang, M. et al. (1997). The course of psychopathologic features in mild to moderate Alzheimer's disease. Archives of General Psychiatry, 54, 257–63.
Devereaux, M. (1997). The effects of individualized music on cognitively impaired nursing home residents exhibiting agitation Unpublished master's thesis. College of St. Catherine St. Paul MN.
Dikmen, S. S., Machamer, M. A., Winn, H. R. et al. (2000). Neuropsychological effects of valproate in traumatic brain injury: a randomised trial. Neurology, 54, 895–902.
Drachman, D. A., Swearer, J. M., O'Donnell, B. F., Mitchell, A. L. & Maloon, A. (1992). The Caretaker Obstreperous-Behavior Rating Assessment (COBRA) Scale. Journal of the American Geriatrics Society, 40, 463–70.
Dwyer, M. & Byrne, G. (2000). Disruptive vocalization and depression in older nursing home residents. International Psychogeriatrics, 12, 463–77.
Eames, P. & Liwood, R. (1999). Lysine vasopressin in post-traumatic memory disorders: an uncontrolled pilot study. Brain Injury, 13, 255–60.
Emroy, L. E., Cole, C. M. & Meyer, W. J. (1995). Use of depo-provera to control sexual aggression in persons with traumatic brain injury. Journal of Head Trauma Rehabilitation, 10, 47–58.
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S. & Damaraju, C. V. (2002). Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet, 359, 1283–90.
Erkinjuntti, T., Roman, G. & Gauthier, S. (2004). Treatment of vascular dementia – evidence from clinical trials with cholinesterase inhibitors. Journal of Neurological Science, 226, 63–6.
Evans, L. & Strumpf, N. (1989). Tying down the elderly: a review of the literature on physical restraint. Journal of the American Geriatrics Society, 37, 65–79.
Evans, R. W., Gualtieri, C. T. & Patterson, D. (1987). Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. Journal of Nervous and Mental Disorders, 175, 106–10.